<body><document>
<type>N-Q
<sequence>1
<filename>filing758.htm
<description>PRIMARY DOCUMENT
<text>


<div style="width:576px"><p style="margin:0px; font-size:12pt" align="center">UNITED STATES<br/>
SECURITIES AND EXCHANGE COMMISSION<br/>Washington, D.C. 20549</p>
<p style="margin:0px" align="center"><br/></p>
<p style="margin:0px; font-size:12pt" align="center"><b>FORM N-Q</b></p>
<p style="margin:0px; font-size:12pt" align="center"><b>QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED MANAGEMENT INVESTMENT COMPANY</b></p>
<p style="margin:0px" align="center"><br/></p>
<p style="margin:0px; font-size:12pt" align="center">Investment Company Act file number &#160;&#160;<u>811-3010</u></p>
<p style="margin:0px" align="center"><br/></p>
<p style="margin:0px; font-size:12pt" align="center"><u>Fidelity Advisor Series VII</u><br/> (Exact name of registrant as specified in charter)</p>
<p style="margin:0px" align="center"><br/></p>
<p style="margin:0px; font-size:12pt" align="center"><u>245 Summer St., Boston, Massachusetts &#160;02210</u><br/> (Address of principal executive offices) &#160; &#160; &#160; (Zip code)</p>
<p style="margin:0px" align="center"><br/></p>
<p style="margin:0px; font-size:12pt" align="center">Marc Bryant, Secretary</p>
<p style="margin:0px; font-size:12pt" align="center">245 Summer St.</p>
<p style="margin:0px; font-size:12pt" align="center"><u>Boston, Massachusetts &#160;02210</u><br/>(Name and address of agent for service)</p>
<p style="margin:0px" align="center"><br/></p>
<p style="margin:0px"><br/></p>
<p style="margin-top:0px; margin-bottom:-2px; width:336px; font-size:12pt; float:left">Registrant's telephone number, including area code:</p>
<p style="margin:0px; text-indent:-2px; font-size:12pt"><u>617-563-7000</u></p>
<p style="margin:0px; clear:left"><br/></p>
<p style="margin:0px"><br/></p>
<table style="margin-top:0px; font-size:10pt" cellpadding="0" cellspacing="0"><tr height="0" style="font-size:0"><td width="187.2"/><td width="264"/></tr>
<tr><td style="margin-top:0px" valign="top" width="187.2" height="19.333"><p style="margin:0px; font-size:12pt">Date of fiscal year end:</p>
</td><td style="margin-top:0px" valign="top" width="264" height="19.333"><p style="margin:0px; font-size:12pt">July 31</p>
</td></tr>
<tr><td style="margin-top:0px" valign="top" width="187.2" height="19.333"><p style="margin:0px"><br/></p>
</td><td style="margin-top:0px" valign="top" width="264" height="19.333"><p style="margin:0px"><br/></p>
</td></tr>
<tr><td style="margin-top:0px" valign="top" width="187.2" height="19.333"><p style="margin:0px; font-size:12pt">Date of reporting period:</p>
</td><td style="margin-top:0px" valign="top" width="264" height="19.333"><p style="margin:0px; font-size:12pt">April 30, 2016</p>
</td></tr>
</table>
<p style="margin:0px"><br/></p>
<p style="margin-top:0px; margin-bottom:-2px; width:96px; font-size:12pt; float:left">Item 1.</p>
<p style="margin:0px; text-indent:-2px; font-size:12pt"><u>Schedule of Investments</u></p>
<p style="margin:0px; clear:left"><br/></p>
<p style="margin:0px"><br/>
<br/></p>
</div>
<div style="font: normal 11pt Arial, Helvetica, sans-serif; width: 780px">
<!-- Automatically produced using the ProofPlus Content Management System -->
<p style="font: bold 18pt Arial, Helvetica, sans-serif; margin-bottom: 0px;" align="center">Quarterly Holdings Report<br clear="all"/>for</p>
<p style="font: bold 20pt Arial, Helvetica, sans-serif; margin-top: 0px;" align="center">Fidelity Advisor&#174; Utilities Fund</p>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-top: 0px;" align="center">April 30, 2016</p>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>AFUG-QTLY-0616<br/>1.800331.112<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<a name="">
<p style="font: bold 16pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Investments April 30, 2016 (Unaudited)</p>
</a>
<p style="font: normal 11pt Arial, Helvetica, sans-serif; margin-top: 0px;">Showing Percentage of Net Assets</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="0" cellpadding="5" width="745">
<tr style="font-weight:bold; color: #ffffff; background-color: #000000;">
<td align="left" valign="top">Common Stocks - 95.8%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">&#160;</td><td/><td style="font-weight: bold;" align="center" valign="bottom">Shares&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Value&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Diversified Telecommunication Services - 1.6%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Integrated Telecommunication Services - 1.6%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">AT&amp;T, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">134,200&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">$5,209,644&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Electric Utilities - 43.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Electric Utilities - 43.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Edison International&#160;</td><td valign="top"/><td align="right" valign="bottom">173,202&#160;</td><td align="right" valign="bottom">12,247,113&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Exelon Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">545,941&#160;</td><td align="right" valign="bottom">19,157,070&#160;</td>
</tr>
<tr>
<td align="left" valign="top">FirstEnergy Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">415,400&#160;</td><td align="right" valign="bottom">13,537,886&#160;</td>
</tr>
<tr>
<td align="left" valign="top">ITC Holdings Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">178,500&#160;</td><td align="right" valign="bottom">7,866,495&#160;</td>
</tr>
<tr>
<td align="left" valign="top">NextEra Energy, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">353,740&#160;</td><td align="right" valign="bottom">41,592,748&#160;</td>
</tr>
<tr>
<td align="left" valign="top">OGE Energy Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">114,523&#160;</td><td align="right" valign="bottom">3,388,736&#160;</td>
</tr>
<tr>
<td align="left" valign="top">PG&amp;E Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">338,638&#160;</td><td align="right" valign="bottom">19,708,732&#160;</td>
</tr>
<tr>
<td align="left" valign="top">PNM Resources, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">141,200&#160;</td><td align="right" valign="bottom">4,473,216&#160;</td>
</tr>
<tr>
<td align="left" valign="top">PPL Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">337,872&#160;</td><td align="right" valign="bottom">12,717,502&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Westar Energy, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">82,700&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">4,268,147&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">138,957,645&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Independent Power and Renewable Electricity Producers - 11.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Independent Power Producers &amp; Energy Traders - 8.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Calpine Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">813,317&#160;</td><td align="right" valign="bottom">12,834,142&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Dynegy, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">294,297&#160;</td><td align="right" valign="bottom">5,188,456&#160;</td>
</tr>
<tr>
<td align="left" valign="top">NRG Energy, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">281,635&#160;</td><td align="right" valign="bottom">4,252,689&#160;</td>
</tr>
<tr>
<td align="left" valign="top">NRG Yield, Inc. Class C (b)&#160;</td><td valign="top"/><td align="right" valign="bottom">203,420&#160;</td><td align="right" valign="bottom">3,291,336&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Talen Energy Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">41,500&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">483,890&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">26,050,513&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Renewable Electricity - 2.9%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">NextEra Energy Partners LP&#160;</td><td valign="top"/><td align="right" valign="bottom">207,300&#160;</td><td align="right" valign="bottom">5,988,897&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Pattern Energy Group, Inc.  (b)&#160;</td><td valign="top"/><td align="right" valign="bottom">132,700&#160;</td><td align="right" valign="bottom">2,786,700&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Terraform Power, Inc.  (b)&#160;</td><td valign="top"/><td align="right" valign="bottom">61,800&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">660,024&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">9,435,621&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL INDEPENDENT POWER AND RENEWABLE ELECTRICITY PRODUCERS&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">35,486,134&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Media - 5.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Cable &amp; Satellite - 5.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Charter Communications, Inc. Class A (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">25,800&#160;</td><td align="right" valign="bottom">5,475,792&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Comcast Corp. Class A&#160;</td><td valign="top"/><td align="right" valign="bottom">205,900&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">12,510,484&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">17,986,276&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Multi-Utilities - 31.8%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Multi-Utilities - 31.8%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Ameren Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">40,930&#160;</td><td align="right" valign="bottom">1,964,640&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Avangrid, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">421,900&#160;</td><td align="right" valign="bottom">16,918,190&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Black Hills Corp.  (b)&#160;</td><td valign="top"/><td align="right" valign="bottom">95,200&#160;</td><td align="right" valign="bottom">5,768,168&#160;</td>
</tr>
<tr>
<td align="left" valign="top">CenterPoint Energy, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">180,565&#160;</td><td align="right" valign="bottom">3,873,119&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Dominion Resources, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">344,199&#160;</td><td align="right" valign="bottom">24,599,903&#160;</td>
</tr>
<tr>
<td align="left" valign="top">DTE Energy Co.&#160;</td><td valign="top"/><td align="right" valign="bottom">149,598&#160;</td><td align="right" valign="bottom">13,338,158&#160;</td>
</tr>
<tr>
<td align="left" valign="top">NiSource, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">158,083&#160;</td><td align="right" valign="bottom">3,590,065&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Sempra Energy&#160;</td><td valign="top"/><td align="right" valign="bottom">317,009&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">32,762,880&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">102,815,123&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Oil, Gas &amp; Consumable Fuels - 1.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Oil &amp; Gas Storage &amp; Transport - 1.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Cheniere Energy Partners LP Holdings LLC&#160;</td><td valign="top"/><td align="right" valign="bottom">118,462&#160;</td><td align="right" valign="bottom">2,307,640&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Cheniere Energy, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">34,600&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">1,345,248&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">3,652,888&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Real Estate Investment Trusts - 1.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Specialized REITs - 1.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Crown Castle International Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">37,100&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">3,223,248&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Semiconductors &amp; Semiconductor Equipment - 0.8%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Semiconductors - 0.8%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">First Solar, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">44,900&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">2,507,216&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">TOTAL COMMON STOCKS&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">(Cost $273,715,620)&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">309,838,174&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold; color: #ffffff; background-color: #000000;">
<td align="left" valign="top">Money Market Funds - 6.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Cash Central Fund, 0.38% (c)&#160;</td><td valign="top"/><td align="right" valign="bottom">14,151,865&#160;</td><td align="right" valign="bottom">14,151,865&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Securities Lending Cash Central Fund, 0.42% (c)(d)&#160;</td><td valign="top"/><td align="right" valign="bottom">5,096,525&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">5,096,525&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">TOTAL MONEY MARKET FUNDS&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">(Cost $19,248,390)&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">19,248,390&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">TOTAL INVESTMENT PORTFOLIO - 101.8%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">(Cost $292,964,010)&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td style="font-weight: bold;" align="right" valign="top">329,086,564&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">NET OTHER ASSETS (LIABILITIES) - (1.8)%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">(5,793,856)&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">NET ASSETS - 100%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="top" style="border-bottom: double 3px black; font-weight: bold;">$323,292,708&#160;</td>
</tr>
</table>
<br/>
<p style="font: bold 12pt Arial, Helvetica, sans-serif;">Legend</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(a)&#160;Non-income producing</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(b)&#160;Security or a portion of the security is on loan at period end.</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(c)&#160;Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request.</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(d)&#160;Investment made with cash collateral received from securities on loan.</p>
<br/>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Affiliated Central Funds</p>
<p style="font: normal 10pt Arial, Helvetica, sans-serif;">Information regarding fiscal year to date income earned by the Fund from investments in Fidelity Central Funds is as follows:</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="7" cellpadding="0" width="745">
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">Fund&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Income earned&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Cash Central Fund&#160;</td><td align="right" valign="bottom">$9,075&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Securities Lending Cash Central Fund&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">6,894&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Total&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$15,969&#160;</td>
</tr>
</table>
<br/>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Investment Valuation</p>
<p style="font: normal 10pt Arial, Helvetica, sans-serif;">All investments are categorized as Level 1 under the Fair Value Hierarchy. The inputs or methodology used for valuing securities may not be an indication of the risk associated with investing in those securities. Additional information on valuation inputs is provided later in this section.</p>
<p>Investments are valued as of 4:00 p.m. Eastern time on the last calendar day of the period. Security transactions are accounted for as of trade date. The Board of Trustees (the Board) has delegated the day to day responsibility for the valuation of the Fund's investments to the Fidelity Management &amp; Research Company (FMR) Fair Value Committee (the Committee). In accordance with valuation policies and procedures approved by the Board, the Fund attempts to obtain prices from one or more third party pricing vendors or brokers to value its investments. When current market prices, quotations or currency exchange rates are not readily available or reliable, investments will be fair valued in good faith by the Committee, in accordance with procedures adopted by the Board. Factors used in determining fair value vary by investment type and may include market or investment specific events. The frequency with which these procedures are used cannot be predicted and they may be utilized to a significant extent. The Committee oversees the Fund&#146;s valuation policies and procedures and reports to the Board on the Committee's activities and fair value determinations. The Board monitors the appropriateness of the procedures used in valuing the Fund's investments and ratifies the fair value determinations of the Committee. The Fund categorizes the inputs to valuation techniques used to value its investments into a disclosure hierarchy consisting of three levels: Level 1 - quoted prices in active markets for identical investments: Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds etc.): Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available). Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. Valuation techniques used to value the Fund's investments by major category are as follows:</p>
<p>Equity securities, including restricted securities, for which market quotations are readily available, are valued at the last reported sale price or official closing price as reported by a third party pricing vendor on the primary market or exchange on which they are traded and are categorized as Level 1 in the hierarchy. In the event there were no sales during the day or closing prices are not available, securities are valued at the last quoted bid price or may be valued using the last available price and are generally categorized as Level 2 in the hierarchy. For foreign equity securities, when market or security specific events arise, comparisons to the valuation of American Depositary Receipts (ADRs), futures contracts, Exchange-Traded Funds (ETFs) and certain indexes as well as quoted prices for similar securities may be used and would be categorized as Level 2 in the hierarchy. Utilizing these techniques may result in transfers between Level 1 and Level 2. For equity securities, including restricted securities, where observable inputs are limited, assumptions about market activity and risk are used and these securities may be categorized as Level 3 in the hierarchy.</p>
<p>Investments in open-end mutual funds, including the Fidelity Central Funds, are valued at their closing net asset value each business day and are categorized as Level 1 in the hierarchy.</p>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Other Information</p>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Income Tax Information</p>
<p>At April 30, 2016, the cost of investment securities for income tax purposes was $294,914,914. Net unrealized appreciation aggregated $34,171,650, of which $39,887,914 related to appreciated investment securities and $5,716,264 related to depreciated investment securities.</p>
<p>For additional information on the Fund's policy regarding valuation of investments and other significant accounting policies, please refer to the Fund's most recent semiannual or annual shareholder report.</p>
<br/>
<br/>
<br/>
<br/>
<p style="font-style: italic;">
</p><p style="font-style: italic;">The fund's schedule of investments as of the date on the cover of this report has not been audited. This report is provided for the general information of the fund's shareholders. For more information regarding the fund and its holdings, please see the fund's most recent prospectus and annual report.</p>

<p style="font-style: italic;">
</p><p style="font-style: italic;">Third party trademarks and service marks are the property of their respective owners. All other trademarks and service marks are the property of FMR LLC or an affiliate.</p>

<hr size="2" noshade="noshade"/>
</div>
<div style="font: normal 11pt Arial, Helvetica, sans-serif; width: 780px">
<!-- Automatically produced using the ProofPlus Content Management System -->
<p style="font: bold 18pt Arial, Helvetica, sans-serif; margin-bottom: 0px;" align="center">Quarterly Holdings Report<br clear="all"/>for</p>
<p style="font: bold 20pt Arial, Helvetica, sans-serif; margin-top: 0px;" align="center">Fidelity Advisor&#174; Industrials Fund</p>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-top: 0px;" align="center">April 30, 2016</p>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>AFCY-QTLY-0616<br/>1.800323.112<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<a name="">
<p style="font: bold 16pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Investments April 30, 2016 (Unaudited)</p>
</a>
<p style="font: normal 11pt Arial, Helvetica, sans-serif; margin-top: 0px;">Showing Percentage of Net Assets</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="0" cellpadding="5" width="745">
<tr style="font-weight:bold; color: #ffffff; background-color: #000000;">
<td align="left" valign="top">Common Stocks - 97.4%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">&#160;</td><td/><td style="font-weight: bold;" align="center" valign="bottom">Shares&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Value&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Aerospace &amp; Defense - 28.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Aerospace &amp; Defense - 28.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">BWX Technologies, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">214,400&#160;</td><td align="right" valign="bottom">$7,158,816&#160;</td>
</tr>
<tr>
<td align="left" valign="top">General Dynamics Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">165,762&#160;</td><td align="right" valign="bottom">23,292,876&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Hexcel Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">93,900&#160;</td><td align="right" valign="bottom">4,250,853&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Honeywell International, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">299,033&#160;</td><td align="right" valign="bottom">34,170,501&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Northrop Grumman Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">92,300&#160;</td><td align="right" valign="bottom">19,037,798&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Orbital ATK, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">88,169&#160;</td><td align="right" valign="bottom">7,670,703&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Raytheon Co.&#160;</td><td valign="top"/><td align="right" valign="bottom">155,600&#160;</td><td align="right" valign="bottom">19,660,060&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Rockwell Collins, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">86,700&#160;</td><td align="right" valign="bottom">7,646,073&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Teledyne Technologies, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">162,965&#160;</td><td align="right" valign="bottom">15,147,597&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Textron, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">228,778&#160;</td><td align="right" valign="bottom">8,849,133&#160;</td>
</tr>
<tr>
<td align="left" valign="top">United Technologies Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">283,051&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">29,542,033&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">176,426,443&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Air Freight &amp; Logistics - 1.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Air Freight &amp; Logistics - 1.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">C.H. Robinson Worldwide, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">99,300&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">7,047,321&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Airlines - 5.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Airlines - 5.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Southwest Airlines Co.&#160;</td><td valign="top"/><td align="right" valign="bottom">723,800&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">32,288,718&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Building Products - 3.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Building Products - 3.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">A.O. Smith Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">176,242&#160;</td><td align="right" valign="bottom">13,609,407&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fortune Brands Home &amp; Security, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">150,800&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">8,355,828&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">21,965,235&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Commercial Services &amp; Supplies - 3.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Commercial Printing - 0.7%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Deluxe Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">70,100&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">4,400,878&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Office Services &amp; Supplies - 2.6%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Regus PLC&#160;</td><td valign="top"/><td align="right" valign="bottom">1,344,200&#160;</td><td align="right" valign="bottom">5,742,964&#160;</td>
</tr>
<tr>
<td align="left" valign="top">West Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">473,232&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">10,141,362&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">15,884,326&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL COMMERCIAL SERVICES &amp; SUPPLIES&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">20,285,204&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Construction &amp; Engineering - 4.4%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Construction &amp; Engineering - 4.4%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">AECOM  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">841,821&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">27,350,764&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Construction Materials - 0.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Construction Materials - 0.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Eagle Materials, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">42,900&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">3,179,748&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Diversified Consumer Services - 1.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Specialized Consumer Services - 1.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">ServiceMaster Global Holdings, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">160,600&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">6,154,192&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Electrical Equipment - 5.7%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Electrical Components &amp; Equipment - 5.7%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">AMETEK, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">318,026&#160;</td><td align="right" valign="bottom">15,293,870&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Eaton Corp. PLC&#160;</td><td valign="top"/><td align="right" valign="bottom">279,800&#160;</td><td align="right" valign="bottom">17,702,946&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Regal Beloit Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">35,300&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">2,274,026&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">35,270,842&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Energy Equipment &amp; Services - 0.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Oil &amp; Gas Equipment &amp; Services - 0.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Aspen Aerogels, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">140,385&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">668,233&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Industrial Conglomerates - 20.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Industrial Conglomerates - 20.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Danaher Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">444,432&#160;</td><td align="right" valign="bottom">42,998,796&#160;</td>
</tr>
<tr>
<td align="left" valign="top">General Electric Co.&#160;</td><td valign="top"/><td align="right" valign="bottom">2,753,048&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">84,656,225&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">127,655,021&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Machinery - 10.4%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Agricultural &amp; Farm Machinery - 0.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Deere &amp; Co.&#160;</td><td valign="top"/><td align="right" valign="bottom">20,000&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">1,682,200&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Construction Machinery &amp; Heavy Trucks - 3.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Caterpillar, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">51,300&#160;</td><td align="right" valign="bottom">3,987,036&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Trinity Industries, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">155,100&#160;</td><td align="right" valign="bottom">3,026,001&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Wabtec Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">160,400&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">13,301,972&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">20,315,009&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Industrial Machinery - 6.8%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">IDEX Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">149,629&#160;</td><td align="right" valign="bottom">12,254,615&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Ingersoll-Rand PLC&#160;</td><td valign="top"/><td align="right" valign="bottom">222,500&#160;</td><td align="right" valign="bottom">14,582,650&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Pentair PLC&#160;</td><td valign="top"/><td align="right" valign="bottom">163,300&#160;</td><td align="right" valign="bottom">9,484,464&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Rexnord Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">132,500&#160;</td><td align="right" valign="bottom">2,888,500&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Snap-On, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">21,600&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">3,440,448&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">42,650,677&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL MACHINERY&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">64,647,886&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Professional Services - 2.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Research &amp; Consulting Services - 2.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">CEB, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">104,054&#160;</td><td align="right" valign="bottom">6,419,091&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Verisk Analytics, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">119,344&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">9,258,708&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">15,677,799&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Road &amp; Rail - 5.4%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Trucking - 5.4%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">J.B. Hunt Transport Services, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">318,584&#160;</td><td align="right" valign="bottom">26,404,242&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Old Dominion Freight Lines, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">107,200&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">7,080,560&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">33,484,802&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Trading Companies &amp; Distributors - 5.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Trading Companies &amp; Distributors - 5.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">AerCap Holdings NV  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">294,300&#160;</td><td align="right" valign="bottom">11,774,943&#160;</td>
</tr>
<tr>
<td align="left" valign="top">HD Supply Holdings, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">467,206&#160;</td><td align="right" valign="bottom">16,015,822&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Wolseley PLC&#160;</td><td valign="top"/><td align="right" valign="bottom">109,276&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">6,120,775&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">33,911,540&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">TOTAL COMMON STOCKS&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">(Cost $501,858,054)&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">606,013,748&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold; color: #ffffff; background-color: #000000;">
<td align="left" valign="top">Money Market Funds - 1.8%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Cash Central Fund, 0.38% (b)&#160;</td><td valign="top"/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">(Cost $11,608,501)&#160;</td><td/><td align="right" valign="top">11,608,501&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">11,608,501&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">TOTAL INVESTMENT PORTFOLIO - 99.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">(Cost $513,466,555)&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td style="font-weight: bold;" align="right" valign="top">617,622,249&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">NET OTHER ASSETS (LIABILITIES) - 0.8%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">4,746,891&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">NET ASSETS - 100%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="top" style="border-bottom: double 3px black; font-weight: bold;">$622,369,140&#160;</td>
</tr>
</table>
<br/>
<p style="font: bold 12pt Arial, Helvetica, sans-serif;">Legend</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(a)&#160;Non-income producing</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(b)&#160;Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request.</p>
<br/>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Affiliated Central Funds</p>
<p style="font: normal 10pt Arial, Helvetica, sans-serif;">Information regarding fiscal year to date income earned by the Fund from investments in Fidelity Central Funds is as follows:</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="7" cellpadding="0" width="745">
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">Fund&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Income earned&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Cash Central Fund&#160;</td><td align="right" valign="bottom">$9,670&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Securities Lending Cash Central Fund&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">2,285&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Total&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$11,955&#160;</td>
</tr>
</table>
<br/>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Investment Valuation</p>
<p style="font: normal 10pt Arial, Helvetica, sans-serif;">The following is a summary of the inputs used, as of April 30, 2016, involving the Fund's assets and liabilities carried at fair value. The inputs or methodology used for valuing securities may not be an indication of the risk associated with investing in those securities. Additional information on valuation inputs, and their aggregation into the levels used below, is provided later in this section.</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="7" cellpadding="0" width="745">
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">&#160;</td><td style="font-weight: bold;" align="center" valign="bottom" colspan="4">Valuation Inputs at Reporting Date:&#160;</td>
</tr>
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">Description&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Total&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Level 1&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Level 2&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Level 3&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top"><u>Investments in Securities:</u>&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Common Stocks&#160;</td><td align="right" valign="bottom">$606,013,748&#160;</td><td align="right" valign="bottom">$599,892,973&#160;</td><td align="right" valign="bottom">$6,120,775&#160;</td><td align="right" valign="bottom">$--&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Money Market Funds&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">11,608,501&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">11,608,501&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">--&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">--&#160;</td>
</tr>
<tr>
<td style="font-weight: bold" valign="top">Total Investments in Securities:&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$617,622,249&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$611,501,474&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$6,120,775&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$--&#160;</td>
</tr>
</table>
<br/>
<p>Investments are valued as of 4:00 p.m. Eastern time on the last calendar day of the period. Security transactions are accounted for as of trade date. The Board of Trustees (the Board) has delegated the day to day responsibility for the valuation of the Fund's investments to the Fidelity SelectCo, LLC (SelectCo) Fair Value Committee (the Committee). In accordance with valuation policies and procedures approved by the Board, the Fund attempts to obtain prices from one or more third party pricing vendors or brokers to value its investments. When current market prices, quotations or currency exchange rates are not readily available or reliable, investments will be fair valued in good faith by the Committee, in accordance with procedures adopted by the Board. Factors used in determining fair value vary by investment type and may include market or investment specific events. The frequency with which these procedures are used cannot be predicted and they may be utilized to a significant extent. The Committee oversees the Fund&#146;s valuation policies and procedures and reports to the Board on the Committee's activities and fair value determinations. The Board monitors the appropriateness of the procedures used in valuing the Fund's investments and ratifies the fair value determinations of the Committee. The Fund categorizes the inputs to valuation techniques used to value its investments into a disclosure hierarchy consisting of three levels: Level 1 - quoted prices in active markets for identical investments: Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds etc.): Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available). Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. Valuation techniques used to value the Fund's investments by major category are as follows:</p>
<p>Equity securities, including restricted securities, for which market quotations are readily available, are valued at the last reported sale price or official closing price as reported by a third party pricing vendor on the primary market or exchange on which they are traded and are categorized as Level 1 in the hierarchy. In the event there were no sales during the day or closing prices are not available, securities are valued at the last quoted bid price or may be valued using the last available price and are generally categorized as Level 2 in the hierarchy. For foreign equity securities, when market or security specific events arise, comparisons to the valuation of American Depositary Receipts (ADRs), futures contracts, Exchange-Traded Funds (ETFs) and certain indexes as well as quoted prices for similar securities may be used and would be categorized as Level 2 in the hierarchy. Utilizing these techniques may result in transfers between Level 1 and Level 2. For equity securities, including restricted securities, where observable inputs are limited, assumptions about market activity and risk are used and these securities may be categorized as Level 3 in the hierarchy.</p>
<p>Investments in open-end mutual funds, including the Fidelity Central Funds, are valued at their closing net asset value each business day and are categorized as Level 1 in the hierarchy.</p>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Other Information</p>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Income Tax Information</p>
<p>At April 30, 2016, the cost of investment securities for income tax purposes was $515,894,569. Net unrealized appreciation aggregated $101,727,680, of which $114,689,262 related to appreciated investment securities and $12,961,582 related to depreciated investment securities.</p>
<p>For additional information on the Fund's policy regarding valuation of investments and other significant accounting policies, please refer to the Fund's most recent semiannual or annual shareholder report.</p>
<br/>
<br/>
<br/>
<br/>
<p style="font-style: italic;">
</p><p style="font-style: italic;">The fund's schedule of investments as of the date on the cover of this report has not been audited. This report is provided for the general information of the fund's shareholders. For more information regarding the fund and its holdings, please see the fund's most recent prospectus and annual report.</p>

<p style="font-style: italic;">
</p><p style="font-style: italic;">Third party trademarks and service marks are the property of their respective owners. All other trademarks and service marks are the property of FMR LLC or an affiliate.</p>

<hr size="2" noshade="noshade"/>
</div>
<div style="font: normal 11pt Arial, Helvetica, sans-serif; width: 780px">
<!-- Automatically produced using the ProofPlus Content Management System -->
<p style="font: bold 18pt Arial, Helvetica, sans-serif; margin-bottom: 0px;" align="center">Quarterly Holdings Report<br clear="all"/>for</p>
<p style="font: bold 20pt Arial, Helvetica, sans-serif; margin-top: 0px;" align="center">Fidelity Advisor&#174; Communications Equipment Fund</p>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-top: 0px;" align="center">April 30, 2016</p>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>AFDC-QTLY-0616<br/>1.800324.112<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<a name="">
<p style="font: bold 16pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Investments April 30, 2016 (Unaudited)</p>
</a>
<p style="font: normal 11pt Arial, Helvetica, sans-serif; margin-top: 0px;">Showing Percentage of Net Assets</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="0" cellpadding="5" width="745">
<tr style="font-weight:bold; color: #ffffff; background-color: #000000;">
<td align="left" valign="top">Common Stocks - 99.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">&#160;</td><td/><td style="font-weight: bold;" align="center" valign="bottom">Shares&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Value&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Communications Equipment - 74.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Communications Equipment - 74.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">ADTRAN, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">5,100&#160;</td><td align="right" valign="bottom">$98,532&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Arris International PLC  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">7,794&#160;</td><td align="right" valign="bottom">177,469&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Brocade Communications Systems, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">49,500&#160;</td><td align="right" valign="bottom">475,695&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Calix Networks, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">2,300&#160;</td><td align="right" valign="bottom">15,939&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Ciena Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">600&#160;</td><td align="right" valign="bottom">10,098&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Cisco Systems, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">77,724&#160;</td><td align="right" valign="bottom">2,136,633&#160;</td>
</tr>
<tr>
<td align="left" valign="top">CommScope Holding Co., Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">21,420&#160;</td><td align="right" valign="bottom">651,382&#160;</td>
</tr>
<tr>
<td align="left" valign="top">EchoStar Holding Corp. Class A (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">450&#160;</td><td align="right" valign="bottom">18,414&#160;</td>
</tr>
<tr>
<td align="left" valign="top">EXFO, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">4,100&#160;</td><td align="right" valign="bottom">17,548&#160;</td>
</tr>
<tr>
<td align="left" valign="top">F5 Networks, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">7,035&#160;</td><td align="right" valign="bottom">736,916&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Finisar Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">10,300&#160;</td><td align="right" valign="bottom">169,538&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Harris Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">6,820&#160;</td><td align="right" valign="bottom">545,668&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Infinera Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">4,217&#160;</td><td align="right" valign="bottom">50,140&#160;</td>
</tr>
<tr>
<td align="left" valign="top">InterDigital, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">2,700&#160;</td><td align="right" valign="bottom">153,846&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Ixia  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">8,490&#160;</td><td align="right" valign="bottom">85,919&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Juniper Networks, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">22,358&#160;</td><td align="right" valign="bottom">523,177&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Lumentum Holdings, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">2,160&#160;</td><td align="right" valign="bottom">54,648&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Mitel Networks Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">3,710&#160;</td><td align="right" valign="bottom">25,896&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Motorola Solutions, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">1,809&#160;</td><td align="right" valign="bottom">136,019&#160;</td>
</tr>
<tr>
<td align="left" valign="top">NETGEAR, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">600&#160;</td><td align="right" valign="bottom">25,440&#160;</td>
</tr>
<tr>
<td align="left" valign="top">NetScout Systems, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">8,500&#160;</td><td align="right" valign="bottom">189,210&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Nokia Corp. sponsored ADR  (b)&#160;</td><td valign="top"/><td align="right" valign="bottom">91,620&#160;</td><td align="right" valign="bottom">537,809&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Oclaro, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">7,500&#160;</td><td align="right" valign="bottom">37,875&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Palo Alto Networks, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">400&#160;</td><td align="right" valign="bottom">60,348&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Plantronics, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">2,710&#160;</td><td align="right" valign="bottom">104,200&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Polycom, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">7,619&#160;</td><td align="right" valign="bottom">91,047&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Radware Ltd.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">16,500&#160;</td><td align="right" valign="bottom">178,200&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Ruckus Wireless, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">13,820&#160;</td><td align="right" valign="bottom">189,887&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Sandvine Corp. (U.K.)&#160;</td><td valign="top"/><td align="right" valign="bottom">10,300&#160;</td><td align="right" valign="bottom">22,247&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Sierra Wireless, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,000&#160;</td><td align="right" valign="bottom">16,130&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Sonus Networks, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">6,550&#160;</td><td align="right" valign="bottom">54,103&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Telefonaktiebolaget LM Ericsson (B Shares) sponsored ADR&#160;</td><td valign="top"/><td align="right" valign="bottom">65,230&#160;</td><td align="right" valign="bottom">527,711&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Viavi Solutions, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">12,800&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">83,328&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">8,201,012&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Diversified Financial Services - 0.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Other Diversified Financial Services - 0.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Broadcom Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">275&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">40,081&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Diversified Telecommunication Services - 0.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Alternative Carriers - 0.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Vonage Holdings Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">4,390&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">20,501&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Electronic Equipment &amp; Components - 1.8%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Electronic Components - 0.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">II-VI, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,360&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">28,383&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Electronic Equipment &amp; Instruments - 0.8%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Keysight Technologies, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">3,600&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">93,888&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Electronic Manufacturing Services - 0.4%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">TE Connectivity Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">700&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">41,636&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Technology Distributors - 0.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">CDW Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">900&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">34,650&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL ELECTRONIC EQUIPMENT &amp; COMPONENTS&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">198,557&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Internet Software &amp; Services - 2.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Internet Software &amp; Services - 2.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Alphabet, Inc.:&#160;</td><td valign="top"/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Class A&#160;</td><td valign="top"/><td align="right" valign="bottom">109&#160;</td><td align="right" valign="bottom">77,159&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Class C&#160;</td><td valign="top"/><td align="right" valign="bottom">88&#160;</td><td align="right" valign="bottom">60,985&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Rackspace Hosting, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">800&#160;</td><td align="right" valign="bottom">18,296&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Web.com Group, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">3,300&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">65,967&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">222,407&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Semiconductors &amp; Semiconductor Equipment - 17.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Semiconductors - 17.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">GSI Technology, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">4,700&#160;</td><td align="right" valign="bottom">18,565&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Marvell Technology Group Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">5,000&#160;</td><td align="right" valign="bottom">49,900&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Maxim Integrated Products, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">900&#160;</td><td align="right" valign="bottom">32,148&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Qorvo, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,100&#160;</td><td align="right" valign="bottom">49,533&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Qualcomm, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">34,161&#160;</td><td align="right" valign="bottom">1,725,814&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Semtech Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,200&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">25,968&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">1,901,928&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Software - 0.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Systems Software - 0.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Oracle Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">770&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">30,692&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Technology Hardware, Storage &amp; Peripherals - 3.4%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Technology Hardware, Storage &amp; Peripherals - 3.4%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">BlackBerry Ltd.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">20,800&#160;</td><td align="right" valign="bottom">146,878&#160;</td>
</tr>
<tr>
<td align="left" valign="top">EMC Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">4,300&#160;</td><td align="right" valign="bottom">112,273&#160;</td>
</tr>
<tr>
<td align="left" valign="top">HP, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">4,600&#160;</td><td align="right" valign="bottom">56,442&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Samsung Electronics Co. Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">53&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">57,595&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">373,188&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">TOTAL COMMON STOCKS&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">(Cost $10,335,420)&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">10,988,366&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold; color: #ffffff; background-color: #000000;">
<td align="left" valign="top">Money Market Funds - 5.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Cash Central Fund, 0.38% (c)&#160;</td><td valign="top"/><td align="right" valign="bottom">89,112&#160;</td><td align="right" valign="bottom">89,112&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Securities Lending Cash Central Fund, 0.42% (c)(d)&#160;</td><td valign="top"/><td align="right" valign="bottom">520,650&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">520,650&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">TOTAL MONEY MARKET FUNDS&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">(Cost $609,762)&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">609,762&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">TOTAL INVESTMENT PORTFOLIO - 104.7%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">(Cost $10,945,182)&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td style="font-weight: bold;" align="right" valign="top">11,598,128&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">NET OTHER ASSETS (LIABILITIES) - (4.7)%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">(515,822)&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">NET ASSETS - 100%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="top" style="border-bottom: double 3px black; font-weight: bold;">$11,082,306&#160;</td>
</tr>
</table>
<br/>
<p style="font: bold 12pt Arial, Helvetica, sans-serif;">Legend</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(a)&#160;Non-income producing</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(b)&#160;Security or a portion of the security is on loan at period end.</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(c)&#160;Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request.</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(d)&#160;Investment made with cash collateral received from securities on loan.</p>
<br/>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Affiliated Central Funds</p>
<p style="font: normal 10pt Arial, Helvetica, sans-serif;">Information regarding fiscal year to date income earned by the Fund from investments in Fidelity Central Funds is as follows:</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="7" cellpadding="0" width="745">
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">Fund&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Income earned&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Cash Central Fund&#160;</td><td align="right" valign="bottom">$225&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Securities Lending Cash Central Fund&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">2,332&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Total&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$2,557&#160;</td>
</tr>
</table>
<br/>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Investment Valuation</p>
<p style="font: normal 10pt Arial, Helvetica, sans-serif;">All investments are categorized as Level 1 under the Fair Value Hierarchy. The inputs or methodology used for valuing securities may not be an indication of the risk associated with investing in those securities. Additional information on valuation inputs is provided later in this section.</p>
<p>Investments are valued as of 4:00 p.m. Eastern time on the last calendar day of the period. Security transactions are accounted for as of trade date. The Board of Trustees (the Board) has delegated the day to day responsibility for the valuation of the Fund's investments to the Fidelity SelectCo, LLC (SelectCo) Fair Value Committee (the Committee). In accordance with valuation policies and procedures approved by the Board, the Fund attempts to obtain prices from one or more third party pricing vendors or brokers to value its investments. When current market prices, quotations or currency exchange rates are not readily available or reliable, investments will be fair valued in good faith by the Committee, in accordance with procedures adopted by the Board. Factors used in determining fair value vary by investment type and may include market or investment specific events. The frequency with which these procedures are used cannot be predicted and they may be utilized to a significant extent. The Committee oversees the Fund&#146;s valuation policies and procedures and reports to the Board on the Committee's activities and fair value determinations. The Board monitors the appropriateness of the procedures used in valuing the Fund's investments and ratifies the fair value determinations of the Committee. The Fund categorizes the inputs to valuation techniques used to value its investments into a disclosure hierarchy consisting of three levels: Level 1 - quoted prices in active markets for identical investments: Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds etc.): Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available). Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. Valuation techniques used to value the Fund's investments by major category are as follows:</p>
<p>Equity securities, including restricted securities, for which market quotations are readily available, are valued at the last reported sale price or official closing price as reported by a third party pricing vendor on the primary market or exchange on which they are traded and are categorized as Level 1 in the hierarchy. In the event there were no sales during the day or closing prices are not available, securities are valued at the last quoted bid price or may be valued using the last available price and are generally categorized as Level 2 in the hierarchy. For foreign equity securities, when market or security specific events arise, comparisons to the valuation of American Depositary Receipts (ADRs), futures contracts, Exchange-Traded Funds (ETFs) and certain indexes as well as quoted prices for similar securities may be used and would be categorized as Level 2 in the hierarchy. Utilizing these techniques may result in transfers between Level 1 and Level 2. For equity securities, including restricted securities, where observable inputs are limited, assumptions about market activity and risk are used and these securities may be categorized as Level 3 in the hierarchy.</p>
<p>Investments in open-end mutual funds, including the Fidelity Central Funds, are valued at their closing net asset value each business day and are categorized as Level 1 in the hierarchy.</p>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Other Information</p>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Income Tax Information</p>
<p>At April 30, 2016, the cost of investment securities for income tax purposes was $10,994,076. Net unrealized appreciation aggregated $604,052, of which $1,482,553 related to appreciated investment securities and $878,501 related to depreciated investment securities.</p>
<p>For additional information on the Fund's policy regarding valuation of investments and other significant accounting policies, please refer to the Fund's most recent semiannual or annual shareholder report.</p>
<br/>
<br/>
<br/>
<br/>
<p style="font-style: italic;">
</p><p style="font-style: italic;">The fund's schedule of investments as of the date on the cover of this report has not been audited. This report is provided for the general information of the fund's shareholders. For more information regarding the fund and its holdings, please see the fund's most recent prospectus and annual report.</p>

<p style="font-style: italic;">
</p><p style="font-style: italic;">Third party trademarks and service marks are the property of their respective owners. All other trademarks and service marks are the property of FMR LLC or an affiliate.</p>

<hr size="2" noshade="noshade"/>
</div>
<div style="font: normal 11pt Arial, Helvetica, sans-serif; width: 780px">
<!-- Automatically produced using the ProofPlus Content Management System -->
<p style="font: bold 18pt Arial, Helvetica, sans-serif; margin-bottom: 0px;" align="center">Quarterly Holdings Report<br clear="all"/>for</p>
<p style="font: bold 20pt Arial, Helvetica, sans-serif; margin-top: 0px;" align="center">Fidelity Advisor&#174; Biotechnology Fund</p>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-top: 0px;" align="center">April 30, 2016</p>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>AFBT-QTLY-0616<br/>1.800321.112<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<a name="">
<p style="font: bold 16pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Investments April 30, 2016 (Unaudited)</p>
</a>
<p style="font: normal 11pt Arial, Helvetica, sans-serif; margin-top: 0px;">Showing Percentage of Net Assets</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="0" cellpadding="5" width="745">
<tr style="font-weight:bold; color: #ffffff; background-color: #000000;">
<td align="left" valign="top">Common Stocks - 97.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">&#160;</td><td/><td style="font-weight: bold;" align="center" valign="bottom">Shares&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Value&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Biotechnology - 86.4%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Biotechnology - 86.4%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">ACADIA Pharmaceuticals, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">499,986&#160;</td><td align="right" valign="bottom">$16,149,548&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Acceleron Pharma, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">594,191&#160;</td><td align="right" valign="bottom">17,796,020&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Achillion Pharmaceuticals, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,456,572&#160;</td><td align="right" valign="bottom">12,453,691&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Acorda Therapeutics, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">316,753&#160;</td><td align="right" valign="bottom">8,188,065&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Actelion Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">129,712&#160;</td><td align="right" valign="bottom">20,958,365&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Adamas Pharmaceuticals, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">987,648&#160;</td><td align="right" valign="bottom">16,671,498&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Adaptimmune Therapeutics PLC sponsored ADR&#160;</td><td valign="top"/><td align="right" valign="bottom">823,742&#160;</td><td align="right" valign="bottom">7,982,060&#160;</td>
</tr>
<tr>
<td align="left" valign="top">ADMA Biologics, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">50,300&#160;</td><td align="right" valign="bottom">346,064&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Aduro Biotech, Inc.  (b)&#160;</td><td valign="top"/><td align="right" valign="bottom">231,318&#160;</td><td align="right" valign="bottom">2,995,568&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Aduro Biotech, Inc.  (c)&#160;</td><td valign="top"/><td align="right" valign="bottom">345,762&#160;</td><td align="right" valign="bottom">4,477,618&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Aegerion Pharmaceuticals, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">978,823&#160;</td><td align="right" valign="bottom">2,789,646&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Agenus, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">487,360&#160;</td><td align="right" valign="bottom">1,715,507&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Agenus, Inc. warrants 1/9/18 (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">452,000&#160;</td><td align="right" valign="bottom">791&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Agios Pharmaceuticals, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">42,471&#160;</td><td align="right" valign="bottom">2,078,955&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Aimmune Therapeutics, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">285,941&#160;</td><td align="right" valign="bottom">3,702,936&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Aimmune Therapeutics, Inc.  (c)&#160;</td><td valign="top"/><td align="right" valign="bottom">460,107&#160;</td><td align="right" valign="bottom">5,958,386&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Akebia Therapeutics, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">325,477&#160;</td><td align="right" valign="bottom">3,056,229&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Alder Biopharmaceuticals, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">724,713&#160;</td><td align="right" valign="bottom">19,241,130&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Aldeyra Therapeutics, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">478,895&#160;</td><td align="right" valign="bottom">3,017,039&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Alexion Pharmaceuticals, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,172,115&#160;</td><td align="right" valign="bottom">163,252,177&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Alkermes PLC  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">393,503&#160;</td><td align="right" valign="bottom">15,641,744&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Alnylam Pharmaceuticals, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">228,835&#160;</td><td align="right" valign="bottom">15,341,098&#160;</td>
</tr>
<tr>
<td align="left" valign="top">AMAG Pharmaceuticals, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">847,577&#160;</td><td align="right" valign="bottom">22,477,742&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Amarin Corp. PLC ADR  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">381,894&#160;</td><td align="right" valign="bottom">698,866&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Amgen, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">30,330&#160;</td><td align="right" valign="bottom">4,801,239&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Amicus Therapeutics, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">892,770&#160;</td><td align="right" valign="bottom">6,668,992&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Anacor Pharmaceuticals, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">659,551&#160;</td><td align="right" valign="bottom">41,380,230&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Applied Genetic Technologies Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">248,336&#160;</td><td align="right" valign="bottom">3,901,359&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Ardelyx, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">985,301&#160;</td><td align="right" valign="bottom">7,892,261&#160;</td>
</tr>
<tr>
<td align="left" valign="top">ARIAD Pharmaceuticals, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">443,595&#160;</td><td align="right" valign="bottom">3,185,012&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Array BioPharma, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">378,104&#160;</td><td align="right" valign="bottom">1,206,152&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Ascendis Pharma A/S sponsored ADR(a)&#160;</td><td valign="top"/><td align="right" valign="bottom">35,700&#160;</td><td align="right" valign="bottom">602,259&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Asterias Biotherapeutics, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">115,938&#160;</td><td align="right" valign="bottom">497,374&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Asterias Biotherapeutics, Inc. warrants 9/30/16 (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">23,187&#160;</td><td align="right" valign="bottom">13,912&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Atara Biotherapeutics, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">444,074&#160;</td><td align="right" valign="bottom">7,997,773&#160;</td>
</tr>
<tr>
<td align="left" valign="top">aTyr Pharma, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">45,620&#160;</td><td align="right" valign="bottom">162,407&#160;</td>
</tr>
<tr>
<td align="left" valign="top">aTyr Pharma, Inc.  (c)&#160;</td><td valign="top"/><td align="right" valign="bottom">55,238&#160;</td><td align="right" valign="bottom">196,647&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Avalanche Biotechnologies, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">125,129&#160;</td><td align="right" valign="bottom">705,728&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Axovant Sciences Ltd.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">183,161&#160;</td><td align="right" valign="bottom">2,381,093&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Biogen, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">670,947&#160;</td><td align="right" valign="bottom">184,503,716&#160;</td>
</tr>
<tr>
<td align="left" valign="top">BioMarin Pharmaceutical, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,341,310&#160;</td><td align="right" valign="bottom">113,582,131&#160;</td>
</tr>
<tr>
<td align="left" valign="top">BioTime, Inc. warrants 10/1/18 (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">2&#160;</td><td align="right" valign="bottom">1&#160;</td>
</tr>
<tr>
<td align="left" valign="top">bluebird bio, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">35,449&#160;</td><td align="right" valign="bottom">1,572,163&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Blueprint Medicines Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">313,700&#160;</td><td align="right" valign="bottom">4,761,966&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Calithera Biosciences, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">441,558&#160;</td><td align="right" valign="bottom">2,353,504&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Cara Therapeutics, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">209,788&#160;</td><td align="right" valign="bottom">1,279,707&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Catabasis Pharmaceuticals, Inc.  (b)&#160;</td><td valign="top"/><td align="right" valign="bottom">138,100&#160;</td><td align="right" valign="bottom">609,021&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Catalyst Pharmaceutical Partners, Inc.:&#160;</td><td valign="top"/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">warrants 5/2/17 (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">8,557&#160;</td><td align="right" valign="bottom">187&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">warrants 5/30/17(a)&#160;</td><td valign="top"/><td align="right" valign="bottom">17,900&#160;</td><td align="right" valign="bottom">921&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Celator Pharmaceuticals, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">244,581&#160;</td><td align="right" valign="bottom">3,685,836&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Celgene Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,731,990&#160;</td><td align="right" valign="bottom">179,105,086&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Cell Therapeutics, Inc. warrants 7/6/16 (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">46,404&#160;</td><td align="right" valign="bottom">0&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Celldex Therapeutics, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">827,627&#160;</td><td align="right" valign="bottom">3,310,508&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Cepheid, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">51,400&#160;</td><td align="right" valign="bottom">1,466,956&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Cerulean Pharma, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">820,836&#160;</td><td align="right" valign="bottom">2,692,342&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Chiasma, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">29,900&#160;</td><td align="right" valign="bottom">100,763&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Chiasma, Inc.  (c)&#160;</td><td valign="top"/><td align="right" valign="bottom">325,192&#160;</td><td align="right" valign="bottom">1,095,897&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Chiasma, Inc. warrants&#160;</td><td valign="top"/><td align="right" valign="bottom">81,298&#160;</td><td align="right" valign="bottom">93,019&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Chimerix, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">281,786&#160;</td><td align="right" valign="bottom">1,685,080&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Cidara Therapeutics, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">19,000&#160;</td><td align="right" valign="bottom">254,220&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Cidara Therapeutics, Inc.  (c)&#160;</td><td valign="top"/><td align="right" valign="bottom">223,967&#160;</td><td align="right" valign="bottom">2,996,678&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Clovis Oncology, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">123,732&#160;</td><td align="right" valign="bottom">1,721,112&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Corvus Pharmaceuticals, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">25,200&#160;</td><td align="right" valign="bottom">308,448&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Corvus Pharmaceuticals, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">180,163&#160;</td><td align="right" valign="bottom">1,984,676&#160;</td>
</tr>
<tr>
<td align="left" valign="top">CTI BioPharma Corp.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">4,239,198&#160;</td><td align="right" valign="bottom">2,134,860&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Cytokinetics, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">152,919&#160;</td><td align="right" valign="bottom">1,244,761&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Cytokinetics, Inc. warrants 6/25/17 (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">244,500&#160;</td><td align="right" valign="bottom">134,693&#160;</td>
</tr>
<tr>
<td align="left" valign="top">CytomX Therapeutics, Inc.  (c)&#160;</td><td valign="top"/><td align="right" valign="bottom">64,961&#160;</td><td align="right" valign="bottom">839,296&#160;</td>
</tr>
<tr>
<td align="left" valign="top">DBV Technologies SA sponsored ADR  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">258,000&#160;</td><td align="right" valign="bottom">8,764,260&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Dicerna Pharmaceuticals, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">125,106&#160;</td><td align="right" valign="bottom">577,990&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Dynavax Technologies Corp.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">357,119&#160;</td><td align="right" valign="bottom">5,860,323&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Edge Therapeutics, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">40,735&#160;</td><td align="right" valign="bottom">335,249&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Editas Medicine, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">165,012&#160;</td><td align="right" valign="bottom">5,453,647&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Editas Medicine, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">53,545&#160;</td><td align="right" valign="bottom">1,592,696&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Emergent BioSolutions, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">146,555&#160;</td><td align="right" valign="bottom">5,645,299&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Enanta Pharmaceuticals, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">89,187&#160;</td><td align="right" valign="bottom">2,604,260&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Epirus Biopharmaceuticals, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">254,100&#160;</td><td align="right" valign="bottom">736,890&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Epizyme, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">2,351,873&#160;</td><td align="right" valign="bottom">24,506,517&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Esperion Therapeutics, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">210,978&#160;</td><td align="right" valign="bottom">3,457,929&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Exact Sciences Corp.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">323,359&#160;</td><td align="right" valign="bottom">2,269,980&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Exelixis, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,040,940&#160;</td><td align="right" valign="bottom">4,798,733&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fate Therapeutics, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">234,604&#160;</td><td align="right" valign="bottom">445,748&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fibrocell Science, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">174,200&#160;</td><td align="right" valign="bottom">480,792&#160;</td>
</tr>
<tr>
<td align="left" valign="top">FibroGen, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">74,322&#160;</td><td align="right" valign="bottom">1,337,796&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Foundation Medicine, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">71,765&#160;</td><td align="right" valign="bottom">1,144,652&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Galapagos Genomics NV sponsored ADR&#160;</td><td valign="top"/><td align="right" valign="bottom">253,629&#160;</td><td align="right" valign="bottom">11,491,930&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Genmab A/S  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">298,702&#160;</td><td align="right" valign="bottom">44,255,893&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Genomic Health, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">54,120&#160;</td><td align="right" valign="bottom">1,422,274&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Geron Corp.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">4,760,774&#160;</td><td align="right" valign="bottom">14,044,283&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Gilead Sciences, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">1,834,365&#160;</td><td align="right" valign="bottom">161,809,337&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Global Blood Therapeutics, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">547,667&#160;</td><td align="right" valign="bottom">11,046,443&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Halozyme Therapeutics, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,034,338&#160;</td><td align="right" valign="bottom">10,912,266&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Heron Therapeutics, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">475,742&#160;</td><td align="right" valign="bottom">10,199,908&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Histogenics Corp.  (a)(d)&#160;</td><td valign="top"/><td align="right" valign="bottom">670,334&#160;</td><td align="right" valign="bottom">1,588,692&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Ignyta, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">579,672&#160;</td><td align="right" valign="bottom">4,011,330&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Immune Design Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">168,668&#160;</td><td align="right" valign="bottom">2,300,632&#160;</td>
</tr>
<tr>
<td align="left" valign="top">ImmunoGen, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,109,651&#160;</td><td align="right" valign="bottom">7,601,109&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Immunomedics, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">2,130,884&#160;</td><td align="right" valign="bottom">7,564,638&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Incyte Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">940,668&#160;</td><td align="right" valign="bottom">67,982,076&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Infinity Pharmaceuticals, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">287,434&#160;</td><td align="right" valign="bottom">1,667,117&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Insys Therapeutics, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">296,394&#160;</td><td align="right" valign="bottom">4,294,749&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Intercept Pharmaceuticals, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">175,060&#160;</td><td align="right" valign="bottom">26,388,544&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Intrexon Corp.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">180,408&#160;</td><td align="right" valign="bottom">4,822,306&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Ionis Pharmaceuticals, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">389,240&#160;</td><td align="right" valign="bottom">15,947,163&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Ironwood Pharmaceuticals, Inc. Class A  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">595,551&#160;</td><td align="right" valign="bottom">6,223,508&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Juno Therapeutics, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">8,100&#160;</td><td align="right" valign="bottom">340,929&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Juno Therapeutics, Inc.  (c)&#160;</td><td valign="top"/><td align="right" valign="bottom">214,673&#160;</td><td align="right" valign="bottom">9,035,587&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Karyopharm Therapeutics, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,159,016&#160;</td><td align="right" valign="bottom">10,778,849&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Keryx Biopharmaceuticals, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">417,052&#160;</td><td align="right" valign="bottom">2,268,763&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Kite Pharma, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">590,320&#160;</td><td align="right" valign="bottom">27,320,010&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Kura Oncology, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">921,702&#160;</td><td align="right" valign="bottom">3,078,485&#160;</td>
</tr>
<tr>
<td align="left" valign="top">La Jolla Pharmaceutical Co.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">290,700&#160;</td><td align="right" valign="bottom">5,380,857&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Lexicon Pharmaceuticals, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">930,237&#160;</td><td align="right" valign="bottom">12,846,573&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Ligand Pharmaceuticals, Inc. Class B (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">105,412&#160;</td><td align="right" valign="bottom">12,741,148&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Lion Biotechnologies, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">369,046&#160;</td><td align="right" valign="bottom">2,092,491&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Loxo Oncology, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">400,471&#160;</td><td align="right" valign="bottom">9,230,857&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Macrogenics, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">516,291&#160;</td><td align="right" valign="bottom">10,614,943&#160;</td>
</tr>
<tr>
<td align="left" valign="top">MannKind Corp.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">320,656&#160;</td><td align="right" valign="bottom">432,886&#160;</td>
</tr>
<tr>
<td align="left" valign="top">MediciNova, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">805,306&#160;</td><td align="right" valign="bottom">5,540,505&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Medivation, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,024,738&#160;</td><td align="right" valign="bottom">59,229,856&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Merrimack Pharmaceuticals, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">291,648&#160;</td><td align="right" valign="bottom">2,064,868&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Mesoblast Ltd. sponsored ADR(a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">224,373&#160;</td><td align="right" valign="bottom">1,826,396&#160;</td>
</tr>
<tr>
<td align="left" valign="top">MiMedx Group, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">250,413&#160;</td><td align="right" valign="bottom">1,885,610&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Minerva Neurosciences, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">921,974&#160;</td><td align="right" valign="bottom">5,928,293&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Mirna Therapeutics, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">280,500&#160;</td><td align="right" valign="bottom">1,309,935&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Momenta Pharmaceuticals, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">121,037&#160;</td><td align="right" valign="bottom">1,151,062&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Myriad Genetics, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">123,557&#160;</td><td align="right" valign="bottom">4,448,052&#160;</td>
</tr>
<tr>
<td align="left" valign="top">NantKwest, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">296,377&#160;</td><td align="right" valign="bottom">2,456,965&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Neurocrine Biosciences, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">669,028&#160;</td><td align="right" valign="bottom">30,494,296&#160;</td>
</tr>
<tr>
<td align="left" valign="top">NewLink Genetics Corp.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">127,579&#160;</td><td align="right" valign="bottom">2,068,056&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Nivalis Therapeutics, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">18,600&#160;</td><td align="right" valign="bottom">78,678&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Novavax, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">2,767,531&#160;</td><td align="right" valign="bottom">14,501,862&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Novelos Therapeutics, Inc. warrants 12/6/16 (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">137,600&#160;</td><td align="right" valign="bottom">1&#160;</td>
</tr>
<tr>
<td align="left" valign="top">OncoMed Pharmaceuticals, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">132,870&#160;</td><td align="right" valign="bottom">1,647,588&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Ophthotech Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">649,537&#160;</td><td align="right" valign="bottom">30,359,359&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Opko Health, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">360,051&#160;</td><td align="right" valign="bottom">3,870,548&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Oragenics, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">223,308&#160;</td><td align="right" valign="bottom">192,045&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Osiris Therapeutics, Inc.  (b)&#160;</td><td valign="top"/><td align="right" valign="bottom">203,971&#160;</td><td align="right" valign="bottom">1,144,277&#160;</td>
</tr>
<tr>
<td align="left" valign="top">OvaScience, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">171,745&#160;</td><td align="right" valign="bottom">1,439,223&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Portola Pharmaceuticals, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">441,388&#160;</td><td align="right" valign="bottom">10,487,379&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Progenics Pharmaceuticals, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">619,743&#160;</td><td align="right" valign="bottom">3,290,835&#160;</td>
</tr>
<tr>
<td align="left" valign="top">ProNai Therapeutics, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">377,900&#160;</td><td align="right" valign="bottom">2,116,240&#160;</td>
</tr>
<tr>
<td align="left" valign="top">ProQR Therapeutics BV  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">237,916&#160;</td><td align="right" valign="bottom">1,315,675&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Proteon Therapeutics, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">74,101&#160;</td><td align="right" valign="bottom">723,226&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Prothena Corp. PLC  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">128,634&#160;</td><td align="right" valign="bottom">5,555,702&#160;</td>
</tr>
<tr>
<td align="left" valign="top">PTC Therapeutics, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">170,178&#160;</td><td align="right" valign="bottom">1,262,721&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Puma Biotechnology, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">324,894&#160;</td><td align="right" valign="bottom">9,970,997&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Radius Health, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">975,562&#160;</td><td align="right" valign="bottom">34,730,007&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Raptor Pharmaceutical Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">799,023&#160;</td><td align="right" valign="bottom">3,923,203&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Regeneron Pharmaceuticals, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">507,017&#160;</td><td align="right" valign="bottom">190,998,377&#160;</td>
</tr>
<tr>
<td align="left" valign="top">REGENXBIO, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">375,750&#160;</td><td align="right" valign="bottom">3,915,315&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Regulus Therapeutics, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">265,221&#160;</td><td align="right" valign="bottom">1,548,891&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Repligen Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">240,527&#160;</td><td align="right" valign="bottom">6,407,639&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Retrophin, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">236,645&#160;</td><td align="right" valign="bottom">3,260,968&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Sage Therapeutics, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">262,168&#160;</td><td align="right" valign="bottom">9,881,112&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Sangamo Biosciences, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">441,652&#160;</td><td align="right" valign="bottom">2,782,408&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Sarepta Therapeutics, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">373,597&#160;</td><td align="right" valign="bottom">5,301,341&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Seattle Genetics, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,006,257&#160;</td><td align="right" valign="bottom">35,701,998&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Seres Therapeutics, Inc.  (b)&#160;</td><td valign="top"/><td align="right" valign="bottom">237,191&#160;</td><td align="right" valign="bottom">7,001,878&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Seres Therapeutics, Inc.  (c)&#160;</td><td valign="top"/><td align="right" valign="bottom">352,270&#160;</td><td align="right" valign="bottom">10,399,010&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Sophiris Bio, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">104,253&#160;</td><td align="right" valign="bottom">124,582&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Spark Therapeutics, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">314,145&#160;</td><td align="right" valign="bottom">11,274,664&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Spectrum Pharmaceuticals, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">338,247&#160;</td><td align="right" valign="bottom">2,398,171&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Stemline Therapeutics, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">348,093&#160;</td><td align="right" valign="bottom">1,914,512&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Sunesis Pharmaceuticals, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">628,104&#160;</td><td align="right" valign="bottom">321,526&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Syndax Pharmaceuticals, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">136,100&#160;</td><td align="right" valign="bottom">1,863,209&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Syndax Pharmaceuticals, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">276,047&#160;</td><td align="right" valign="bottom">3,401,175&#160;</td>
</tr>
<tr>
<td align="left" valign="top">TESARO, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">355,737&#160;</td><td align="right" valign="bottom">14,741,741&#160;</td>
</tr>
<tr>
<td align="left" valign="top">TG Therapeutics, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,270,593&#160;</td><td align="right" valign="bottom">11,575,102&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Threshold Pharmaceuticals, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">26,804&#160;</td><td align="right" valign="bottom">11,791&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Tobira Therapeutics, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">265,951&#160;</td><td align="right" valign="bottom">2,093,034&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Tokai Pharmaceuticals, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">91,000&#160;</td><td align="right" valign="bottom">667,030&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Trevena, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">286,767&#160;</td><td align="right" valign="bottom">2,233,915&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Ultragenyx Pharmaceutical, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">366,427&#160;</td><td align="right" valign="bottom">24,777,794&#160;</td>
</tr>
<tr>
<td align="left" valign="top">uniQure B.V. (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">158,829&#160;</td><td align="right" valign="bottom">2,053,659&#160;</td>
</tr>
<tr>
<td align="left" valign="top">United Therapeutics Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">131,494&#160;</td><td align="right" valign="bottom">13,833,169&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Versartis, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">355,976&#160;</td><td align="right" valign="bottom">3,225,143&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Vertex Pharmaceuticals, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,169,419&#160;</td><td align="right" valign="bottom">98,628,798&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Vical, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">659,862&#160;</td><td align="right" valign="bottom">263,285&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Vitae Pharmaceuticals, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">826,902&#160;</td><td align="right" valign="bottom">5,945,425&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Vital Therapies, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">497,937&#160;</td><td align="right" valign="bottom">4,267,320&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Voyager Therapeutics, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,016,525&#160;</td><td align="right" valign="bottom">11,842,516&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Voyager Therapeutics, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">282,352&#160;</td><td align="right" valign="bottom">3,256,507&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Xencor, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">363,108&#160;</td><td align="right" valign="bottom">4,448,073&#160;</td>
</tr>
<tr>
<td align="left" valign="top">XOMA Corp.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">598,065&#160;</td><td align="right" valign="bottom">489,576&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Zafgen, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,356,174&#160;</td><td align="right" valign="bottom">8,638,828&#160;</td>
</tr>
<tr>
<td align="left" valign="top">ZIOPHARM Oncology, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">256,414&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">2,015,414&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">2,312,368,422&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Capital Markets - 0.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Asset Management &amp; Custody Banks - 0.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">RPI International Holdings LP  (e)&#160;</td><td valign="top"/><td align="right" valign="bottom">12,210&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">1,638,338&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Health Care Equipment &amp; Supplies - 0.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Health Care Equipment - 0.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Bellerophon Therapeutics, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">227,700&#160;</td><td align="right" valign="bottom">453,123&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Novocure Ltd.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">161,218&#160;</td><td align="right" valign="bottom">2,079,712&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Novocure Ltd.  (c)&#160;</td><td valign="top"/><td align="right" valign="bottom">155,553&#160;</td><td align="right" valign="bottom">2,006,634&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Vermillion, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">991,800&#160;</td><td align="right" valign="bottom">1,378,602&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Zosano Pharma Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">598,503&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">1,286,781&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">7,204,852&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Life Sciences Tools &amp; Services - 0.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Life Sciences Tools &amp; Services - 0.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">JHL Biotech, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">459,540&#160;</td><td align="right" valign="bottom">1,242,634&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Transgenomic, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">13,500&#160;</td><td align="right" valign="bottom">8,235&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Transgenomic, Inc. warrants 2/3/17 (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">81,000&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">1&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">1,250,870&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Personal Products - 0.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Personal Products - 0.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">MYOS Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">6,666&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">11,399&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Pharmaceuticals - 10.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Pharmaceuticals - 10.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Achaogen, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">125,415&#160;</td><td align="right" valign="bottom">425,157&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Adimab LLC unit (a)(e)(f)&#160;</td><td valign="top"/><td align="right" valign="bottom">398,401&#160;</td><td align="right" valign="bottom">7,629,379&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Aradigm Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">8,786&#160;</td><td align="right" valign="bottom">43,754&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Auris Medical Holding AG  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">261,667&#160;</td><td align="right" valign="bottom">957,701&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Avexis, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">48,273&#160;</td><td align="right" valign="bottom">1,206,825&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Axsome Therapeutics, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">931,260&#160;</td><td align="right" valign="bottom">10,662,927&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Cempra, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,143,578&#160;</td><td align="right" valign="bottom">19,360,776&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Dermira, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">389,114&#160;</td><td align="right" valign="bottom">9,840,693&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Dermira, Inc.  (c)&#160;</td><td valign="top"/><td align="right" valign="bottom">162,931&#160;</td><td align="right" valign="bottom">4,120,525&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Egalet Corp.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,252,974&#160;</td><td align="right" valign="bottom">8,545,283&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Eisai Co. Ltd.  (g)&#160;</td><td valign="top"/><td align="right" valign="bottom">114,400&#160;</td><td align="right" valign="bottom">7,081,328&#160;</td>
</tr>
<tr>
<td align="left" valign="top">GW Pharmaceuticals PLC ADR  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">282,536&#160;</td><td align="right" valign="bottom">22,891,067&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Horizon Pharma PLC  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,691,209&#160;</td><td align="right" valign="bottom">25,993,882&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Intra-Cellular Therapies, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">274,154&#160;</td><td align="right" valign="bottom">9,408,965&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Jazz Pharmaceuticals PLC  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">254,367&#160;</td><td align="right" valign="bottom">38,333,107&#160;</td>
</tr>
<tr>
<td align="left" valign="top">MyoKardia, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">831,134&#160;</td><td align="right" valign="bottom">9,508,173&#160;</td>
</tr>
<tr>
<td align="left" valign="top">MyoKardia, Inc.  (c)&#160;</td><td valign="top"/><td align="right" valign="bottom">484,646&#160;</td><td align="right" valign="bottom">5,544,350&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Nektar Therapeutics  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">246,332&#160;</td><td align="right" valign="bottom">3,862,486&#160;</td>
</tr>
<tr>
<td align="left" valign="top">NeurogesX, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">150,000&#160;</td><td align="right" valign="bottom">750&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Ocular Therapeutix, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">337,771&#160;</td><td align="right" valign="bottom">4,147,828&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Orexigen Therapeutics, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">860,457&#160;</td><td align="right" valign="bottom">384,624&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Pacira Pharmaceuticals, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">371,220&#160;</td><td align="right" valign="bottom">20,086,714&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Paratek Pharmaceuticals, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">799,460&#160;</td><td align="right" valign="bottom">10,888,645&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Parnell Pharmaceuticals Holdings Ltd.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">123,569&#160;</td><td align="right" valign="bottom">249,609&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Repros Therapeutics, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">652,054&#160;</td><td align="right" valign="bottom">1,545,368&#160;</td>
</tr>
<tr>
<td align="left" valign="top">SCYNEXIS, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">101,000&#160;</td><td align="right" valign="bottom">401,980&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Sun Pharmaceutical Industries Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">490,668&#160;</td><td align="right" valign="bottom">5,992,863&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Tetraphase Pharmaceuticals, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">378,131&#160;</td><td align="right" valign="bottom">2,117,534&#160;</td>
</tr>
<tr>
<td align="left" valign="top">The Medicines Company  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">565,722&#160;</td><td align="right" valign="bottom">20,134,046&#160;</td>
</tr>
<tr>
<td align="left" valign="top">TherapeuticsMD, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,497,500&#160;</td><td align="right" valign="bottom">12,354,375&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Theravance Biopharma, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">367,503&#160;</td><td align="right" valign="bottom">7,625,687&#160;</td>
</tr>
<tr>
<td align="left" valign="top">WAVE Life Sciences&#160;</td><td valign="top"/><td align="right" valign="bottom">230,144&#160;</td><td align="right" valign="bottom">3,080,431&#160;</td>
</tr>
<tr>
<td align="left" valign="top">WAVE Life Sciences  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">138,344&#160;</td><td align="right" valign="bottom">1,870,411&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Zogenix, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">594,534&#160;</td><td align="right" valign="bottom">6,093,974&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Zogenix, Inc. warrants 7/27/17 (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">32,985&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">838&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">282,392,055&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">TOTAL COMMON STOCKS&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">(Cost $2,679,065,945)&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">2,604,865,936&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold; color: #ffffff; background-color: #000000;">
<td align="left" valign="top">Preferred Stocks - 1.8%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Convertible Preferred Stocks - 1.7%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Biotechnology - 1.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Biotechnology - 1.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">23andMe, Inc. Series E  (e)&#160;</td><td valign="top"/><td align="right" valign="bottom">341,730&#160;</td><td align="right" valign="bottom">3,396,796&#160;</td>
</tr>
<tr>
<td align="left" valign="top">AC Immune SA Series E  (e)&#160;</td><td valign="top"/><td align="right" valign="bottom">101,250&#160;</td><td align="right" valign="bottom">976,050&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Gensight Biologics Series B  (e)&#160;</td><td valign="top"/><td align="right" valign="bottom">76,600&#160;</td><td align="right" valign="bottom">369,263&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Immunocore Ltd. Series A  (e)&#160;</td><td valign="top"/><td align="right" valign="bottom">17,149&#160;</td><td align="right" valign="bottom">4,421,855&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Intellia Therapeutics, Inc. Series B  (e)&#160;</td><td valign="top"/><td align="right" valign="bottom">78,635&#160;</td><td align="right" valign="bottom">1,273,887&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Jounce Therapeutics, Inc. Series B  (e)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,591,779&#160;</td><td align="right" valign="bottom">2,187,104&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Moderna LLC:&#160;</td><td valign="top"/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Series D, 8.00% (a)(e)&#160;</td><td valign="top"/><td align="right" valign="bottom">26,918&#160;</td><td align="right" valign="bottom">1,245,173&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Series E  (a)(e)&#160;</td><td valign="top"/><td align="right" valign="bottom">54,410&#160;</td><td align="right" valign="bottom">2,516,898&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Ovid Therapeutics, Inc. Series B  (e)&#160;</td><td valign="top"/><td align="right" valign="bottom">246,448&#160;</td><td align="right" valign="bottom">917,279&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Pronutria Biosciences, Inc. Series C  (a)(e)&#160;</td><td valign="top"/><td align="right" valign="bottom">341,857&#160;</td><td align="right" valign="bottom">5,876,522&#160;</td>
</tr>
<tr>
<td align="left" valign="top">RaNA Therapeutics LLC Series B  (e)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,310,353&#160;</td><td align="right" valign="bottom">744,281&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Scholar Rock LLC Series B  (e)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,083,994&#160;</td><td align="right" valign="bottom">2,306,739&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Twist Bioscience Corp.:&#160;</td><td valign="top"/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Series C  (e)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,866,791&#160;</td><td align="right" valign="bottom">4,005,573&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Series D  (e)&#160;</td><td valign="top"/><td align="right" valign="bottom">453,587&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">973,262&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">31,210,682&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Health Care Providers &amp; Services - 0.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Health Care Services - 0.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Allena Pharmaceuticals, Inc. Series C  (e)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,505,538&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">2,681,363&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Health Care Technology - 0.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Health Care Technology - 0.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Codiak Biosciences, Inc.:&#160;</td><td valign="top"/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Series A  (e)&#160;</td><td valign="top"/><td align="right" valign="bottom">213,402&#160;</td><td align="right" valign="bottom">464,149&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Series B  (e)&#160;</td><td valign="top"/><td align="right" valign="bottom">693,558&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">1,508,489&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">1,972,638&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Pharmaceuticals - 0.4%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Pharmaceuticals - 0.4%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Afferent Pharmaceuticals, Inc. Series C  (e)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,915,787&#160;</td><td align="right" valign="bottom">2,693,597&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Kolltan Pharmaceuticals, Inc. Series D  (a)(e)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,610,391&#160;</td><td align="right" valign="bottom">1,272,209&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Stemcentrx, Inc. Series G  (e)&#160;</td><td valign="top"/><td align="right" valign="bottom">208,907&#160;</td><td align="right" valign="bottom">5,473,363&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Syros Pharmaceuticals, Inc. Series B, 6.00% (a)(e)&#160;</td><td valign="top"/><td align="right" valign="bottom">234,635&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">591,280&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">10,030,449&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL CONVERTIBLE PREFERRED STOCKS&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">45,895,132&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Nonconvertible Preferred Stocks - 0.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Biotechnology - 0.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Biotechnology - 0.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Yumanity Holdings LLC Class A  (e)&#160;</td><td valign="top"/><td align="right" valign="bottom">151,084&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">1,166,368&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">TOTAL PREFERRED STOCKS&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">(Cost $49,246,944)&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">47,061,500&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold; color: #ffffff; background-color: #000000;">
<td align="left" valign="top">Money Market Funds - 10.4%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Cash Central Fund, 0.38% (h)&#160;</td><td valign="top"/><td align="right" valign="bottom">22,580,694&#160;</td><td align="right" valign="bottom">22,580,694&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Securities Lending Cash Central Fund, 0.42% (h)(i)&#160;</td><td valign="top"/><td align="right" valign="bottom">257,187,687&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">257,187,687&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">TOTAL MONEY MARKET FUNDS&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">(Cost $279,768,381)&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">279,768,381&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">TOTAL INVESTMENT PORTFOLIO - 109.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">(Cost $3,008,081,270)&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td style="font-weight: bold;" align="right" valign="top">2,931,695,817&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">NET OTHER ASSETS (LIABILITIES) - (9.5)%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">(253,849,675)&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">NET ASSETS - 100%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="top" style="border-bottom: double 3px black; font-weight: bold;">$2,677,846,142&#160;</td>
</tr>
</table>
<br/>
<p style="font: bold 12pt Arial, Helvetica, sans-serif;">Legend</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(a)&#160;Non-income producing</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(b)&#160;Security or a portion of the security is on loan at period end.</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(c)&#160;Security exempt from registration under Rule 144A of the Securities Act of 1933.  These securities may be resold in transactions exempt from registration, normally to qualified institutional buyers. At the end of the period, the value of these securities amounted to $46,670,628 or 1.7% of net assets.</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(d)&#160;Affiliated company</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(e)&#160;Restricted securities - Investment in securities not registered under the Securities Act of 1933 (excluding 144A issues). At the end of the period, the value of restricted securities (excluding 144A issues) amounted to $56,329,217 or 2.1% of net assets.</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(f)&#160;Investment is owned by a wholly-owned subsidiary (Subsidiary) that is treated as a corporation for U.S. tax purposes.</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(g)&#160;A portion of the security sold on a delayed delivery basis.</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(h)&#160;Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request.</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(i)&#160;Investment made with cash collateral received from securities on loan.</p>
<br/>
<p style="font: normal 10pt Arial, Helvetica, sans-serif;">Additional information on each restricted holding is as follows:</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="7" cellpadding="0" width="745">
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">Security&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Acquisition Date&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Acquisition Cost&#160;</td>
</tr>
<tr>
<td align="left" valign="top">23andMe, Inc. Series E&#160;</td><td align="right" valign="bottom">6/18/15&#160;</td><td align="right" valign="bottom">$3,700,003&#160;</td>
</tr>
<tr>
<td align="left" valign="top">AC Immune SA Series E&#160;</td><td align="right" valign="bottom">10/19/15&#160;</td><td align="right" valign="bottom">$975,669&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Adimab LLC unit&#160;</td><td align="right" valign="bottom">9/17/14 - 6/5/15&#160;</td><td align="right" valign="bottom">$6,416,091&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Afferent Pharmaceuticals, Inc. Series C&#160;</td><td align="right" valign="bottom">7/1/15&#160;</td><td align="right" valign="bottom">$4,700,000&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Allena Pharmaceuticals, Inc. Series C&#160;</td><td align="right" valign="bottom">11/25/15&#160;</td><td align="right" valign="bottom">$3,989,676&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Codiak Biosciences, Inc. Series A&#160;</td><td align="right" valign="bottom">11/12/15&#160;</td><td align="right" valign="bottom">$213,402&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Codiak Biosciences, Inc. Series B&#160;</td><td align="right" valign="bottom">11/12/15&#160;</td><td align="right" valign="bottom">$2,080,674&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Gensight Biologics Series B&#160;</td><td align="right" valign="bottom">7/2/15&#160;</td><td align="right" valign="bottom">$590,265&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Immunocore Ltd. Series A&#160;</td><td align="right" valign="bottom">7/27/15&#160;</td><td align="right" valign="bottom">$3,227,085&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Intellia Therapeutics, Inc. Series B&#160;</td><td align="right" valign="bottom">8/20/15&#160;</td><td align="right" valign="bottom">$638,484&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Jounce Therapeutics, Inc. Series B&#160;</td><td align="right" valign="bottom">4/17/15&#160;</td><td align="right" valign="bottom">$3,597,421&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Kolltan Pharmaceuticals, Inc. Series D&#160;</td><td align="right" valign="bottom">3/13/14&#160;</td><td align="right" valign="bottom">$1,610,391&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Moderna LLC Series D, 8.00%&#160;</td><td align="right" valign="bottom">11/6/13&#160;</td><td align="right" valign="bottom">$574,161&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Moderna LLC Series E&#160;</td><td align="right" valign="bottom">12/18/14&#160;</td><td align="right" valign="bottom">$3,355,465&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Ovid Therapeutics, Inc. Series B&#160;</td><td align="right" valign="bottom">8/10/15&#160;</td><td align="right" valign="bottom">$1,535,371&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Pronutria Biosciences, Inc. Series C&#160;</td><td align="right" valign="bottom">1/30/15&#160;</td><td align="right" valign="bottom">$3,445,919&#160;</td>
</tr>
<tr>
<td align="left" valign="top">RaNA Therapeutics LLC Series B&#160;</td><td align="right" valign="bottom">7/17/15&#160;</td><td align="right" valign="bottom">$1,415,181&#160;</td>
</tr>
<tr>
<td align="left" valign="top">RPI International Holdings LP&#160;</td><td align="right" valign="bottom">5/21/15&#160;</td><td align="right" valign="bottom">$1,439,559&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Scholar Rock LLC Series B&#160;</td><td align="right" valign="bottom">12/17/15&#160;</td><td align="right" valign="bottom">$3,251,982&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Stemcentrx, Inc. Series G&#160;</td><td align="right" valign="bottom">8/14/15&#160;</td><td align="right" valign="bottom">$4,813,217&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Syros Pharmaceuticals, Inc. Series B, 6.00%&#160;</td><td align="right" valign="bottom">10/9/14 - 1/12/16&#160;</td><td align="right" valign="bottom">$738,186&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Twist Bioscience Corp. Series C&#160;</td><td align="right" valign="bottom">5/29/15&#160;</td><td align="right" valign="bottom">$2,800,000&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Twist Bioscience Corp. Series D&#160;</td><td align="right" valign="bottom">1/8/16&#160;</td><td align="right" valign="bottom">$973,262&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Yumanity Holdings LLC Class A&#160;</td><td align="right" valign="bottom">2/8/16&#160;</td><td align="right" valign="bottom">$1,021,131&#160;</td>
</tr>
</table>
<br/>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Affiliated Central Funds</p>
<p style="font: normal 10pt Arial, Helvetica, sans-serif;">Information regarding fiscal year to date income earned by the Fund from investments in Fidelity Central Funds is as follows:</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="7" cellpadding="0" width="745">
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">Fund&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Income earned&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Cash Central Fund&#160;</td><td align="right" valign="bottom">$34,344&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Securities Lending Cash Central Fund&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">4,888,273&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Total&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$4,922,617&#160;</td>
</tr>
</table>
<br/>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Other Affiliated Issuers</p>
<p>An affiliated company is a company in which the Fund has ownership of at least 5% of the voting securities.  Fiscal year to date transactions with companies which are or were affiliates are as follows:</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="7" cellpadding="0" width="745">
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">Affiliate&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Value, beginning of period&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Purchases&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Sales Proceeds&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Dividend Income&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Value, end of period&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Adamas Pharmaceuticals, Inc.&#160;</td><td align="right" valign="bottom">$22,064,924&#160;</td><td align="right" valign="bottom">$3,508,766&#160;</td><td align="right" valign="bottom">$835,689&#160;</td><td align="right" valign="bottom">$--&#160;</td><td align="right" valign="bottom">$--&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Aegerion Pharmaceuticals, Inc.&#160;</td><td align="right" valign="bottom">27,497,252&#160;</td><td align="right" valign="bottom">--&#160;</td><td align="right" valign="bottom">2,124,959&#160;</td><td align="right" valign="bottom">--&#160;</td><td align="right" valign="bottom">--&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Egalet Corp.&#160;</td><td align="right" valign="bottom">5,675,368&#160;</td><td align="right" valign="bottom">9,528,212&#160;</td><td align="right" valign="bottom">--&#160;</td><td align="right" valign="bottom">--&#160;</td><td align="right" valign="bottom">--&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Histogenics Corp.&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">4,284,042&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">--&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">5,027&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">--&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">1,588,692&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Total&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$59,521,586&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$13,036,978&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$2,965,675&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$--&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$1,588,692&#160;</td>
</tr>
</table>
<br/>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Investment Valuation</p>
<p style="font: normal 10pt Arial, Helvetica, sans-serif;">The following is a summary of the inputs used, as of April 30, 2016, involving the Fund's assets and liabilities carried at fair value. The inputs or methodology used for valuing securities may not be an indication of the risk associated with investing in those securities. Additional information on valuation inputs, and their aggregation into the levels used below, is provided later in this section.</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="7" cellpadding="0" width="745">
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">&#160;</td><td style="font-weight: bold;" align="center" valign="bottom" colspan="4">Valuation Inputs at Reporting Date:&#160;</td>
</tr>
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">Description&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Total&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Level 1&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Level 2&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Level 3&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top"><u>Investments in Securities:</u>&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Common Stocks&#160;</td><td align="right" valign="bottom">$2,604,865,936&#160;</td><td align="right" valign="bottom">$2,574,970,205&#160;</td><td align="right" valign="bottom">$20,627,264&#160;</td><td align="right" valign="bottom">$9,268,467&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Preferred Stocks&#160;</td><td align="right" valign="bottom">47,061,500&#160;</td><td align="right" valign="bottom">--&#160;</td><td align="right" valign="bottom">1,273,887&#160;</td><td align="right" valign="bottom">45,787,613&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Money Market Funds&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">279,768,381&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">279,768,381&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">--&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">--&#160;</td>
</tr>
<tr>
<td style="font-weight: bold" valign="top">Total Investments in Securities:&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$2,931,695,817&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$2,854,738,586&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$21,901,151&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$55,056,080&#160;</td>
</tr>
</table>
<br/>
<p style="font: normal 10pt Arial, Helvetica, sans-serif;">The following is a reconciliation of Investments in Securities for which Level 3 inputs were used in determining value:</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="7" cellpadding="0" width="745">
<tr style="font-weight:bold;">
<td align="left" valign="top">Investments in Securities:&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="border-bottom: solid 1px black;">Other Investments in Securities&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Beginning Balance&#160;</td><td align="right" valign="bottom">$13,219,438&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Total Realized Gain (Loss)&#160;</td><td align="right" valign="bottom">--&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Total Unrealized Gain (Loss)&#160;</td><td align="right" valign="bottom">(1,027,385)&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Cost of Purchases&#160;</td><td align="right" valign="bottom">13,447&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Proceeds of Sales&#160;</td><td align="right" valign="bottom">(878,043)&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Amortization/Accretion&#160;</td><td align="right" valign="bottom">--&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Transfers in to Level 3&#160;</td><td align="right" valign="bottom">900&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Transfers out of Level 3&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">(2,059,890)&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Ending Balance&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$9,268,467&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">The change in unrealized gain (loss) for the period attributable to Level 3 securities held at April 30, 2016&#160;</td><td align="right" valign="bottom">$156,628&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="border-bottom: solid 1px black;">Preferred Stocks&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Beginning Balance&#160;</td><td align="right" valign="bottom">$59,208,008&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Total Realized Gain (Loss)&#160;</td><td align="right" valign="bottom">--&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Total Unrealized Gain (Loss)&#160;</td><td align="right" valign="bottom">(12,705,485)&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Cost of Purchases&#160;</td><td align="right" valign="bottom">19,076,628&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Proceeds of Sales&#160;</td><td align="right" valign="bottom">(19,791,538)&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Amortization/Accretion&#160;</td><td align="right" valign="bottom">--&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Transfers in to Level 3&#160;</td><td align="right" valign="bottom">--&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Transfers out of Level 3&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">--&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Ending Balance&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$45,787,613&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">The change in unrealized gain (loss) for the period attributable to Level 3 securities held at April 30, 2016&#160;</td><td align="right" valign="bottom">$(3,912,634)&#160;</td>
</tr>
</table>
<br/>
<p style="font: italic 10pt Arial, Helvetica, sans-serif;">The information used in the above reconciliations represents fiscal year to date activity for any Investments in Securities identified as using Level 3 inputs at either the beginning or the end of the current fiscal period. Transfers in or out of Level 3 represent the beginning value of any Security or Instrument where a change in the pricing level occurred from the beginning to the end of the period. The cost of purchases and the proceeds of sales may include securities received or delivered through corporate actions or exchanges.</p>
<p>Investments are valued as of 4:00 p.m. Eastern time on the last calendar day of the period. Security transactions are accounted for as of trade date. The Board of Trustees (the Board) has delegated the day to day responsibility for the valuation of the Fund's investments to the Fidelity SelectCo, LLC (SelectCo) Fair Value Committee (the Committee). In accordance with valuation policies and procedures approved by the Board, the Fund attempts to obtain prices from one or more third party pricing vendors or brokers to value its investments. When current market prices, quotations or currency exchange rates are not readily available or reliable, investments will be fair valued in good faith by the Committee, in accordance with procedures adopted by the Board. Factors used in determining fair value vary by investment type and may include market or investment specific events. The frequency with which these procedures are used cannot be predicted and they may be utilized to a significant extent. The Committee oversees the Fund&#146;s valuation policies and procedures and reports to the Board on the Committee's activities and fair value determinations. The Board monitors the appropriateness of the procedures used in valuing the Fund's investments and ratifies the fair value determinations of the Committee. The Fund categorizes the inputs to valuation techniques used to value its investments into a disclosure hierarchy consisting of three levels: Level 1 - quoted prices in active markets for identical investments: Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds etc.): Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available). Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. Valuation techniques used to value the Fund's investments by major category are as follows:</p>
<p>Equity securities, including restricted securities, for which market quotations are readily available, are valued at the last reported sale price or official closing price as reported by a third party pricing vendor on the primary market or exchange on which they are traded and are categorized as Level 1 in the hierarchy. In the event there were no sales during the day or closing prices are not available, securities are valued at the last quoted bid price or may be valued using the last available price and are generally categorized as Level 2 in the hierarchy. For foreign equity securities, when market or security specific events arise, comparisons to the valuation of American Depositary Receipts (ADRs), futures contracts, Exchange-Traded Funds (ETFs) and certain indexes as well as quoted prices for similar securities may be used and would be categorized as Level 2 in the hierarchy. Utilizing these techniques may result in transfers between Level 1 and Level 2. For equity securities, including restricted securities, where observable inputs are limited, assumptions about market activity and risk are used and these securities may be categorized as Level 3 in the hierarchy. Equity securities, including restricted securities, for which observable inputs are not available, are valued using alternate valuation approaches, including the market approach and the income approach and are categorized as Level 3 in the hierarchy. The market approach generally consists of using comparable market transactions while the income approach generally consists of using the net present value of estimated future cash flows, adjusted as appropriate for liquidity, credit, market and/or other risk factors.</p>
<p>The following provides information on Level 3 securities held by the fund that were valued at period end based on unobservable inputs. These amounts exclude valuations provided by a broker.</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="7" cellpadding="0" width="745">
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">Asset Type&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Fair Value at 04/30/16&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Valuation Technique (s)&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Unobservable Input&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Amount or Range / Weighted Average&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Impact to Valuation from an Increase in Input(a)&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Equities&#160;</td><td align="right" valign="bottom">$55,056,080&#160;</td><td align="right" valign="bottom">Discount cash flow&#160;</td><td align="right" valign="bottom">Discount rate&#160;</td><td align="right" valign="bottom">3.5% - 15.0% / 10.1%&#160;</td><td align="right" valign="bottom">Decrease&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">Discount for lack of marketability&#160;</td><td align="right" valign="bottom">10.0%&#160;</td><td align="right" valign="bottom">Decrease&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">Probability rate&#160;</td><td align="right" valign="bottom">6.3% - 31.7% / 15.8%&#160;</td><td align="right" valign="bottom">Increase&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">Entity valuation&#160;</td><td align="right" valign="bottom">Entity valuation&#160;</td><td align="right" valign="bottom">$136.18&#160;</td><td align="right" valign="bottom">Increase&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">Last transaction price&#160;</td><td align="right" valign="bottom">Transaction price&#160;</td><td align="right" valign="bottom">$0.01 - $150.00 / $28.92&#160;</td><td align="right" valign="bottom">Increase&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">Market comparable&#160;</td><td align="right" valign="bottom">EV/Sales multiple&#160;</td><td align="right" valign="bottom">2.2&#160;</td><td align="right" valign="bottom">Increase&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">Discount rate&#160;</td><td align="right" valign="bottom">23.0%&#160;</td><td align="right" valign="bottom">Decrease&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">Proxy adjustment&#160;</td><td align="right" valign="bottom">Proxy movement&#160;</td><td align="right" valign="bottom">2.0% - 47.4% / 27.1%&#160;</td><td align="right" valign="bottom">Increase&#160;</td>
</tr>
</table>
<br/>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(a)&#160;<i>Represents the expected directional change in the fair value of the Level 3 investments that would result from an increase in the corresponding input. A decrease to the unobservable input would have the opposite effect. Significant changes in these inputs could result in significantly higher or lower fair value measurements.</i>
</p>
<br/>
<p>Investments in open-end mutual funds, including the Fidelity Central Funds, are valued at their closing net asset value each business day and are categorized as Level 1 in the hierarchy.</p>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Other Information</p>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Income Tax Information</p>
<p>At April 30, 2016, the cost of investment securities for income tax purposes was $3,024,204,563. Net unrealized depreciation aggregated $92,508,746, of which $533,687,488 related to appreciated investment securities and $626,196,234 related to depreciated investment securities.</p>
<p>For additional information on the Fund's policy regarding valuation of investments and other significant accounting policies, please refer to the Fund's most recent semiannual or annual shareholder report.</p>
<br/>
<br/>
<br/>
<br/>
<p style="font-style: italic;">
</p><p style="font-style: italic;">The fund's schedule of investments as of the date on the cover of this report has not been audited. This report is provided for the general information of the fund's shareholders. For more information regarding the fund and its holdings, please see the fund's most recent prospectus and annual report.</p>

<p style="font-style: italic;">
</p><p style="font-style: italic;">Third party trademarks and service marks are the property of their respective owners. All other trademarks and service marks are the property of FMR LLC or an affiliate.</p>

<hr size="2" noshade="noshade"/>
</div>
<div style="font: normal 11pt Arial, Helvetica, sans-serif; width: 780px">
<!-- Automatically produced using the ProofPlus Content Management System -->
<p style="font: bold 18pt Arial, Helvetica, sans-serif; margin-bottom: 0px;" align="center">Quarterly Holdings Report<br clear="all"/>for</p>
<p style="font: bold 20pt Arial, Helvetica, sans-serif; margin-top: 0px;" align="center">Fidelity Advisor&#174; Technology Fund</p>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-top: 0px;" align="center">April 30, 2016</p>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>AFTF-QTLY-0616<br/>1.800330.112<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<a name="">
<p style="font: bold 16pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Investments April 30, 2016 (Unaudited)</p>
</a>
<p style="font: normal 11pt Arial, Helvetica, sans-serif; margin-top: 0px;">Showing Percentage of Net Assets</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="0" cellpadding="5" width="745">
<tr style="font-weight:bold; color: #ffffff; background-color: #000000;">
<td align="left" valign="top">Common Stocks - 96.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">&#160;</td><td/><td style="font-weight: bold;" align="center" valign="bottom">Shares&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Value&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Automobiles - 1.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Automobile Manufacturers - 1.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Tesla Motors, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">76,709&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">$18,468,459&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Biotechnology - 0.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Biotechnology - 0.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">BeiGene Ltd. ADR&#160;</td><td valign="top"/><td align="right" valign="bottom">40,537&#160;</td><td align="right" valign="bottom">1,125,307&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Genscript Biotech Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">15,144,000&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">2,427,931&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">3,553,238&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Chemicals - 0.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Specialty Chemicals - 0.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Duk San Neolux Co. Ltd.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">168,686&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">4,004,852&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Communications Equipment - 1.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Communications Equipment - 1.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Ciena Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">77,800&#160;</td><td align="right" valign="bottom">1,309,374&#160;</td>
</tr>
<tr>
<td align="left" valign="top">CommScope Holding Co., Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">200,100&#160;</td><td align="right" valign="bottom">6,085,041&#160;</td>
</tr>
<tr>
<td align="left" valign="top">F5 Networks, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">74,100&#160;</td><td align="right" valign="bottom">7,761,975&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Palo Alto Networks, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">25,600&#160;</td><td align="right" valign="bottom">3,862,272&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Radware Ltd.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">610&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">6,588&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">19,025,250&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Consumer Finance - 0.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Consumer Finance - 0.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">LendingClub Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">700&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">5,530&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Diversified Consumer Services - 2.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Education Services - 2.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">New Oriental Education &amp; Technology Group, Inc. sponsored ADR&#160;</td><td valign="top"/><td align="right" valign="bottom">761,300&#160;</td><td align="right" valign="bottom">29,812,508&#160;</td>
</tr>
<tr>
<td align="left" valign="top">TAL Education Group ADR  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">36,800&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">2,129,248&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">31,941,756&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Specialized Consumer Services - 0.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">LifeLock, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">867&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">10,092&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL DIVERSIFIED CONSUMER SERVICES&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">31,951,848&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Diversified Financial Services - 2.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Other Diversified Financial Services - 2.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Broadcom Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">206,700&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">30,126,525&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Specialized Finance - 0.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">MSCI, Inc. Class A&#160;</td><td valign="top"/><td align="right" valign="bottom">31,700&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">2,407,298&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL DIVERSIFIED FINANCIAL SERVICES&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">32,533,823&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Diversified Telecommunication Services - 0.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Alternative Carriers - 0.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">8x8, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,200&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">13,608&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Electrical Equipment - 0.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Electrical Components &amp; Equipment - 0.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Lumenpulse, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">21,700&#160;</td><td align="right" valign="bottom">294,706&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Nidec Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">10,100&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">740,068&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">1,034,774&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Electronic Equipment &amp; Components - 4.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Electronic Components - 2.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Alps Electric Co. Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">42,500&#160;</td><td align="right" valign="bottom">734,557&#160;</td>
</tr>
<tr>
<td align="left" valign="top">InvenSense, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">185,500&#160;</td><td align="right" valign="bottom">1,424,640&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Largan Precision Co. Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">112,000&#160;</td><td align="right" valign="bottom">7,870,476&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Ledlink Optics, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">791,075&#160;</td><td align="right" valign="bottom">1,261,194&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Murata Manufacturing Co. Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">22,900&#160;</td><td align="right" valign="bottom">2,986,419&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Samsung SDI Co. Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">59,376&#160;</td><td align="right" valign="bottom">5,908,189&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Sunny Optical Technology Group Co. Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">839,100&#160;</td><td align="right" valign="bottom">2,587,999&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Universal Display Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">73,100&#160;</td><td align="right" valign="bottom">4,262,461&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Yageo Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">2,450,660&#160;</td><td align="right" valign="bottom">3,990,487&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Yaskawa Electric Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">1,100&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">12,882&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">31,039,304&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Electronic Equipment &amp; Instruments - 0.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Chroma ATE, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">1,700,683&#160;</td><td align="right" valign="bottom">3,769,585&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Cognex Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">34,600&#160;</td><td align="right" valign="bottom">1,229,338&#160;</td>
</tr>
<tr>
<td align="left" valign="top">FEI Co.&#160;</td><td valign="top"/><td align="right" valign="bottom">200&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">17,804&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">5,016,727&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Electronic Manufacturing Services - 1.8%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Trimble Navigation Ltd.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,082,796&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">25,932,964&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Technology Distributors - 0.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Digital China Holdings Ltd. (H Shares)&#160;</td><td valign="top"/><td align="right" valign="bottom">23,000&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">15,879&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL ELECTRONIC EQUIPMENT &amp; COMPONENTS&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">62,004,874&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Health Care Equipment &amp; Supplies - 0.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Health Care Equipment - 0.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Intai Technology Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">517,000&#160;</td><td align="right" valign="bottom">2,448,720&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Olympus Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">4,500&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">175,305&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">2,624,025&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Health Care Providers &amp; Services - 0.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Managed Health Care - 0.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">HealthEquity, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">11,300&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">284,195&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Health Care Technology - 1.8%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Health Care Technology - 1.8%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">athenahealth, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">70,194&#160;</td><td align="right" valign="bottom">9,356,860&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Inovalon Holdings, Inc. Class A (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">201,700&#160;</td><td align="right" valign="bottom">3,449,070&#160;</td>
</tr>
<tr>
<td align="left" valign="top">M3, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">31,000&#160;</td><td align="right" valign="bottom">836,270&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Medidata Solutions, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">242,100&#160;</td><td align="right" valign="bottom">10,562,823&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Veeva Systems, Inc. Class A (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">81,500&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">2,242,065&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">26,447,088&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Hotels, Restaurants &amp; Leisure - 0.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Casinos &amp; Gaming - 0.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">500.com Ltd. sponsored ADR Class A (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">252,600&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">4,746,354&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Hotels, Resorts &amp; Cruise Lines - 0.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Tuniu Corp. Class A sponsored ADR  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">217,908&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">2,316,362&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL HOTELS, RESTAURANTS &amp; LEISURE&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">7,062,716&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Household Durables - 0.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Consumer Electronics - 0.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Sony Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">200,900&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">4,866,124&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Internet &amp; Catalog Retail - 2.7%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Catalog Retail - 0.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Liberty Interactive Corp. QVC Group Series A  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">309&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">8,096&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Internet Retail - 2.7%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Amazon.com, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">16,100&#160;</td><td align="right" valign="bottom">10,619,399&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Ctrip.com International Ltd. ADR  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">80,500&#160;</td><td align="right" valign="bottom">3,510,605&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Groupon, Inc. Class A (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">157,100&#160;</td><td align="right" valign="bottom">568,702&#160;</td>
</tr>
<tr>
<td align="left" valign="top">JD.com, Inc. sponsored ADR  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">174,600&#160;</td><td align="right" valign="bottom">4,462,776&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Jumei International Holding Ltd. sponsored ADR  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">524,953&#160;</td><td align="right" valign="bottom">3,322,952&#160;</td>
</tr>
<tr>
<td align="left" valign="top">MySale Group PLC  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">19,300&#160;</td><td align="right" valign="bottom">16,638&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Qunar Cayman Islands Ltd. sponsored ADR  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">247,994&#160;</td><td align="right" valign="bottom">10,120,635&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Vipshop Holdings Ltd. ADR  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">543,300&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">7,410,612&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">40,032,319&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL INTERNET &amp; CATALOG RETAIL&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">40,040,415&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Internet Software &amp; Services - 27.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Internet Software &amp; Services - 27.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">58.com, Inc. ADR  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">478,100&#160;</td><td align="right" valign="bottom">26,128,165&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Alibaba Group Holding Ltd. sponsored ADR  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">306,200&#160;</td><td align="right" valign="bottom">23,559,028&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Alphabet, Inc.:&#160;</td><td valign="top"/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Class A&#160;</td><td valign="top"/><td align="right" valign="bottom">109,887&#160;</td><td align="right" valign="bottom">77,786,810&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Class C&#160;</td><td valign="top"/><td align="right" valign="bottom">115,555&#160;</td><td align="right" valign="bottom">80,080,771&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Baidu.com, Inc. sponsored ADR  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">19,800&#160;</td><td align="right" valign="bottom">3,847,140&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Benefitfocus, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">47,089&#160;</td><td align="right" valign="bottom">1,784,673&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Box, Inc. Class A (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">58,500&#160;</td><td align="right" valign="bottom">756,405&#160;</td>
</tr>
<tr>
<td align="left" valign="top">ChannelAdvisor Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">35,576&#160;</td><td align="right" valign="bottom">443,277&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Cornerstone OnDemand, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">158,632&#160;</td><td align="right" valign="bottom">5,449,009&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Cvent, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">50,808&#160;</td><td align="right" valign="bottom">1,796,063&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Demandware, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">188,006&#160;</td><td align="right" valign="bottom">8,663,316&#160;</td>
</tr>
<tr>
<td align="left" valign="top">DeNA Co. Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">192,700&#160;</td><td align="right" valign="bottom">3,243,046&#160;</td>
</tr>
<tr>
<td align="left" valign="top">eBay, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">28,700&#160;</td><td align="right" valign="bottom">701,141&#160;</td>
</tr>
<tr>
<td align="left" valign="top">eGain Communications Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">64,050&#160;</td><td align="right" valign="bottom">238,266&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Endurance International Group Holdings, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">655,200&#160;</td><td align="right" valign="bottom">7,017,192&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Envestnet, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">245&#160;</td><td align="right" valign="bottom">7,688&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Facebook, Inc. Class A (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">712,311&#160;</td><td align="right" valign="bottom">83,753,527&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Hortonworks, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">207,600&#160;</td><td align="right" valign="bottom">2,401,932&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Instructure, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">103,253&#160;</td><td align="right" valign="bottom">2,079,515&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Marketo, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">186,213&#160;</td><td align="right" valign="bottom">4,094,824&#160;</td>
</tr>
<tr>
<td align="left" valign="top">NetEase, Inc. sponsored ADR&#160;</td><td valign="top"/><td align="right" valign="bottom">5,300&#160;</td><td align="right" valign="bottom">745,710&#160;</td>
</tr>
<tr>
<td align="left" valign="top">New Relic, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">122,222&#160;</td><td align="right" valign="bottom">3,150,883&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Q2 Holdings, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">700&#160;</td><td align="right" valign="bottom">16,737&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Rackspace Hosting, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">159,639&#160;</td><td align="right" valign="bottom">3,650,944&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Renren, Inc. ADR  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">272,700&#160;</td><td align="right" valign="bottom">859,005&#160;</td>
</tr>
<tr>
<td align="left" valign="top">SciQuest, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">279,854&#160;</td><td align="right" valign="bottom">3,867,582&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Shopify, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">2,300&#160;</td><td align="right" valign="bottom">73,255&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Shopify, Inc. Class A&#160;</td><td valign="top"/><td align="right" valign="bottom">32,700&#160;</td><td align="right" valign="bottom">1,041,495&#160;</td>
</tr>
<tr>
<td align="left" valign="top">SINA Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">122,398&#160;</td><td align="right" valign="bottom">6,130,916&#160;</td>
</tr>
<tr>
<td align="left" valign="top">SouFun Holdings Ltd. ADR  (b)&#160;</td><td valign="top"/><td align="right" valign="bottom">927,100&#160;</td><td align="right" valign="bottom">5,275,199&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Twitter, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">27,800&#160;</td><td align="right" valign="bottom">406,436&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Web.com Group, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">156,886&#160;</td><td align="right" valign="bottom">3,136,151&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Weibo Corp. sponsored ADR  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">800&#160;</td><td align="right" valign="bottom">19,576&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Xunlei Ltd. sponsored ADR  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">602,744&#160;</td><td align="right" valign="bottom">3,917,836&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Yahoo!, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,108,100&#160;</td><td align="right" valign="bottom">40,556,460&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Zillow Group, Inc.:&#160;</td><td valign="top"/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Class A (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">710&#160;</td><td align="right" valign="bottom">17,764&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Class C (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">720&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">17,309&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">406,715,046&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">IT Services - 6.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Data Processing &amp; Outsourced Services - 5.9%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Amadeus IT Holding SA Class A&#160;</td><td valign="top"/><td align="right" valign="bottom">176,000&#160;</td><td align="right" valign="bottom">8,008,755&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity National Information Services, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">36,195&#160;</td><td align="right" valign="bottom">2,381,631&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fiserv, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">43,600&#160;</td><td align="right" valign="bottom">4,260,592&#160;</td>
</tr>
<tr>
<td align="left" valign="top">FleetCor Technologies, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">9,700&#160;</td><td align="right" valign="bottom">1,500,396&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Global Payments, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">126,500&#160;</td><td align="right" valign="bottom">9,130,770&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Optimal Payments PLC (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,400,300&#160;</td><td align="right" valign="bottom">7,799,536&#160;</td>
</tr>
<tr>
<td align="left" valign="top">PayPal Holdings, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">77,100&#160;</td><td align="right" valign="bottom">3,020,778&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Sabre Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">52,300&#160;</td><td align="right" valign="bottom">1,514,085&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Total System Services, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">31,553&#160;</td><td align="right" valign="bottom">1,613,620&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Travelport Worldwide Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">345,223&#160;</td><td align="right" valign="bottom">4,815,861&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Vantiv, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">26,900&#160;</td><td align="right" valign="bottom">1,467,126&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Visa, Inc. Class A&#160;</td><td valign="top"/><td align="right" valign="bottom">528,900&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">40,852,236&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">86,365,386&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">IT Consulting &amp; Other Services - 0.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Cognizant Technology Solutions Corp. Class A (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">2,494&#160;</td><td align="right" valign="bottom">145,575&#160;</td>
</tr>
<tr>
<td align="left" valign="top">EPAM Systems, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">20,761&#160;</td><td align="right" valign="bottom">1,514,100&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Virtusa Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">400&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">14,216&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">1,673,891&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL IT SERVICES&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">88,039,277&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Life Sciences Tools &amp; Services - 0.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Life Sciences Tools &amp; Services - 0.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">JHL Biotech, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">555,476&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">1,502,053&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Machinery - 0.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Industrial Machinery - 0.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Harmonic Drive Systems, Inc.  (b)&#160;</td><td valign="top"/><td align="right" valign="bottom">38,600&#160;</td><td align="right" valign="bottom">864,625&#160;</td>
</tr>
<tr>
<td align="left" valign="top">King Slide Works Co. Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">29,000&#160;</td><td align="right" valign="bottom">343,389&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Minebea Mitsumi, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">117,000&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">958,346&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">2,166,360&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Media - 0.4%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Advertising - 0.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">iCar Asia Ltd.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,257,513&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">850,974&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Cable &amp; Satellite - 0.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Naspers Ltd. Class N&#160;</td><td valign="top"/><td align="right" valign="bottom">25,745&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">3,532,474&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Publishing - 0.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">NEXT Co. Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">21,800&#160;</td><td align="right" valign="bottom">243,773&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Schibsted ASA:&#160;</td><td valign="top"/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">(A Shares)&#160;</td><td valign="top"/><td align="right" valign="bottom">22,300&#160;</td><td align="right" valign="bottom">650,567&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">(B Shares)&#160;</td><td valign="top"/><td align="right" valign="bottom">51,941&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">1,476,592&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">2,370,932&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL MEDIA&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">6,754,380&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Professional Services - 0.6%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Human Resource &amp; Employment Services - 0.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">51job, Inc. sponsored ADR  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">400&#160;</td><td align="right" valign="bottom">11,920&#160;</td>
</tr>
<tr>
<td align="left" valign="top">WageWorks, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">127,844&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">6,885,678&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">6,897,598&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Research &amp; Consulting Services - 0.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">ICF International, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">33,600&#160;</td><td align="right" valign="bottom">1,322,832&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Verisk Analytics, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">168&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">13,033&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">1,335,865&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL PROFESSIONAL SERVICES&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">8,233,463&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Semiconductors &amp; Semiconductor Equipment - 16.8%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Semiconductor Equipment - 1.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Amkor Technology, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,180,846&#160;</td><td align="right" valign="bottom">6,742,631&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Applied Materials, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">900&#160;</td><td align="right" valign="bottom">18,423&#160;</td>
</tr>
<tr>
<td align="left" valign="top">ASM Pacific Technology Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">35,500&#160;</td><td align="right" valign="bottom">255,818&#160;</td>
</tr>
<tr>
<td align="left" valign="top">EO Technics Co. Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">69,078&#160;</td><td align="right" valign="bottom">6,837,406&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Hermes Microvision, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">83,000&#160;</td><td align="right" valign="bottom">2,556,574&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Nanometrics, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">9,409&#160;</td><td align="right" valign="bottom">168,045&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Rubicon Technology, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">444,367&#160;</td><td align="right" valign="bottom">311,012&#160;</td>
</tr>
<tr>
<td align="left" valign="top">SolarEdge Technologies, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">57,300&#160;</td><td align="right" valign="bottom">1,535,067&#160;</td>
</tr>
<tr>
<td align="left" valign="top">SunEdison, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">700&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">166&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">18,425,142&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Semiconductors - 15.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Advanced Micro Devices, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">361,400&#160;</td><td align="right" valign="bottom">1,282,970&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Advanced Semiconductor Engineering, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">7,701,000&#160;</td><td align="right" valign="bottom">7,398,703&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Advanced Semiconductor Engineering, Inc. sponsored ADR&#160;</td><td valign="top"/><td align="right" valign="bottom">1,253,362&#160;</td><td align="right" valign="bottom">6,429,747&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Ambarella, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">178,100&#160;</td><td align="right" valign="bottom">7,319,910&#160;</td>
</tr>
<tr>
<td align="left" valign="top">ams AG&#160;</td><td valign="top"/><td align="right" valign="bottom">10,410&#160;</td><td align="right" valign="bottom">275,090&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Cavium, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">68,200&#160;</td><td align="right" valign="bottom">3,367,034&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Chipbond Technology Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">2,799,000&#160;</td><td align="right" valign="bottom">3,725,877&#160;</td>
</tr>
<tr>
<td align="left" valign="top">ChipMOS TECHNOLOGIES (Bermuda) Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">284,629&#160;</td><td align="right" valign="bottom">4,787,460&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Cirrus Logic, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">22,714&#160;</td><td align="right" valign="bottom">819,975&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Dialog Semiconductor PLC  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">129,200&#160;</td><td align="right" valign="bottom">4,488,514&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Everlight Electronics Co. Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">1,099,000&#160;</td><td align="right" valign="bottom">1,539,478&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Genesis Photonics, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">794,066&#160;</td><td align="right" valign="bottom">138,150&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Himax Technologies, Inc. sponsored ADR  (b)&#160;</td><td valign="top"/><td align="right" valign="bottom">431,304&#160;</td><td align="right" valign="bottom">4,481,249&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Hua Hong Semiconductor Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">3,272,000&#160;</td><td align="right" valign="bottom">3,291,072&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Infineon Technologies AG&#160;</td><td valign="top"/><td align="right" valign="bottom">110,400&#160;</td><td align="right" valign="bottom">1,575,140&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Inphi Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">11,000&#160;</td><td align="right" valign="bottom">326,370&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Integrated Device Technology, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">85,000&#160;</td><td align="right" valign="bottom">1,638,800&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Intersil Corp. Class A&#160;</td><td valign="top"/><td align="right" valign="bottom">351,594&#160;</td><td align="right" valign="bottom">4,110,134&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Lextar Electronics Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">437,000&#160;</td><td align="right" valign="bottom">211,039&#160;</td>
</tr>
<tr>
<td align="left" valign="top">M/A-COM Technology Solutions Holdings, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">56,200&#160;</td><td align="right" valign="bottom">2,298,018&#160;</td>
</tr>
<tr>
<td align="left" valign="top">MagnaChip Semiconductor Corp.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">114,554&#160;</td><td align="right" valign="bottom">591,099&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Marvell Technology Group Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">3,017,861&#160;</td><td align="right" valign="bottom">30,118,253&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Maxim Integrated Products, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">287,300&#160;</td><td align="right" valign="bottom">10,262,356&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Melexis NV&#160;</td><td valign="top"/><td align="right" valign="bottom">293&#160;</td><td align="right" valign="bottom">16,178&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Micron Technology, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,978,400&#160;</td><td align="right" valign="bottom">21,267,800&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Microsemi Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">162,300&#160;</td><td align="right" valign="bottom">5,484,117&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Monolithic Power Systems, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">85,401&#160;</td><td align="right" valign="bottom">5,330,730&#160;</td>
</tr>
<tr>
<td align="left" valign="top">NXP Semiconductors NV  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">173,880&#160;</td><td align="right" valign="bottom">14,828,486&#160;</td>
</tr>
<tr>
<td align="left" valign="top">ON Semiconductor Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">780,400&#160;</td><td align="right" valign="bottom">7,390,388&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Power Integrations, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">46,100&#160;</td><td align="right" valign="bottom">2,224,325&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Qorvo, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">303,658&#160;</td><td align="right" valign="bottom">13,673,720&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Qualcomm, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">594,200&#160;</td><td align="right" valign="bottom">30,018,984&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Sanken Electric Co. Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">386,000&#160;</td><td align="right" valign="bottom">1,279,681&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Semiconductor Manufacturing International Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">16,310,000&#160;</td><td align="right" valign="bottom">1,340,814&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Semtech Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">471,898&#160;</td><td align="right" valign="bottom">10,211,873&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Silicon Laboratories, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">30,400&#160;</td><td align="right" valign="bottom">1,422,720&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Silicon Motion Technology Corp. sponsored ADR&#160;</td><td valign="top"/><td align="right" valign="bottom">90,688&#160;</td><td align="right" valign="bottom">3,496,022&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Sitronix Technology Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">235,000&#160;</td><td align="right" valign="bottom">686,747&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Skyworks Solutions, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">143,100&#160;</td><td align="right" valign="bottom">9,561,942&#160;</td>
</tr>
<tr>
<td align="left" valign="top">STMicroelectronics NV&#160;</td><td valign="top"/><td align="right" valign="bottom">1,630&#160;</td><td align="right" valign="bottom">10,022&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Vanguard International Semiconductor Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">431,000&#160;</td><td align="right" valign="bottom">659,782&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Xilinx, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">300&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">12,924&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">229,393,693&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL SEMICONDUCTORS &amp; SEMICONDUCTOR EQUIPMENT&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">247,818,835&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Software - 17.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Application Software - 7.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Adobe Systems, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">209,516&#160;</td><td align="right" valign="bottom">19,740,598&#160;</td>
</tr>
<tr>
<td align="left" valign="top">ANSYS, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">175&#160;</td><td align="right" valign="bottom">15,885&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Autodesk, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">266,400&#160;</td><td align="right" valign="bottom">15,936,048&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Blackbaud, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">17,200&#160;</td><td align="right" valign="bottom">1,062,444&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Callidus Software, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">55,800&#160;</td><td align="right" valign="bottom">1,021,140&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Citrix Systems, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">28,615&#160;</td><td align="right" valign="bottom">2,341,852&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Guidewire Software, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">190&#160;</td><td align="right" valign="bottom">10,824&#160;</td>
</tr>
<tr>
<td align="left" valign="top">HubSpot, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">7,700&#160;</td><td align="right" valign="bottom">341,033&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Intuit, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">70,600&#160;</td><td align="right" valign="bottom">7,122,834&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Kingdee International Software Group Co. Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">365,800&#160;</td><td align="right" valign="bottom">118,632&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Linx SA&#160;</td><td valign="top"/><td align="right" valign="bottom">700&#160;</td><td align="right" valign="bottom">9,627&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Mobileye NV  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">202,700&#160;</td><td align="right" valign="bottom">7,733,005&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Parametric Technology Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">500&#160;</td><td align="right" valign="bottom">18,230&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Paycom Software, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">900&#160;</td><td align="right" valign="bottom">34,389&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Paylocity Holding Corp.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">95,900&#160;</td><td align="right" valign="bottom">3,670,093&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Qlik Technologies, Inc. (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">400&#160;</td><td align="right" valign="bottom">12,316&#160;</td>
</tr>
<tr>
<td align="left" valign="top">RealPage, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">8,300&#160;</td><td align="right" valign="bottom">182,517&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Salesforce.com, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">350,519&#160;</td><td align="right" valign="bottom">26,569,340&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Splunk, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">79,700&#160;</td><td align="right" valign="bottom">4,142,806&#160;</td>
</tr>
<tr>
<td align="left" valign="top">SS&amp;C Technologies Holdings, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">35,700&#160;</td><td align="right" valign="bottom">2,183,055&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Ultimate Software Group, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">76&#160;</td><td align="right" valign="bottom">14,941&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Workday, Inc. Class A (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">64,600&#160;</td><td align="right" valign="bottom">4,843,708&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Workiva, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">51,400&#160;</td><td align="right" valign="bottom">612,174&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Zendesk, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">288,700&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">6,524,620&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">104,262,111&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Home Entertainment Software - 2.6%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Activision Blizzard, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">306,470&#160;</td><td align="right" valign="bottom">10,564,021&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Electronic Arts, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">59,900&#160;</td><td align="right" valign="bottom">3,704,815&#160;</td>
</tr>
<tr>
<td align="left" valign="top">NCSOFT Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">45,458&#160;</td><td align="right" valign="bottom">9,086,243&#160;</td>
</tr>
<tr>
<td align="left" valign="top">NHN Entertainment Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">88,294&#160;</td><td align="right" valign="bottom">4,662,567&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Nintendo Co. Ltd.  (c)&#160;</td><td valign="top"/><td align="right" valign="bottom">64,100&#160;</td><td align="right" valign="bottom">8,679,206&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Nintendo Co. Ltd. ADR&#160;</td><td valign="top"/><td align="right" valign="bottom">85,100&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">1,451,806&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">38,148,658&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Systems Software - 7.6%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Allot Communications Ltd.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">288,719&#160;</td><td align="right" valign="bottom">1,564,857&#160;</td>
</tr>
<tr>
<td align="left" valign="top">CommVault Systems, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">300&#160;</td><td align="right" valign="bottom">13,131&#160;</td>
</tr>
<tr>
<td align="left" valign="top">CyberArk Software Ltd.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">116,800&#160;</td><td align="right" valign="bottom">4,770,112&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fleetmatics Group PLC (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">360,130&#160;</td><td align="right" valign="bottom">13,054,713&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fortinet, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">462&#160;</td><td align="right" valign="bottom">15,020&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Imperva, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">64,200&#160;</td><td align="right" valign="bottom">2,984,016&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Infoblox, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">900&#160;</td><td align="right" valign="bottom">15,057&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Microsoft Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">1,047,100&#160;</td><td align="right" valign="bottom">52,218,877&#160;</td>
</tr>
<tr>
<td align="left" valign="top">NetSuite, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">232,777&#160;</td><td align="right" valign="bottom">18,864,248&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Oracle Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">189,800&#160;</td><td align="right" valign="bottom">7,565,428&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Progress Software Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">52,200&#160;</td><td align="right" valign="bottom">1,332,144&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Proofpoint, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">142,900&#160;</td><td align="right" valign="bottom">8,325,354&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Rapid7, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">2,500&#160;</td><td align="right" valign="bottom">31,300&#160;</td>
</tr>
<tr>
<td align="left" valign="top">ServiceNow, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">2,395&#160;</td><td align="right" valign="bottom">171,195&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Tableau Software, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">3,300&#160;</td><td align="right" valign="bottom">170,610&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Varonis Systems, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">900&#160;</td><td align="right" valign="bottom">17,235&#160;</td>
</tr>
<tr>
<td align="left" valign="top">VMware, Inc. Class A (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">28,595&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">1,627,341&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">112,740,638&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL SOFTWARE&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">255,151,407&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Technology Hardware, Storage &amp; Peripherals - 10.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Technology Hardware, Storage &amp; Peripherals - 10.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Apple, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">1,494,329&#160;</td><td align="right" valign="bottom">140,078,400&#160;</td>
</tr>
<tr>
<td align="left" valign="top">BlackBerry Ltd.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,486&#160;</td><td align="right" valign="bottom">10,493&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Catcher Technology Co. Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">319,000&#160;</td><td align="right" valign="bottom">2,241,680&#160;</td>
</tr>
<tr>
<td align="left" valign="top">EMC Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">142,300&#160;</td><td align="right" valign="bottom">3,715,453&#160;</td>
</tr>
<tr>
<td align="left" valign="top">HTC Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">1,567,000&#160;</td><td align="right" valign="bottom">3,997,177&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Nimble Storage, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,900&#160;</td><td align="right" valign="bottom">14,022&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Silicon Graphics International Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">166,658&#160;</td><td align="right" valign="bottom">746,628&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Stratasys Ltd.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">100&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">2,447&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">150,806,300&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">TOTAL COMMON STOCKS&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">(Cost $1,253,535,948)&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">1,421,107,940&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold; color: #ffffff; background-color: #000000;">
<td align="left" valign="top">Preferred Stocks - 1.7%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Convertible Preferred Stocks - 1.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Internet &amp; Catalog Retail - 0.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Internet Retail - 0.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">China Internet Plus Holdings Ltd. Series B  (d)&#160;</td><td valign="top"/><td align="right" valign="bottom">2,042,487&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">7,885,430&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Internet Software &amp; Services - 0.8%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Internet Software &amp; Services - 0.8%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Uber Technologies, Inc. Series D, 8.00% (a)(d)&#160;</td><td valign="top"/><td align="right" valign="bottom">232,064&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">11,318,278&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">IT Services - 0.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Data Processing &amp; Outsourced Services - 0.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Nutanix, Inc. Series E  (a)(d)&#160;</td><td valign="top"/><td align="right" valign="bottom">39,963&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">573,869&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL CONVERTIBLE PREFERRED STOCKS&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">19,777,577&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Nonconvertible Preferred Stocks - 0.4%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Internet &amp; Catalog Retail - 0.4%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Internet Retail - 0.4%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">China Internet Plus Holdings Ltd. Series A-11  (d)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,516,912&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">5,856,342&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">TOTAL PREFERRED STOCKS&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">(Cost $16,815,545)&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">25,633,919&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold; color: #ffffff; background-color: #000000;">
<td align="left" valign="top">Money Market Funds - 8.4%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Cash Central Fund, 0.38% (e)&#160;</td><td valign="top"/><td align="right" valign="bottom">26,845,508&#160;</td><td align="right" valign="bottom">26,845,508&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Securities Lending Cash Central Fund, 0.42% (e)(f)&#160;</td><td valign="top"/><td align="right" valign="bottom">96,373,137&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">96,373,137&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">TOTAL MONEY MARKET FUNDS&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">(Cost $123,218,645)&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">123,218,645&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">TOTAL INVESTMENT PORTFOLIO - 106.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">(Cost $1,393,570,138)&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td style="font-weight: bold;" align="right" valign="top">1,569,960,504&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">NET OTHER ASSETS (LIABILITIES) - (6.3)%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">(92,562,021)&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">NET ASSETS - 100%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="top" style="border-bottom: double 3px black; font-weight: bold;">$1,477,398,483&#160;</td>
</tr>
</table>
<br/>
<p style="font: bold 12pt Arial, Helvetica, sans-serif;">Legend</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(a)&#160;Non-income producing</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(b)&#160;Security or a portion of the security is on loan at period end.</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(c)&#160;Security or a portion of the security purchased on a delayed delivery or when-issued basis.</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(d)&#160;Restricted securities - Investment in securities not registered under the Securities Act of 1933 (excluding 144A issues). At the end of the period, the value of restricted securities (excluding 144A issues) amounted to $25,633,919 or 1.7% of net assetss.</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(e)&#160;Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request.</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(f)&#160;Investment made with cash collateral received from securities on loan.</p>
<br/>
<p style="font: normal 10pt Arial, Helvetica, sans-serif;">Additional information on each restricted holding is as follows:</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="7" cellpadding="0" width="745">
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">Security&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Acquisition Date&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Acquisition Cost&#160;</td>
</tr>
<tr>
<td align="left" valign="top">China Internet Plus Holdings Ltd. Series A-11&#160;</td><td align="right" valign="bottom">1/26/15&#160;</td><td align="right" valign="bottom">$4,794,731&#160;</td>
</tr>
<tr>
<td align="left" valign="top">China Internet Plus Holdings Ltd. Series B&#160;</td><td align="right" valign="bottom">12/11/15&#160;</td><td align="right" valign="bottom">$7,885,430&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Nutanix, Inc. Series E&#160;</td><td align="right" valign="bottom">8/26/14&#160;</td><td align="right" valign="bottom">$535,364&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Uber Technologies, Inc. Series D, 8.00%&#160;</td><td align="right" valign="bottom">6/6/14&#160;</td><td align="right" valign="bottom">$3,600,020&#160;</td>
</tr>
</table>
<br/>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Affiliated Central Funds</p>
<p style="font: normal 10pt Arial, Helvetica, sans-serif;">Information regarding fiscal year to date income earned by the Fund from investments in Fidelity Central Funds is as follows:</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="7" cellpadding="0" width="745">
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">Fund&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Income earned&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Cash Central Fund&#160;</td><td align="right" valign="bottom">$46,942&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Securities Lending Cash Central Fund&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">1,074,496&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Total&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$1,121,438&#160;</td>
</tr>
</table>
<br/>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Investment Valuation</p>
<p style="font: normal 10pt Arial, Helvetica, sans-serif;">The following is a summary of the inputs used, as of April 30, 2016, involving the Fund's assets and liabilities carried at fair value. The inputs or methodology used for valuing securities may not be an indication of the risk associated with investing in those securities. Additional information on valuation inputs, and their aggregation into the levels used below, is provided later in this section.</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="7" cellpadding="0" width="745">
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">&#160;</td><td style="font-weight: bold;" align="center" valign="bottom" colspan="4">Valuation Inputs at Reporting Date:&#160;</td>
</tr>
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">Description&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Total&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Level 1&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Level 2&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Level 3&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top"><u>Investments in Securities:</u>&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Common Stocks&#160;</td><td align="right" valign="bottom">$1,421,107,940&#160;</td><td align="right" valign="bottom">$1,376,465,628&#160;</td><td align="right" valign="bottom">$44,642,312&#160;</td><td align="right" valign="bottom">$--&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Preferred Stocks&#160;</td><td align="right" valign="bottom">25,633,919&#160;</td><td align="right" valign="bottom">--&#160;</td><td align="right" valign="bottom">--&#160;</td><td align="right" valign="bottom">25,633,919&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Money Market Funds&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">123,218,645&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">123,218,645&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">--&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">--&#160;</td>
</tr>
<tr>
<td style="font-weight: bold" valign="top">Total Investments in Securities:&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$1,569,960,504&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$1,499,684,273&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$44,642,312&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$25,633,919&#160;</td>
</tr>
</table>
<br/>
<p style="font: normal 10pt Arial, Helvetica, sans-serif;">The following is a summary of transfers between Level 1 and Level 2 for the period ended April 30, 2016. Transfers are assumed to have occurred at the beginning of the period, and are primarily attributable to the valuation techniques used for foreign equity securities, as discussed at the end of this section:</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="7" cellpadding="0" width="745">
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">Transfers&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Total&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Level 1 to Level 2&#160;</td><td align="right" valign="bottom">$49,932,528&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Level 2 to Level 1&#160;</td><td align="right" valign="bottom">$0&#160;</td>
</tr>
</table>
<br/>
<p style="font: normal 10pt Arial, Helvetica, sans-serif;">The following is a reconciliation of Investments in Securities for which Level 3 inputs were used in determining value:</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="7" cellpadding="0" width="745">
<tr style="font-weight:bold;">
<td align="left" valign="top">Investments in Securities:&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="border-bottom: solid 1px black;">Preferred Stocks&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Beginning Balance&#160;</td><td align="right" valign="bottom">$15,728,431&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Total Realized Gain (Loss)&#160;</td><td align="right" valign="bottom">--&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Total Unrealized Gain (Loss)&#160;</td><td align="right" valign="bottom">2,020,058&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Cost of Purchases&#160;</td><td align="right" valign="bottom">12,680,161&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Proceeds of Sales&#160;</td><td align="right" valign="bottom">(4,794,731)&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Amortization/Accretion&#160;</td><td align="right" valign="bottom">--&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Transfers in to Level 3&#160;</td><td align="right" valign="bottom">--&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Transfers out of Level 3&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">--&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Ending Balance&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$25,633,919&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">The change in unrealized gain (loss) for the period attributable to Level 3 securities held at April 30, 2016&#160;</td><td align="right" valign="bottom">$2,020,058&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="border-bottom: solid 1px black;">Other Investments in Securities&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Beginning Balance&#160;</td><td align="right" valign="bottom">$12,656,409&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Total Realized Gain (Loss)&#160;</td><td align="right" valign="bottom">(2,808,173)&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Total Unrealized Gain (Loss)&#160;</td><td align="right" valign="bottom">2,141,068&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Cost of Purchases&#160;</td><td align="right" valign="bottom">--&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Proceeds of Sales&#160;</td><td align="right" valign="bottom">(11,989,304)&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Amortization/Accretion&#160;</td><td align="right" valign="bottom">--&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Transfers in to Level 3&#160;</td><td align="right" valign="bottom">--&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Transfers out of Level 3&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">--&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Ending Balance&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$--&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">The change in unrealized gain (loss) for the period attributable to Level 3 securities held at April 30, 2016&#160;</td><td align="right" valign="bottom">$--&#160;</td>
</tr>
</table>
<br/>
<p style="font: italic 10pt Arial, Helvetica, sans-serif;">The information used in the above reconciliations represents fiscal year to date activity for any Investments in Securities identified as using Level 3 inputs at either the beginning or the end of the current fiscal period. Transfers in or out of Level 3 represent the beginning value of any Security or Instrument where a change in the pricing level occurred from the beginning to the end of the period. The cost of purchases and the proceeds of sales may include securities received or delivered through corporate actions or exchanges.</p>
<p>Investments are valued as of 4:00 p.m. Eastern time on the last calendar day of the period. Security transactions are accounted for as of trade date. The Board of Trustees (the Board) has delegated the day to day responsibility for the valuation of the Fund's investments to the Fidelity Management &amp; Research Company (FMR) Fair Value Committee (the Committee). In accordance with valuation policies and procedures approved by the Board, the Fund attempts to obtain prices from one or more third party pricing vendors or brokers to value its investments. When current market prices, quotations or currency exchange rates are not readily available or reliable, investments will be fair valued in good faith by the Committee, in accordance with procedures adopted by the Board. Factors used in determining fair value vary by investment type and may include market or investment specific events. The frequency with which these procedures are used cannot be predicted and they may be utilized to a significant extent. The Committee oversees the Fund&#146;s valuation policies and procedures and reports to the Board on the Committee's activities and fair value determinations. The Board monitors the appropriateness of the procedures used in valuing the Fund's investments and ratifies the fair value determinations of the Committee. The Fund categorizes the inputs to valuation techniques used to value its investments into a disclosure hierarchy consisting of three levels: Level 1 - quoted prices in active markets for identical investments: Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds etc.): Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available). Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. Valuation techniques used to value the Fund's investments by major category are as follows:</p>
<p>Equity securities, including restricted securities, for which market quotations are readily available, are valued at the last reported sale price or official closing price as reported by a third party pricing vendor on the primary market or exchange on which they are traded and are categorized as Level 1 in the hierarchy. In the event there were no sales during the day or closing prices are not available, securities are valued at the last quoted bid price or may be valued using the last available price and are generally categorized as Level 2 in the hierarchy. For foreign equity securities, when market or security specific events arise, comparisons to the valuation of American Depositary Receipts (ADRs), futures contracts, Exchange-Traded Funds (ETFs) and certain indexes as well as quoted prices for similar securities may be used and would be categorized as Level 2 in the hierarchy. Utilizing these techniques may result in transfers between Level 1 and Level 2. For equity securities, including restricted securities, where observable inputs are limited, assumptions about market activity and risk are used and these securities may be categorized as Level 3 in the hierarchy. Equity securities, including restricted securities, for which observable inputs are not available, are valued using alternate valuation approaches, including the market approach and the income approach and are categorized as Level 3 in the hierarchy. The market approach generally consists of using comparable market transactions while the income approach generally consists of using the net present value of estimated future cash flows, adjusted as appropriate for liquidity, credit, market and/or other risk factors.</p>
<p>Investments in open-end mutual funds, including the Fidelity Central Funds, are valued at their closing net asset value each business day and are categorized as Level 1 in the hierarchy.</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="7" cellpadding="0" width="745">
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">Asset Type&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Fair Value at 04/30/16&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Valuation Technique (s)&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Unobservable Input&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Amount or Range / Weighted Average&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Impact to Valuation from an Increase in Input(a)&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Equities&#160;</td><td align="right" valign="bottom">$25,633,919&#160;</td><td align="right" valign="bottom">Last transaction price&#160;</td><td align="right" valign="bottom">Transaction price&#160;</td><td align="right" valign="bottom">$3.86 - $48.77 / $24.14&#160;</td><td align="right" valign="bottom">Increase&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">Market comparable&#160;</td><td align="right" valign="bottom">EV/Sales multiple&#160;</td><td align="right" valign="bottom">3.0&#160;</td><td align="right" valign="bottom">Increase&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">Discount rate&#160;</td><td align="right" valign="bottom">10.0%&#160;</td><td align="right" valign="bottom">Decrease&#160;</td>
</tr>
</table>
<br/>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(a)&#160;<i>Represents the expected directional change in the fair value of the Level 3 investments that would result from an increase in the corresponding input. A decrease to the unobservable input would have the opposite effect. Significant changes in these inputs could result in significantly higher or lower fair value measurements.</i>
</p>
<br/>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Other Information</p>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Income Tax Information</p>
<p>At April 30, 2016, the cost of investment securities for income tax purposes was $1,404,366,842. Net unrealized appreciation aggregated $165,593,662, of which $246,794,208 related to appreciated investment securities and $81,200,546 related to depreciated investment securities.</p>
<p>For additional information on the Fund's policy regarding valuation of investments and other significant accounting policies, please refer to the Fund's most recent semiannual or annual shareholder report.</p>
<br/>
<br/>
<br/>
<br/>
<p style="font-style: italic;">
</p><p style="font-style: italic;">The fund's schedule of investments as of the date on the cover of this report has not been audited. This report is provided for the general information of the fund's shareholders. For more information regarding the fund and its holdings, please see the fund's most recent prospectus and annual report.</p>

<p style="font-style: italic;">
</p><p style="font-style: italic;">Third party trademarks and service marks are the property of their respective owners. All other trademarks and service marks are the property of FMR LLC or an affiliate.</p>

<hr size="2" noshade="noshade"/>
</div>
<div style="font: normal 11pt Arial, Helvetica, sans-serif; width: 780px">
<!-- Automatically produced using the ProofPlus Content Management System -->
<p style="font: bold 18pt Arial, Helvetica, sans-serif; margin-bottom: 0px;" align="center">Quarterly Holdings Report<br clear="all"/>for</p>
<p style="font: bold 20pt Arial, Helvetica, sans-serif; margin-top: 0px;" align="center">Fidelity Advisor&#174; Financial Services Fund</p>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-top: 0px;" align="center">April 30, 2016</p>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>AFFS-QTLY-0616<br/>1.800326.112<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<a name="">
<p style="font: bold 16pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Investments April 30, 2016 (Unaudited)</p>
</a>
<p style="font: normal 11pt Arial, Helvetica, sans-serif; margin-top: 0px;">Showing Percentage of Net Assets</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="0" cellpadding="5" width="745">
<tr style="font-weight:bold; color: #ffffff; background-color: #000000;">
<td align="left" valign="top">Common Stocks - 94.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">&#160;</td><td/><td style="font-weight: bold;" align="center" valign="bottom">Shares&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Value&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Banks - 25.6%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Diversified Banks - 20.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Bank of America Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">596,056&#160;</td><td align="right" valign="bottom">$8,678,575&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Citigroup, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">189,765&#160;</td><td align="right" valign="bottom">8,782,324&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Comerica, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">29,719&#160;</td><td align="right" valign="bottom">1,319,524&#160;</td>
</tr>
<tr>
<td align="left" valign="top">JPMorgan Chase &amp; Co.&#160;</td><td valign="top"/><td align="right" valign="bottom">125,931&#160;</td><td align="right" valign="bottom">7,958,839&#160;</td>
</tr>
<tr>
<td align="left" valign="top">U.S. Bancorp&#160;</td><td valign="top"/><td align="right" valign="bottom">180,508&#160;</td><td align="right" valign="bottom">7,705,887&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Wells Fargo &amp; Co.&#160;</td><td valign="top"/><td align="right" valign="bottom">144,748&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">7,234,505&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">41,679,654&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Regional Banks - 5.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">CoBiz, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">71,391&#160;</td><td align="right" valign="bottom">864,545&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Huntington Bancshares, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">194,100&#160;</td><td align="right" valign="bottom">1,952,646&#160;</td>
</tr>
<tr>
<td align="left" valign="top">M&amp;T Bank Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">31,500&#160;</td><td align="right" valign="bottom">3,727,080&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Popular, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">52,200&#160;</td><td align="right" valign="bottom">1,551,384&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Preferred Bank, Los Angeles&#160;</td><td valign="top"/><td align="right" valign="bottom">200&#160;</td><td align="right" valign="bottom">6,352&#160;</td>
</tr>
<tr>
<td align="left" valign="top">SunTrust Banks, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">54,900&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">2,291,526&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">10,393,533&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL BANKS&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">52,073,187&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Capital Markets - 7.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Asset Management &amp; Custody Banks - 3.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Affiliated Managers Group, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">7,254&#160;</td><td align="right" valign="bottom">1,235,501&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Invesco Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">54,838&#160;</td><td align="right" valign="bottom">1,700,526&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Northern Trust Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">34,100&#160;</td><td align="right" valign="bottom">2,423,828&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Oaktree Capital Group LLC Class A&#160;</td><td valign="top"/><td align="right" valign="bottom">37,600&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">1,816,456&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">7,176,311&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Investment Banking &amp; Brokerage - 3.6%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">E*TRADE Financial Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">72,600&#160;</td><td align="right" valign="bottom">1,828,068&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Goldman Sachs Group, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">26,550&#160;</td><td align="right" valign="bottom">4,357,121&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Virtu Financial, Inc. Class A&#160;</td><td valign="top"/><td align="right" valign="bottom">51,200&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">1,067,520&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">7,252,709&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL CAPITAL MARKETS&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">14,429,020&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Consumer Finance - 6.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Consumer Finance - 6.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">American Express Co.&#160;</td><td valign="top"/><td align="right" valign="bottom">38,400&#160;</td><td align="right" valign="bottom">2,512,512&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Capital One Financial Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">84,438&#160;</td><td align="right" valign="bottom">6,112,467&#160;</td>
</tr>
<tr>
<td align="left" valign="top">OneMain Holdings, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">29,400&#160;</td><td align="right" valign="bottom">935,508&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Synchrony Financial  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">100,700&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">3,078,399&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">12,638,886&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Diversified Consumer Services - 0.9%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Specialized Consumer Services - 0.9%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">H&amp;R Block, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">93,300&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">1,888,392&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Diversified Financial Services - 8.7%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Multi-Sector Holdings - 5.8%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Berkshire Hathaway, Inc. Class B (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">81,269&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">11,823,012&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Specialized Finance - 2.9%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">CME Group, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">17,100&#160;</td><td align="right" valign="bottom">1,571,661&#160;</td>
</tr>
<tr>
<td align="left" valign="top">IntercontinentalExchange, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">17,964&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">4,311,899&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">5,883,560&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL DIVERSIFIED FINANCIAL SERVICES&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">17,706,572&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Insurance - 17.6%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Insurance Brokers - 4.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Brown &amp; Brown, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">98,200&#160;</td><td align="right" valign="bottom">3,447,802&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Marsh &amp; McLennan Companies, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">78,100&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">4,932,015&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">8,379,817&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Life &amp; Health Insurance - 2.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Torchmark Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">75,980&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">4,398,482&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Multi-Line Insurance - 0.4%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">American Financial Group, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">13,000&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">898,430&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Property &amp; Casualty Insurance - 10.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Allied World Assurance Co. Holdings AG&#160;</td><td valign="top"/><td align="right" valign="bottom">86,002&#160;</td><td align="right" valign="bottom">3,059,951&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Allstate Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">75,990&#160;</td><td align="right" valign="bottom">4,943,150&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Chubb Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">67,157&#160;</td><td align="right" valign="bottom">7,915,124&#160;</td>
</tr>
<tr>
<td align="left" valign="top">FNF Group&#160;</td><td valign="top"/><td align="right" valign="bottom">138,550&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">4,419,745&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">20,337,970&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Reinsurance - 0.9%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Reinsurance Group of America, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">19,100&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">1,818,702&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL INSURANCE&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">35,833,401&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">IT Services - 5.7%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Data Processing &amp; Outsourced Services - 5.7%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">MasterCard, Inc. Class A&#160;</td><td valign="top"/><td align="right" valign="bottom">30,700&#160;</td><td align="right" valign="bottom">2,977,593&#160;</td>
</tr>
<tr>
<td align="left" valign="top">PayPal Holdings, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">23,100&#160;</td><td align="right" valign="bottom">905,058&#160;</td>
</tr>
<tr>
<td align="left" valign="top">The Western Union Co.&#160;</td><td valign="top"/><td align="right" valign="bottom">126,700&#160;</td><td align="right" valign="bottom">2,534,000&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Visa, Inc. Class A&#160;</td><td valign="top"/><td align="right" valign="bottom">67,120&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">5,184,349&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">11,601,000&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Professional Services - 0.6%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Research &amp; Consulting Services - 0.6%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Verisk Analytics, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">14,800&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">1,148,184&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Real Estate Investment Trusts - 19.4%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Diversified REITs - 0.7%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Store Capital Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">7,300&#160;</td><td align="right" valign="bottom">187,391&#160;</td>
</tr>
<tr>
<td align="left" valign="top">VEREIT, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">137,100&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">1,217,448&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">1,404,839&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Health Care REIT's - 2.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Ventas, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">71,800&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">4,460,216&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Industrial REITs - 0.7%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">DCT Industrial Trust, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">33,300&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">1,344,321&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Mortgage REITs - 2.9%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Altisource Residential Corp. Class B&#160;</td><td valign="top"/><td align="right" valign="bottom">103,250&#160;</td><td align="right" valign="bottom">1,199,765&#160;</td>
</tr>
<tr>
<td align="left" valign="top">American Capital Agency Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">93,900&#160;</td><td align="right" valign="bottom">1,724,943&#160;</td>
</tr>
<tr>
<td align="left" valign="top">American Capital Mortgage Investment Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">35,400&#160;</td><td align="right" valign="bottom">524,982&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Redwood Trust, Inc.  (b)&#160;</td><td valign="top"/><td align="right" valign="bottom">131,900&#160;</td><td align="right" valign="bottom">1,709,424&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Two Harbors Investment Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">105,800&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">828,414&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">5,987,528&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Office REITs - 2.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Boston Properties, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">29,600&#160;</td><td align="right" valign="bottom">3,814,256&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Douglas Emmett, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">7,300&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">236,885&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">4,051,141&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Residential REITs - 4.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">American Campus Communities, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">55,473&#160;</td><td align="right" valign="bottom">2,482,417&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Equity Residential (SBI)&#160;</td><td valign="top"/><td align="right" valign="bottom">42,200&#160;</td><td align="right" valign="bottom">2,872,554&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Essex Property Trust, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">4,300&#160;</td><td align="right" valign="bottom">947,935&#160;</td>
</tr>
<tr>
<td align="left" valign="top">UDR, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">59,400&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">2,074,248&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">8,377,154&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Specialized REITs - 6.8%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">American Tower Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">69,500&#160;</td><td align="right" valign="bottom">7,289,160&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Outfront Media, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">76,830&#160;</td><td align="right" valign="bottom">1,666,443&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Public Storage&#160;</td><td valign="top"/><td align="right" valign="bottom">19,950&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">4,883,960&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">13,839,563&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL REAL ESTATE INVESTMENT TRUSTS&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">39,464,762&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Real Estate Management &amp; Development - 1.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Real Estate Services - 1.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Realogy Holdings Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">73,600&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">2,630,464&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Thrifts &amp; Mortgage Finance - 0.6%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Thrifts &amp; Mortgage Finance - 0.6%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">MGIC Investment Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">105,000&#160;</td><td align="right" valign="bottom">759,150&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Radian Group, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">32,200&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">411,838&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">1,170,988&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Trading Companies &amp; Distributors - 0.8%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Trading Companies &amp; Distributors - 0.8%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">AerCap Holdings NV  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">42,800&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">1,712,428&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">TOTAL COMMON STOCKS&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">(Cost $193,987,486)&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">192,297,284&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold; color: #ffffff; background-color: #000000;">
<td align="left" valign="top">Money Market Funds - 5.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Cash Central Fund, 0.38% (c)&#160;</td><td valign="top"/><td align="right" valign="bottom">10,390,768&#160;</td><td align="right" valign="bottom">10,390,768&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Securities Lending Cash Central Fund, 0.42% (c)(d)&#160;</td><td valign="top"/><td align="right" valign="bottom">873,175&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">873,175&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">TOTAL MONEY MARKET FUNDS&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">(Cost $11,263,943)&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">11,263,943&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">TOTAL INVESTMENT PORTFOLIO - 100.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">(Cost $205,251,429)&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td style="font-weight: bold;" align="right" valign="top">203,561,227&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">NET OTHER ASSETS (LIABILITIES) - 0.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">(57,812)&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">NET ASSETS - 100%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="top" style="border-bottom: double 3px black; font-weight: bold;">$203,503,415&#160;</td>
</tr>
</table>
<br/>
<p style="font: bold 12pt Arial, Helvetica, sans-serif;">Legend</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(a)&#160;Non-income producing</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(b)&#160;Security or a portion of the security is on loan at period end.</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(c)&#160;Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request.</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(d)&#160;Investment made with cash collateral received from securities on loan.</p>
<br/>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Affiliated Central Funds</p>
<p style="font: normal 10pt Arial, Helvetica, sans-serif;">Information regarding fiscal year to date income earned by the Fund from investments in Fidelity Central Funds is as follows:</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="7" cellpadding="0" width="745">
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">Fund&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Income earned&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Cash Central Fund&#160;</td><td align="right" valign="bottom">$22,165&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Securities Lending Cash Central Fund&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">2,058&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Total&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$24,223&#160;</td>
</tr>
</table>
<br/>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Investment Valuation</p>
<p style="font: normal 10pt Arial, Helvetica, sans-serif;">All investments are categorized as Level 1 under the Fair Value Hierarchy. The inputs or methodology used for valuing securities may not be an indication of the risk associated with investing in those securities. Additional information on valuation inputs is provided later in this section.</p>
<p>Investments are valued as of 4:00 p.m. Eastern time on the last calendar day of the period. Security transactions are accounted for as of trade date. The Board of Trustees (the Board) has delegated the day to day responsibility for the valuation of the Fund's investments to the Fidelity SelectCo, LLC (SelectCo) Fair Value Committee (the Committee). In accordance with valuation policies and procedures approved by the Board, the Fund attempts to obtain prices from one or more third party pricing vendors or brokers to value its investments. When current market prices, quotations or currency exchange rates are not readily available or reliable, investments will be fair valued in good faith by the Committee, in accordance with procedures adopted by the Board. Factors used in determining fair value vary by investment type and may include market or investment specific events. The frequency with which these procedures are used cannot be predicted and they may be utilized to a significant extent. The Committee oversees the Fund&#146;s valuation policies and procedures and reports to the Board on the Committee's activities and fair value determinations. The Board monitors the appropriateness of the procedures used in valuing the Fund's investments and ratifies the fair value determinations of the Committee. The Fund categorizes the inputs to valuation techniques used to value its investments into a disclosure hierarchy consisting of three levels: Level 1 - quoted prices in active markets for identical investments: Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds etc.): Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available). Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. Valuation techniques used to value the Fund's investments by major category are as follows:</p>
<p>Equity securities, including restricted securities, for which market quotations are readily available, are valued at the last reported sale price or official closing price as reported by a third party pricing vendor on the primary market or exchange on which they are traded and are categorized as Level 1 in the hierarchy. In the event there were no sales during the day or closing prices are not available, securities are valued at the last quoted bid price or may be valued using the last available price and are generally categorized as Level 2 in the hierarchy. For foreign equity securities, when market or security specific events arise, comparisons to the valuation of American Depositary Receipts (ADRs), futures contracts, Exchange-Traded Funds (ETFs) and certain indexes as well as quoted prices for similar securities may be used and would be categorized as Level 2 in the hierarchy. Utilizing these techniques may result in transfers between Level 1 and Level 2. For equity securities, including restricted securities, where observable inputs are limited, assumptions about market activity and risk are used and these securities may be categorized as Level 3 in the hierarchy.</p>
<p>Investments in open-end mutual funds, including the Fidelity Central Funds, are valued at their closing net asset value each business day and are categorized as Level 1 in the hierarchy.</p>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Other Information</p>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Income Tax Information</p>
<p>At April 30, 2016, the cost of investment securities for income tax purposes was $205,710,071. Net unrealized depreciation aggregated $2,148,844, of which $9,904,118 related to appreciated investment securities and $12,052,962 related to depreciated investment securities.</p>
<p>For additional information on the Fund's policy regarding valuation of investments and other significant accounting policies, please refer to the Fund's most recent semiannual or annual shareholder report.</p>
<br/>
<br/>
<br/>
<br/>
<p style="font-style: italic;">
</p><p style="font-style: italic;">The fund's schedule of investments as of the date on the cover of this report has not been audited. This report is provided for the general information of the fund's shareholders. For more information regarding the fund and its holdings, please see the fund's most recent prospectus and annual report.</p>

<p style="font-style: italic;">
</p><p style="font-style: italic;">Third party trademarks and service marks are the property of their respective owners. All other trademarks and service marks are the property of FMR LLC or an affiliate.</p>

<hr size="2" noshade="noshade"/>
</div>
<div style="font: normal 11pt Arial, Helvetica, sans-serif; width: 780px">
<!-- Automatically produced using the ProofPlus Content Management System -->
<p style="font: bold 18pt Arial, Helvetica, sans-serif; margin-bottom: 0px;" align="center">Quarterly Holdings Report<br clear="all"/>for</p>
<p style="font: bold 20pt Arial, Helvetica, sans-serif; margin-top: 0px;" align="center">Fidelity Advisor&#174; Consumer Discretionary Fund</p>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-top: 0px;" align="center">April 30, 2016</p>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>AFCI-QTLY-0616<br/>1.800322.112<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<a name="">
<p style="font: bold 16pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Investments April 30, 2016 (Unaudited)</p>
</a>
<p style="font: normal 11pt Arial, Helvetica, sans-serif; margin-top: 0px;">Showing Percentage of Net Assets</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="0" cellpadding="5" width="745">
<tr style="font-weight:bold; color: #ffffff; background-color: #000000;">
<td align="left" valign="top">Common Stocks - 96.9%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">&#160;</td><td/><td style="font-weight: bold;" align="center" valign="bottom">Shares&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Value&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Auto Components - 3.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Auto Parts &amp; Equipment - 3.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Delphi Automotive PLC&#160;</td><td valign="top"/><td align="right" valign="bottom">24,884&#160;</td><td align="right" valign="bottom">$1,832,209&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Tenneco, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">107,400&#160;</td><td align="right" valign="bottom">5,724,420&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Visteon Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">33,100&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">2,637,077&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">10,193,706&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Automobiles - 0.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Automobile Manufacturers - 0.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Ferrari NV&#160;</td><td valign="top"/><td align="right" valign="bottom">16,700&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">765,695&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Beverages - 1.8%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Distillers &amp; Vintners - 0.7%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Constellation Brands, Inc. Class A (sub. vtg.)&#160;</td><td valign="top"/><td align="right" valign="bottom">16,027&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">2,501,174&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Soft Drinks - 1.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Monster Beverage Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">25,249&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">3,641,411&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL BEVERAGES&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">6,142,585&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Commercial Services &amp; Supplies - 0.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Diversified Support Services - 0.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">KAR Auction Services, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">6,300&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">236,880&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Food &amp; Staples Retailing - 0.7%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Hypermarkets &amp; Super Centers - 0.7%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Costco Wholesale Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">16,760&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">2,482,659&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Hotels, Restaurants &amp; Leisure - 14.8%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Casinos &amp; Gaming - 1.7%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Las Vegas Sands Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">131,080&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">5,918,262&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Hotels, Resorts &amp; Cruise Lines - 3.8%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Accor SA  (b)&#160;</td><td valign="top"/><td align="right" valign="bottom">57,109&#160;</td><td align="right" valign="bottom">2,529,715&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Hilton Worldwide Holdings, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">474,700&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">10,467,135&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">12,996,850&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Leisure Facilities - 1.6%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Vail Resorts, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">40,800&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">5,289,312&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Restaurants - 7.7%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Buffalo Wild Wings, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">9,400&#160;</td><td align="right" valign="bottom">1,256,404&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Del Frisco's Restaurant Group, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">40,500&#160;</td><td align="right" valign="bottom">645,165&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Domino's Pizza, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">18,000&#160;</td><td align="right" valign="bottom">2,175,840&#160;</td>
</tr>
<tr>
<td align="left" valign="top">McDonald's Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">43,300&#160;</td><td align="right" valign="bottom">5,477,017&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Starbucks Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">293,276&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">16,490,909&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">26,045,335&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL HOTELS, RESTAURANTS &amp; LEISURE&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">50,249,759&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Household Durables - 1.8%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Home Furnishings - 0.4%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Tempur Sealy International, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">21,259&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">1,289,784&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Household Appliances - 1.4%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Techtronic Industries Co. Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">1,333,500&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">4,998,851&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL HOUSEHOLD DURABLES&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">6,288,635&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Household Products - 2.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Household Products - 2.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Spectrum Brands Holdings, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">59,710&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">6,783,056&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Internet &amp; Catalog Retail - 14.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Internet Retail - 14.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Amazon.com, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">62,780&#160;</td><td align="right" valign="bottom">41,409,058&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Netflix, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">26,300&#160;</td><td align="right" valign="bottom">2,367,789&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Ocado Group PLC  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,115,940&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">4,819,923&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">48,596,770&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Leisure Products - 0.7%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Leisure Products - 0.7%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Mattel, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">73,200&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">2,275,788&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Media - 23.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Advertising - 2.4%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Interpublic Group of Companies, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">355,000&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">8,143,700&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Broadcasting - 1.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">ITV PLC&#160;</td><td valign="top"/><td align="right" valign="bottom">1,106,453&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">3,640,794&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Cable &amp; Satellite - 10.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Charter Communications, Inc. Class A (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">110,620&#160;</td><td align="right" valign="bottom">23,477,989&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Comcast Corp. Class A&#160;</td><td valign="top"/><td align="right" valign="bottom">126,900&#160;</td><td align="right" valign="bottom">7,710,444&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Naspers Ltd. Class N&#160;</td><td valign="top"/><td align="right" valign="bottom">28,470&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">3,906,371&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">35,094,804&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Movies &amp; Entertainment - 9.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">The Walt Disney Co.&#160;</td><td valign="top"/><td align="right" valign="bottom">265,506&#160;</td><td align="right" valign="bottom">27,416,150&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Time Warner, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">56,100&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">4,215,354&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">31,631,504&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL MEDIA&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">78,510,802&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Multiline Retail - 0.9%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">General Merchandise Stores - 0.9%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">B&amp;M European Value Retail S.A.&#160;</td><td valign="top"/><td align="right" valign="bottom">797,628&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">3,232,970&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Software - 0.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Application Software - 0.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Mobileye NV  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">43,400&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">1,655,710&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Specialty Retail - 24.9%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Apparel Retail - 10.7%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Inditex SA&#160;</td><td valign="top"/><td align="right" valign="bottom">64,069&#160;</td><td align="right" valign="bottom">2,056,710&#160;</td>
</tr>
<tr>
<td align="left" valign="top">L Brands, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">186,700&#160;</td><td align="right" valign="bottom">14,616,743&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Ross Stores, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">263,220&#160;</td><td align="right" valign="bottom">14,945,632&#160;</td>
</tr>
<tr>
<td align="left" valign="top">TJX Companies, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">61,508&#160;</td><td align="right" valign="bottom">4,663,537&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Zumiez, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">7,400&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">124,172&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">36,406,794&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Automotive Retail - 4.7%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">AutoZone, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">15,020&#160;</td><td align="right" valign="bottom">11,493,755&#160;</td>
</tr>
<tr>
<td align="left" valign="top">O'Reilly Automotive, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">17,700&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">4,649,436&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">16,143,191&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Home Improvement Retail - 9.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Home Depot, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">234,260&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">31,365,071&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Specialty Stores - 0.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Sally Beauty Holdings, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">22,000&#160;</td><td align="right" valign="bottom">690,800&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Ulta Salon, Cosmetics &amp; Fragrance, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">600&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">124,968&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">815,768&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL SPECIALTY RETAIL&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">84,730,824&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Textiles, Apparel &amp; Luxury Goods - 8.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Apparel, Accessories &amp; Luxury Goods - 3.6%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">G-III Apparel Group Ltd.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">65,280&#160;</td><td align="right" valign="bottom">2,953,920&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Regina Miracle International Holdings Ltd.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">157,635&#160;</td><td align="right" valign="bottom">239,184&#160;</td>
</tr>
<tr>
<td align="left" valign="top">VF Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">143,780&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">9,065,329&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">12,258,433&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Footwear - 4.6%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">NIKE, Inc. Class B&#160;</td><td valign="top"/><td align="right" valign="bottom">268,434&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">15,821,500&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL TEXTILES, APPAREL &amp; LUXURY GOODS&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">28,079,933&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">TOTAL COMMON STOCKS&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">(Cost $294,746,426)&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">330,225,772&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold; color: #ffffff; background-color: #000000;">
<td align="left" valign="top">Money Market Funds - 11.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Cash Central Fund, 0.38% (c)&#160;</td><td valign="top"/><td align="right" valign="bottom">11,622,327&#160;</td><td align="right" valign="bottom">11,622,327&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Securities Lending Cash Central Fund, 0.42% (c)(d)&#160;</td><td valign="top"/><td align="right" valign="bottom">26,487,632&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">26,487,632&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">TOTAL MONEY MARKET FUNDS&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">(Cost $38,109,959)&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">38,109,959&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">TOTAL INVESTMENT PORTFOLIO - 108.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">(Cost $332,856,385)&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td style="font-weight: bold;" align="right" valign="top">368,335,731&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">NET OTHER ASSETS (LIABILITIES) - (8.1)%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">(27,635,023)&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">NET ASSETS - 100%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="top" style="border-bottom: double 3px black; font-weight: bold;">$340,700,708&#160;</td>
</tr>
</table>
<br/>
<p style="font: bold 12pt Arial, Helvetica, sans-serif;">Legend</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(a)&#160;Non-income producing</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(b)&#160;Security or a portion of the security is on loan at period end.</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(c)&#160;Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements  are available on the SEC's website or upon request.</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(d)&#160;Investment made with cash collateral received from securities on loan.</p>
<br/>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Affiliated Central Funds</p>
<p style="font: normal 10pt Arial, Helvetica, sans-serif;">Information regarding fiscal year to date income earned by the Fund from investments in Fidelity Central Funds is as follows:</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="7" cellpadding="0" width="745">
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">Fund&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Income earned&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Cash Central Fund&#160;</td><td align="right" valign="bottom">$24,159&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Securities Lending Cash Central Fund&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">221,069&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Total&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$245,228&#160;</td>
</tr>
</table>
<br/>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Investment Valuation</p>
<p style="font: normal 10pt Arial, Helvetica, sans-serif;">The following is a summary of the inputs used, as of April 30, 2016, involving the Fund's assets and liabilities carried at fair value. The inputs or methodology used for valuing securities may not be an indication of the risk associated with investing in those securities. Additional information on valuation inputs, and their aggregation into the levels used below, is provided later in this section.</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="7" cellpadding="0" width="745">
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">&#160;</td><td style="font-weight: bold;" align="center" valign="bottom" colspan="4">Valuation Inputs at Reporting Date:&#160;</td>
</tr>
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">Description&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Total&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Level 1&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Level 2&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Level 3&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top"><u>Investments in Securities:</u>&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Common Stocks&#160;</td><td align="right" valign="bottom">$330,225,772&#160;</td><td align="right" valign="bottom">$324,987,737&#160;</td><td align="right" valign="bottom">$5,238,035&#160;</td><td align="right" valign="bottom">$--&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Money Market Funds&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">38,109,959&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">38,109,959&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">--&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">--&#160;</td>
</tr>
<tr>
<td style="font-weight: bold" valign="top">Total Investments in Securities:&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$368,335,731&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$363,097,696&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$5,238,035&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$--&#160;</td>
</tr>
</table>
<br/>
<p>Investments are valued as of 4:00 p.m. Eastern time on the last calendar day of the period. Security transactions are accounted for as of trade date. The Board of Trustees (the Board) has delegated the day to day responsibility for the valuation of the Fund's investments to the Fidelity SelectCo, LLC (SelectCo) Fair Value Committee (the Committee). In accordance with valuation policies and procedures approved by the Board, the Fund attempts to obtain prices from one or more third party pricing vendors or brokers to value its investments. When current market prices, quotations or currency exchange rates are not readily available or reliable, investments will be fair valued in good faith by the Committee, in accordance with procedures adopted by the Board. Factors used in determining fair value vary by investment type and may include market or investment specific events. The frequency with which these procedures are used cannot be predicted and they may be utilized to a significant extent. The Committee oversees the Fund&#146;s valuation policies and procedures and reports to the Board on the Committee's activities and fair value determinations. The Board monitors the appropriateness of the procedures used in valuing the Fund's investments and ratifies the fair value determinations of the Committee. The Fund categorizes the inputs to valuation techniques used to value its investments into a disclosure hierarchy consisting of three levels: Level 1 - quoted prices in active markets for identical investments: Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds etc.): Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available). Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. Valuation techniques used to value the Fund's investments by major category are as follows:</p>
<p>Equity securities, including restricted securities, for which market quotations are readily available, are valued at the last reported sale price or official closing price as reported by a third party pricing vendor on the primary market or exchange on which they are traded and are categorized as Level 1 in the hierarchy. In the event there were no sales during the day or closing prices are not available, securities are valued at the last quoted bid price or may be valued using the last available price and are generally categorized as Level 2 in the hierarchy. For foreign equity securities, when market or security specific events arise, comparisons to the valuation of American Depositary Receipts (ADRs), futures contracts, Exchange-Traded Funds (ETFs) and certain indexes as well as quoted prices for similar securities may be used and would be categorized as Level 2 in the hierarchy. Utilizing these techniques may result in transfers between Level 1 and Level 2. For equity securities, including restricted securities, where observable inputs are limited, assumptions about market activity and risk are used and these securities may be categorized as Level 3 in the hierarchy.</p>
<p>Investments in open-end mutual funds, including the Fidelity Central Funds, are valued at their closing net asset value each business day and are categorized as Level 1 in the hierarchy.</p>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Other Information</p>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Income Tax Information</p>
<p>At April 30, 2016, the cost of investment securities for income tax purposes was $333,442,144. Net unrealized appreciation aggregated $34,893,587, of which $46,257,455 related to appreciated investment securities and $11,363,868 related to depreciated investment securities.</p>
<p>For additional information on the Fund's policy regarding valuation of investments and other significant accounting policies, please refer to the Fund's most recent semiannual or annual shareholder report.</p>
<br/>
<br/>
<br/>
<br/>
<p style="font-style: italic;">
</p><p style="font-style: italic;">The fund's schedule of investments as of the date on the cover of this report has not been audited. This report is provided for the general information of the fund's shareholders. For more information regarding the fund and its holdings, please see the fund's most recent prospectus and annual report.</p>

<p style="font-style: italic;">
</p><p style="font-style: italic;">Third party trademarks and service marks are the property of their respective owners. All other trademarks and service marks are the property of FMR LLC or an affiliate.</p>

<hr size="2" noshade="noshade"/>
</div>
<div style="font: normal 11pt Arial, Helvetica, sans-serif; width: 780px">
<!-- Automatically produced using the ProofPlus Content Management System -->
<p style="font: bold 18pt Arial, Helvetica, sans-serif; margin-bottom: 0px;" align="center">Quarterly Holdings Report<br clear="all"/>for</p>
<p style="font: bold 20pt Arial, Helvetica, sans-serif; margin-top: 0px;" align="center">Fidelity Advisor&#174; Electronics Fund</p>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-top: 0px;" align="center">April 30, 2016</p>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>AFEL-QTLY-0616<br/>1.800325.112<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<a name="">
<p style="font: bold 16pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Investments April 30, 2016 (Unaudited)</p>
</a>
<p style="font: normal 11pt Arial, Helvetica, sans-serif; margin-top: 0px;">Showing Percentage of Net Assets</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="0" cellpadding="5" width="745">
<tr style="font-weight:bold; color: #ffffff; background-color: #000000;">
<td align="left" valign="top">Common Stocks - 95.9%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">&#160;</td><td/><td style="font-weight: bold;" align="center" valign="bottom">Shares&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Value&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Biotechnology - 0.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Biotechnology - 0.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Arrowhead Pharmaceuticals, Inc. warrants 5/21/17 (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">64,879&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">$1&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Commercial Services &amp; Supplies - 0.6%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Office Services &amp; Supplies - 0.6%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">West Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">18,800&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">402,884&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Communications Equipment - 0.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Communications Equipment - 0.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Ciena Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">9,900&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">166,617&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Diversified Financial Services - 8.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Other Diversified Financial Services - 8.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Broadcom Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">41,800&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">6,092,350&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Electronic Equipment &amp; Components - 5.7%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Electronic Equipment &amp; Instruments - 0.4%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Keysight Technologies, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">11,400&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">297,312&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Electronic Manufacturing Services - 5.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Benchmark Electronics, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">3,600&#160;</td><td align="right" valign="bottom">69,912&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Jabil Circuit, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">138,476&#160;</td><td align="right" valign="bottom">2,403,943&#160;</td>
</tr>
<tr>
<td align="left" valign="top">TTM Technologies, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">220,324&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">1,436,512&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">3,910,367&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL ELECTRONIC EQUIPMENT &amp; COMPONENTS&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">4,207,679&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Internet Software &amp; Services - 0.4%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Internet Software &amp; Services - 0.4%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Rackspace Hosting, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">13,000&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">297,310&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">IT Services - 0.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Data Processing &amp; Outsourced Services - 0.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">EVERTEC, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">6,200&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">83,514&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Semiconductors &amp; Semiconductor Equipment - 76.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Semiconductor Equipment - 8.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Amkor Technology, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">41,800&#160;</td><td align="right" valign="bottom">238,678&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Applied Materials, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">118,600&#160;</td><td align="right" valign="bottom">2,427,742&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Lam Research Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">36,481&#160;</td><td align="right" valign="bottom">2,787,148&#160;</td>
</tr>
<tr>
<td align="left" valign="top">PDF Solutions, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">14,100&#160;</td><td align="right" valign="bottom">189,645&#160;</td>
</tr>
<tr>
<td align="left" valign="top">SunEdison Semiconductor Ltd.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">32,900&#160;</td><td align="right" valign="bottom">189,175&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Xcerra Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">19,400&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">114,460&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">5,946,848&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Semiconductors - 68.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Advanced Micro Devices, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">43,200&#160;</td><td align="right" valign="bottom">153,360&#160;</td>
</tr>
<tr>
<td align="left" valign="top">ams AG&#160;</td><td valign="top"/><td align="right" valign="bottom">7,580&#160;</td><td align="right" valign="bottom">200,305&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Analog Devices, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">14,928&#160;</td><td align="right" valign="bottom">840,745&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Applied Micro Circuits Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">39,137&#160;</td><td align="right" valign="bottom">244,215&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Cavium, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">19,000&#160;</td><td align="right" valign="bottom">938,030&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Cree, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">9,900&#160;</td><td align="right" valign="bottom">242,649&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Diodes, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">32,400&#160;</td><td align="right" valign="bottom">603,288&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Exar Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">5,000&#160;</td><td align="right" valign="bottom">30,500&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Infineon Technologies AG&#160;</td><td valign="top"/><td align="right" valign="bottom">8,800&#160;</td><td align="right" valign="bottom">125,555&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Integrated Device Technology, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">500&#160;</td><td align="right" valign="bottom">9,640&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Intel Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">363,278&#160;</td><td align="right" valign="bottom">11,000,057&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Intersil Corp. Class A&#160;</td><td valign="top"/><td align="right" valign="bottom">152,637&#160;</td><td align="right" valign="bottom">1,784,327&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Lattice Semiconductor Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">37,400&#160;</td><td align="right" valign="bottom">208,318&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Marvell Technology Group Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">173,900&#160;</td><td align="right" valign="bottom">1,735,522&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Maxim Integrated Products, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">91,922&#160;</td><td align="right" valign="bottom">3,283,454&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Microchip Technology, Inc.  (b)&#160;</td><td valign="top"/><td align="right" valign="bottom">36,200&#160;</td><td align="right" valign="bottom">1,758,958&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Micron Technology, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">190,012&#160;</td><td align="right" valign="bottom">2,042,629&#160;</td>
</tr>
<tr>
<td align="left" valign="top">NVIDIA Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">31,323&#160;</td><td align="right" valign="bottom">1,112,906&#160;</td>
</tr>
<tr>
<td align="left" valign="top">NXP Semiconductors NV  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">35,591&#160;</td><td align="right" valign="bottom">3,035,200&#160;</td>
</tr>
<tr>
<td align="left" valign="top">ON Semiconductor Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">371,700&#160;</td><td align="right" valign="bottom">3,519,999&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Qorvo, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">46,600&#160;</td><td align="right" valign="bottom">2,098,398&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Qualcomm, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">193,626&#160;</td><td align="right" valign="bottom">9,781,986&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Semtech Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">93,422&#160;</td><td align="right" valign="bottom">2,021,652&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Skyworks Solutions, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">38,200&#160;</td><td align="right" valign="bottom">2,552,524&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Xilinx, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">24,000&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">1,033,920&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">50,358,137&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL SEMICONDUCTORS &amp; SEMICONDUCTOR EQUIPMENT&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">56,304,985&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Technology Hardware, Storage &amp; Peripherals - 4.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Technology Hardware, Storage &amp; Peripherals - 4.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Lenovo Group Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">300,000&#160;</td><td align="right" valign="bottom">237,328&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Nimble Storage, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">49,100&#160;</td><td align="right" valign="bottom">362,358&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Seagate Technology LLC&#160;</td><td valign="top"/><td align="right" valign="bottom">58,200&#160;</td><td align="right" valign="bottom">1,267,014&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Western Digital Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">36,100&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">1,475,227&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">3,341,927&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">TOTAL COMMON STOCKS&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">(Cost $71,611,733)&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">70,897,267&#160;</td>
</tr>
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">&#160;</td><td/><td style="font-weight: bold;" align="center" valign="bottom">Principal Amount&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Value&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold; color: #ffffff; background-color: #000000;">
<td align="left" valign="top">Nonconvertible Bonds - 0.4%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Semiconductors &amp; Semiconductor Equipment - 0.4%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Semiconductors - 0.4%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Advanced Micro Devices, Inc.:&#160;</td><td valign="top"/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">7% 7/1/24&#160;</td><td valign="top"/><td align="right" valign="bottom">215,000&#160;</td><td align="right" valign="bottom">161,788&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">7.75% 8/1/20&#160;</td><td valign="top"/><td align="right" valign="bottom">130,000&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">105,300&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">TOTAL NONCONVERTIBLE BONDS&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">(Cost $293,872)&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">267,088&#160;</td>
</tr>
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">&#160;</td><td/><td style="font-weight: bold;" align="center" valign="bottom">Shares&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Value&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold; color: #ffffff; background-color: #000000;">
<td align="left" valign="top">Money Market Funds - 4.7%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Cash Central Fund, 0.38% (c)&#160;</td><td valign="top"/><td align="right" valign="bottom">2,925,839&#160;</td><td align="right" valign="bottom">2,925,839&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Securities Lending Cash Central Fund, 0.42% (c)(d)&#160;</td><td valign="top"/><td align="right" valign="bottom">556,150&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">556,150&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">TOTAL MONEY MARKET FUNDS&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">(Cost $3,481,989)&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">3,481,989&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">TOTAL INVESTMENT PORTFOLIO - 101.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">(Cost $75,387,594)&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td style="font-weight: bold;" align="right" valign="top">74,646,344&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">NET OTHER ASSETS (LIABILITIES) - (1.0)%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">(703,977)&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">NET ASSETS - 100%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="top" style="border-bottom: double 3px black; font-weight: bold;">$73,942,367&#160;</td>
</tr>
</table>
<br/>
<p style="font: bold 12pt Arial, Helvetica, sans-serif;">Legend</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(a)&#160;Non-income producing</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(b)&#160;Security or a portion of the security is on loan at period end.</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(c)&#160;Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request.</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(d)&#160;Investment made with cash collateral received from securities on loan.</p>
<br/>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Affiliated Central Funds</p>
<p style="font: normal 10pt Arial, Helvetica, sans-serif;">Information regarding fiscal year to date income earned by the Fund from investments in Fidelity Central Funds is as follows:</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="7" cellpadding="0" width="745">
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">Fund&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Income earned&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Cash Central Fund&#160;</td><td align="right" valign="bottom">$3,490&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Securities Lending Cash Central Fund&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">18,816&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Total&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$22,306&#160;</td>
</tr>
</table>
<br/>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Investment Valuation</p>
<p style="font: normal 10pt Arial, Helvetica, sans-serif;">The following is a summary of the inputs used, as of April 30, 2016, involving the Fund's assets and liabilities carried at fair value. The inputs or methodology used for valuing securities may not be an indication of the risk associated with investing in those securities. Additional information on valuation inputs, and their aggregation into the levels used below, is provided later in this section.</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="7" cellpadding="0" width="745">
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">&#160;</td><td style="font-weight: bold;" align="center" valign="bottom" colspan="4">Valuation Inputs at Reporting Date:&#160;</td>
</tr>
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">Description&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Total&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Level 1&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Level 2&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Level 3&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top"><u>Investments in Securities:</u>&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Common Stocks&#160;</td><td align="right" valign="bottom">$70,897,267&#160;</td><td align="right" valign="bottom">$70,659,938&#160;</td><td align="right" valign="bottom">$237,329&#160;</td><td align="right" valign="bottom">$--&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Nonconvertible Bonds&#160;</td><td align="right" valign="bottom">267,088&#160;</td><td align="right" valign="bottom">--&#160;</td><td align="right" valign="bottom">267,088&#160;</td><td align="right" valign="bottom">--&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Money Market Funds&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">3,481,989&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">3,481,989&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">--&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">--&#160;</td>
</tr>
<tr>
<td style="font-weight: bold" valign="top">Total Investments in Securities:&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$74,646,344&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$74,141,927&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$504,417&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$--&#160;</td>
</tr>
</table>
<br/>
<p>Investments are valued as of 4:00 p.m. Eastern time on the last calendar day of the period. Security transactions are accounted for as of trade date. The Board of Trustees (the Board) has delegated the day to day responsibility for the valuation of the Fund's investments to the Fidelity SelectCo, LLC (SelectCo) Fair Value Committee (the Committee). In accordance with valuation policies and procedures approved by the Board, the Fund attempts to obtain prices from one or more third party pricing vendors or brokers to value its investments. When current market prices, quotations or currency exchange rates are not readily available or reliable, investments will be fair valued in good faith by the Committee, in accordance with procedures adopted by the Board. Factors used in determining fair value vary by investment type and may include market or investment specific events, changes in interest rates and credit quality. The frequency with which these procedures are used cannot be predicted and they may be utilized to a significant extent. The Committee oversees the Fund&#146;s valuation policies and procedures and reports to the Board on the Committee's activities and fair value determinations. The Board monitors the appropriateness of the procedures used in valuing the Fund's investments and ratifies the fair value determinations of the Committee. The Fund categorizes the inputs to valuation techniques used to value its investments into a disclosure hierarchy consisting of three levels: Level 1 - quoted prices in active markets for identical investments: Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds etc.): Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available). Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. Valuation techniques used to value the Fund's investments by major category are as follows:</p>
<p>Equity securities, including restricted securities, for which market quotations are readily available, are valued at the last reported sale price or official closing price as reported by a third party pricing vendor on the primary market or exchange on which they are traded and are categorized as Level 1 in the hierarchy. In the event there were no sales during the day or closing prices are not available, securities are valued at the last quoted bid price or may be valued using the last available price and are generally categorized as Level 2 in the hierarchy. For foreign equity securities, when market or security specific events arise, comparisons to the valuation of American Depositary Receipts (ADRs), futures contracts, Exchange-Traded Funds (ETFs) and certain indexes as well as quoted prices for similar securities may be used and would be categorized as Level 2 in the hierarchy. Utilizing these techniques may result in transfers between Level 1 and Level 2. For equity securities, including restricted securities, where observable inputs are limited, assumptions about market activity and risk are used and these securities may be categorized as Level 3 in the hierarchy.</p>
<p>Debt securities, including restricted securities, are valued based on evaluated prices received from third party pricing vendors or from brokers who make markets in such securities. Corporate bonds are valued by pricing vendors who utilize matrix pricing which considers yield or price of bonds of comparable quality, coupon, maturity and type or by broker supplied prices.</p>
<p>When independent prices are unavailable or unreliable, debt securities may be valued utilizing pricing methodologies which consider similar factors that would be used by third party pricing vendors. Debt securities are generally categorized as Level 2 in the hierarchy but may be Level 3 depending on the circumstances.</p>
<p>Investments in open-end mutual funds, including the Fidelity Central Funds, are valued at their closing net asset value each business day and are categorized as Level 1 in the hierarchy.</p>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Other Information</p>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Income Tax Information</p>
<p>At April 30, 2016, the cost of investment securities for income tax purposes was $77,702,737. Net unrealized depreciation aggregated $3,056,393, of which $4,295,841 related to appreciated investment securities and $7,352,234 related to depreciated investment securities.</p>
<p>For additional information on the Fund's policy regarding valuation of investments and other significant accounting policies, please refer to the Fund's most recent semiannual or annual shareholder report.</p>
<br/>
<br/>
<br/>
<br/>
<p style="font-style: italic;">
</p><p style="font-style: italic;">The fund's schedule of investments as of the date on the cover of this report has not been audited. This report is provided for the general information of the fund's shareholders. For more information regarding the fund and its holdings, please see the fund's most recent prospectus and annual report.</p>

<p style="font-style: italic;">
</p><p style="font-style: italic;">Third party trademarks and service marks are the property of their respective owners. All other trademarks and service marks are the property of FMR LLC or an affiliate.</p>

<hr size="2" noshade="noshade"/>
</div>
<div style="font: normal 11pt Arial, Helvetica, sans-serif; width: 780px">
<!-- Automatically produced using the ProofPlus Content Management System -->
<p style="font: bold 18pt Arial, Helvetica, sans-serif; margin-bottom: 0px;" align="center">Quarterly Holdings Report<br clear="all"/>for</p>
<p style="font: bold 20pt Arial, Helvetica, sans-serif; margin-top: 0px;" align="center">Fidelity Advisor&#174; Real Estate Fund</p>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-top: 0px;" align="center">April 30, 2016</p>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>ARE-QTLY-0616<br/>1.800329.112<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<a name="">
<p style="font: bold 16pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Investments April 30, 2016 (Unaudited)</p>
</a>
<p style="font: normal 11pt Arial, Helvetica, sans-serif; margin-top: 0px;">Showing Percentage of Net Assets</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="0" cellpadding="5" width="745">
<tr style="font-weight:bold; color: #ffffff; background-color: #000000;">
<td align="left" valign="top">Common Stocks - 98.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">&#160;</td><td/><td style="font-weight: bold;" align="center" valign="bottom">Shares&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Value&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Hotels, Restaurants &amp; Leisure - 1.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Hotels, Resorts &amp; Cruise Lines - 1.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Hilton Worldwide Holdings, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">439,500&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">$9,690,975&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Real Estate Investment Trusts - 97.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">REITs - Apartments - 17.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">AvalonBay Communities, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">164,540&#160;</td><td align="right" valign="bottom">29,089,027&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Equity Residential (SBI)&#160;</td><td valign="top"/><td align="right" valign="bottom">408,509&#160;</td><td align="right" valign="bottom">27,807,208&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Essex Property Trust, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">171,347&#160;</td><td align="right" valign="bottom">37,773,446&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Mid-America Apartment Communities, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">340,300&#160;</td><td align="right" valign="bottom">32,570,113&#160;</td>
</tr>
<tr>
<td align="left" valign="top">UDR, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">1,104,000&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">38,551,680&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">165,791,474&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">REITs - Diversified - 5.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Cousins Properties, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">618,943&#160;</td><td align="right" valign="bottom">6,406,060&#160;</td>
</tr>
<tr>
<td align="left" valign="top">DuPont Fabros Technology, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">292,900&#160;</td><td align="right" valign="bottom">11,663,278&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Forest City Realty Trust, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">892,767&#160;</td><td align="right" valign="bottom">18,551,698&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Liberty Property Trust (SBI)&#160;</td><td valign="top"/><td align="right" valign="bottom">219,500&#160;</td><td align="right" valign="bottom">7,660,550&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Vornado Realty Trust&#160;</td><td valign="top"/><td align="right" valign="bottom">39,783&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">3,808,427&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">48,090,013&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">REITs - Health Care - 11.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Healthcare Realty Trust, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">826,600&#160;</td><td align="right" valign="bottom">25,029,448&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Healthcare Trust of America, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">23,500&#160;</td><td align="right" valign="bottom">678,915&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Sabra Health Care REIT, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">504,800&#160;</td><td align="right" valign="bottom">10,646,232&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Ventas, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">809,405&#160;</td><td align="right" valign="bottom">50,280,239&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Welltower, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">263,019&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">18,258,779&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">104,893,613&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">REITs - Hotels - 4.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Ashford Hospitality Prime, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">311,400&#160;</td><td align="right" valign="bottom">3,484,566&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Chesapeake Lodging Trust&#160;</td><td valign="top"/><td align="right" valign="bottom">99,100&#160;</td><td align="right" valign="bottom">2,440,833&#160;</td>
</tr>
<tr>
<td align="left" valign="top">FelCor Lodging Trust, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">2,294,689&#160;</td><td align="right" valign="bottom">16,429,973&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Host Hotels &amp; Resorts, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">1,153,534&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">18,248,908&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">40,604,280&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">REITs - Management/Investment - 3.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Coresite Realty Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">139,200&#160;</td><td align="right" valign="bottom">10,430,256&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Empire State Realty Trust, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">1,104,600&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">20,446,146&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">30,876,402&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">REITs - Manufactured Homes - 1.9%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Equity Lifestyle Properties, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">73,600&#160;</td><td align="right" valign="bottom">5,040,864&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Sun Communities, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">193,222&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">13,113,977&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">18,154,841&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">REITs - Office Property - 15.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Alexandria Real Estate Equities, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">101,133&#160;</td><td align="right" valign="bottom">9,400,312&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Boston Properties, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">434,647&#160;</td><td align="right" valign="bottom">56,008,612&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Douglas Emmett, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">105,400&#160;</td><td align="right" valign="bottom">3,420,230&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Mack-Cali Realty Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">1,420,100&#160;</td><td align="right" valign="bottom">36,297,756&#160;</td>
</tr>
<tr>
<td align="left" valign="top">New York (REIT), Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">248,400&#160;</td><td align="right" valign="bottom">2,441,772&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Parkway Properties, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">650,300&#160;</td><td align="right" valign="bottom">10,697,435&#160;</td>
</tr>
<tr>
<td align="left" valign="top">SL Green Realty Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">151,065&#160;</td><td align="right" valign="bottom">15,873,910&#160;</td>
</tr>
<tr>
<td align="left" valign="top">VEREIT, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">1,078,300&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">9,575,304&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">143,715,331&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">REITs - Regional Malls - 16.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">General Growth Properties, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">655,900&#160;</td><td align="right" valign="bottom">18,384,877&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Pennsylvania Real Estate Investment Trust (SBI)&#160;</td><td valign="top"/><td align="right" valign="bottom">202,000&#160;</td><td align="right" valign="bottom">4,633,880&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Simon Property Group, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">565,850&#160;</td><td align="right" valign="bottom">113,832,042&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Taubman Centers, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">90,300&#160;</td><td align="right" valign="bottom">6,271,335&#160;</td>
</tr>
<tr>
<td align="left" valign="top">The Macerich Co.&#160;</td><td valign="top"/><td align="right" valign="bottom">124,300&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">9,456,744&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">152,578,878&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">REITs - Shopping Centers - 9.4%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Acadia Realty Trust (SBI)&#160;</td><td valign="top"/><td align="right" valign="bottom">8,100&#160;</td><td align="right" valign="bottom">272,970&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Brixmor Property Group, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">220,100&#160;</td><td align="right" valign="bottom">5,557,525&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Cedar Shopping Centers, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">1,411,243&#160;</td><td align="right" valign="bottom">9,765,802&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Federal Realty Investment Trust (SBI)&#160;</td><td valign="top"/><td align="right" valign="bottom">204,802&#160;</td><td align="right" valign="bottom">31,146,288&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Kite Realty Group Trust&#160;</td><td valign="top"/><td align="right" valign="bottom">247,332&#160;</td><td align="right" valign="bottom">6,734,850&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Ramco-Gershenson Properties Trust (SBI)&#160;</td><td valign="top"/><td align="right" valign="bottom">494,122&#160;</td><td align="right" valign="bottom">8,750,901&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Urban Edge Properties&#160;</td><td valign="top"/><td align="right" valign="bottom">1,075,241&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">27,891,752&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">90,120,088&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">REITs - Storage - 9.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Extra Space Storage, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">520,900&#160;</td><td align="right" valign="bottom">44,250,455&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Public Storage&#160;</td><td valign="top"/><td align="right" valign="bottom">189,850&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">46,477,179&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">90,727,634&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">REITs - Warehouse/Industrial - 4.8%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">DCT Industrial Trust, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">718,250&#160;</td><td align="right" valign="bottom">28,995,753&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Prologis, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">238,577&#160;</td><td align="right" valign="bottom">10,833,782&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Terreno Realty Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">265,400&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">6,043,158&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">45,872,693&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Specialized REITs - 0.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Gaming &amp; Leisure Properties&#160;</td><td valign="top"/><td align="right" valign="bottom">14,700&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">482,013&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL REAL ESTATE INVESTMENT TRUSTS&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">931,907,260&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">TOTAL COMMON STOCKS&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">(Cost $721,231,235)&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">941,598,235&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold; color: #ffffff; background-color: #000000;">
<td align="left" valign="top">Money Market Funds - 1.8%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Cash Central Fund, 0.38% (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">(Cost $17,427,510)&#160;</td><td/><td align="right" valign="top">17,427,510&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">17,427,510&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">TOTAL INVESTMENT PORTFOLIO - 100.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">(Cost $738,658,745)&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td style="font-weight: bold;" align="right" valign="top">959,025,745&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">NET OTHER ASSETS (LIABILITIES) - (0.3)%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">(3,121,167)&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">NET ASSETS - 100%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="top" style="border-bottom: double 3px black; font-weight: bold;">$955,904,578&#160;</td>
</tr>
</table>
<br/>
<p style="font: bold 12pt Arial, Helvetica, sans-serif;">Legend</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(a)&#160;Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements  are available on the SEC's website or upon request.</p>
<br/>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Affiliated Central Funds</p>
<p style="font: normal 10pt Arial, Helvetica, sans-serif;">Information regarding fiscal year to date income earned by the Fund from investments in Fidelity Central Funds is as follows:</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="7" cellpadding="0" width="745">
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">Fund&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Income earned&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Cash Central Fund&#160;</td><td align="right" valign="bottom">$35,613&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Securities Lending Cash Central Fund&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">133&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Total&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$35,746&#160;</td>
</tr>
</table>
<br/>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Investment Valuation</p>
<p style="font: normal 10pt Arial, Helvetica, sans-serif;">All investments are categorized as Level 1 under the Fair Value Hierarchy. The inputs or methodology used for valuing securities may not be an indication of the risk associated with investing in those securities. Additional information on valuation inputs is provided later in this section.</p>
<p>Investments are valued as of 4:00 p.m. Eastern time on the last calendar day of the period. Security transactions are accounted for as of trade date. The Board of Trustees (the Board) has delegated the day to day responsibility for the valuation of the Fund's investments to the Fidelity SelectCo, LLC (SelectCo) Fair Value Committee (the Committee). In accordance with valuation policies and procedures approved by the Board, the Fund attempts to obtain prices from one or more third party pricing vendors or brokers to value its investments. When current market prices, quotations or currency exchange rates are not readily available or reliable, investments will be fair valued in good faith by the Committee, in accordance with procedures adopted by the Board. Factors used in determining fair value vary by investment type and may include market or investment specific events. The frequency with which these procedures are used cannot be predicted and they may be utilized to a significant extent. The Committee oversees the Fund&#146;s valuation policies and procedures and reports to the Board on the Committee's activities and fair value determinations. The Board monitors the appropriateness of the procedures used in valuing the Fund's investments and ratifies the fair value determinations of the Committee. The Fund categorizes the inputs to valuation techniques used to value its investments into a disclosure hierarchy consisting of three levels: Level 1 - quoted prices in active markets for identical investments: Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds etc.): Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available). Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. Valuation techniques used to value the Fund's investments by major category are as follows:</p>
<p>Equity securities, including restricted securities, for which market quotations are readily available, are valued at the last reported sale price or official closing price as reported by a third party pricing vendor on the primary market or exchange on which they are traded and are categorized as Level 1 in the hierarchy. In the event there were no sales during the day or closing prices are not available, securities are valued at the last quoted bid price or may be valued using the last available price and are generally categorized as Level 2 in the hierarchy. For foreign equity securities, when market or security specific events arise, comparisons to the valuation of American Depositary Receipts (ADRs), futures contracts, Exchange-Traded Funds (ETFs) and certain indexes as well as quoted prices for similar securities may be used and would be categorized as Level 2 in the hierarchy. Utilizing these techniques may result in transfers between Level 1 and Level 2. For equity securities, including restricted securities, where observable inputs are limited, assumptions about market activity and risk are used and these securities may be categorized as Level 3 in the hierarchy.</p>
<p>Investments in open-end mutual funds, including the Fidelity Central Funds, are valued at their closing net asset value each business day and are categorized as Level 1 in the hierarchy.</p>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Other Information</p>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Income Tax Information</p>
<p>At April 30, 2016, the cost of investment securities for income tax purposes was $742,352,164. Net unrealized appreciation aggregated $216,673,581, of which $232,071,843 related to appreciated investment securities and $15,398,262 related to depreciated investment securities.</p>
<p>For additional information on the Fund's policy regarding valuation of investments and other significant accounting policies, please refer to the Fund's most recent semiannual or annual shareholder report.</p>
<br/>
<br/>
<br/>
<br/>
<p style="font-style: italic;">
</p><p style="font-style: italic;">The fund's schedule of investments as of the date on the cover of this report has not been audited. This report is provided for the general information of the fund's shareholders. For more information regarding the fund and its holdings, please see the fund's most recent prospectus and annual report.</p>

<p style="font-style: italic;">
</p><p style="font-style: italic;">Third party trademarks and service marks are the property of their respective owners. All other trademarks and service marks are the property of FMR LLC or an affiliate.</p>

<hr size="2" noshade="noshade"/>
</div>
<div style="font: normal 11pt Arial, Helvetica, sans-serif; width: 780px">
<!-- Automatically produced using the ProofPlus Content Management System -->
<p style="font: bold 18pt Arial, Helvetica, sans-serif; margin-bottom: 0px;" align="center">Quarterly Holdings Report<br clear="all"/>for</p>
<p style="font: bold 20pt Arial, Helvetica, sans-serif; margin-top: 0px;" align="center">Fidelity Advisor&#174; Energy Fund</p>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-top: 0px;" align="center">April 30, 2016</p>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>ANR-QTLY-0616<br/>1.800328.112<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<a name="">
<p style="font: bold 16pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Investments April 30, 2016 (Unaudited)</p>
</a>
<p style="font: normal 11pt Arial, Helvetica, sans-serif; margin-top: 0px;">Showing Percentage of Net Assets</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="0" cellpadding="5" width="745">
<tr style="font-weight:bold; color: #ffffff; background-color: #000000;">
<td align="left" valign="top">Common Stocks - 98.7%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">&#160;</td><td/><td style="font-weight: bold;" align="center" valign="bottom">Shares&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Value&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Chemicals - 0.7%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Commodity Chemicals - 0.7%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">LyondellBasell Industries NV Class A&#160;</td><td valign="top"/><td align="right" valign="bottom">75,400&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">$6,233,318&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Energy Equipment &amp; Services - 18.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Oil &amp; Gas Drilling - 1.4%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Nabors Industries Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">974,200&#160;</td><td align="right" valign="bottom">9,547,160&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Odfjell Drilling A/S  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">567,856&#160;</td><td align="right" valign="bottom">382,245&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Transocean Partners LLC&#160;</td><td valign="top"/><td align="right" valign="bottom">44,200&#160;</td><td align="right" valign="bottom">522,444&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Trinidad Drilling Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">279,200&#160;</td><td align="right" valign="bottom">540,732&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Xtreme Drilling &amp; Coil Services Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">813,202&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">1,574,943&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">12,567,524&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Oil &amp; Gas Equipment &amp; Services - 16.6%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Baker Hughes, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">604,700&#160;</td><td align="right" valign="bottom">29,243,292&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Bristow Group, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">27,500&#160;</td><td align="right" valign="bottom">630,300&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Dril-Quip, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">141,191&#160;</td><td align="right" valign="bottom">9,152,001&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Exterran Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">51,700&#160;</td><td align="right" valign="bottom">791,010&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Frank's International NV&#160;</td><td valign="top"/><td align="right" valign="bottom">627,400&#160;</td><td align="right" valign="bottom">10,446,210&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Newpark Resources, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">375,100&#160;</td><td align="right" valign="bottom">1,751,717&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Oceaneering International, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">216,273&#160;</td><td align="right" valign="bottom">7,926,405&#160;</td>
</tr>
<tr>
<td align="left" valign="top">RigNet, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">90,000&#160;</td><td align="right" valign="bottom">1,539,000&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Schlumberger Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">978,418&#160;</td><td align="right" valign="bottom">78,606,103&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Superior Energy Services, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">120,700&#160;</td><td align="right" valign="bottom">2,035,002&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Tesco Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">214,800&#160;</td><td align="right" valign="bottom">2,032,008&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Total Energy Services, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">38,900&#160;</td><td align="right" valign="bottom">408,935&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Weatherford International Ltd.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">543,100&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">4,415,403&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">148,977,386&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL ENERGY EQUIPMENT &amp; SERVICES&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">161,544,910&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Independent Power and Renewable Electricity Producers - 0.8%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Renewable Electricity - 0.8%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">NextEra Energy Partners LP&#160;</td><td valign="top"/><td align="right" valign="bottom">241,300&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">6,971,157&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Metals &amp; Mining - 0.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Diversified Metals &amp; Mining - 0.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Hi-Crush Partners LP&#160;</td><td valign="top"/><td align="right" valign="bottom">144,303&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">1,010,121&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Oil, Gas &amp; Consumable Fuels - 78.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Coal &amp; Consumable Fuels - 0.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">CONSOL Energy, Inc.  (b)&#160;</td><td valign="top"/><td align="right" valign="bottom">179,000&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">2,693,950&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Integrated Oil &amp; Gas - 5.8%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Cenovus Energy, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">58,000&#160;</td><td align="right" valign="bottom">919,439&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Chevron Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">281,809&#160;</td><td align="right" valign="bottom">28,795,244&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Exxon Mobil Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">207,361&#160;</td><td align="right" valign="bottom">18,330,712&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Occidental Petroleum Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">49,600&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">3,801,840&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">51,847,235&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Oil &amp; Gas Exploration &amp; Production - 60.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Anadarko Petroleum Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">765,883&#160;</td><td align="right" valign="bottom">40,407,987&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Apache Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">392,500&#160;</td><td align="right" valign="bottom">21,352,000&#160;</td>
</tr>
<tr>
<td align="left" valign="top">ARC Resources Ltd.  (b)&#160;</td><td valign="top"/><td align="right" valign="bottom">58,100&#160;</td><td align="right" valign="bottom">980,296&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Bankers Petroleum Ltd.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">314,900&#160;</td><td align="right" valign="bottom">476,855&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Bill Barrett Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">55,400&#160;</td><td align="right" valign="bottom">440,984&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Black Stone Minerals LP&#160;</td><td valign="top"/><td align="right" valign="bottom">111,591&#160;</td><td align="right" valign="bottom">1,868,033&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Cabot Oil &amp; Gas Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">261,900&#160;</td><td align="right" valign="bottom">6,128,460&#160;</td>
</tr>
<tr>
<td align="left" valign="top">California Resources Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">892,387&#160;</td><td align="right" valign="bottom">1,963,251&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Callon Petroleum Co.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">380,700&#160;</td><td align="right" valign="bottom">4,001,157&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Carrizo Oil &amp; Gas, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">407,600&#160;</td><td align="right" valign="bottom">14,416,812&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Cimarex Energy Co.&#160;</td><td valign="top"/><td align="right" valign="bottom">259,647&#160;</td><td align="right" valign="bottom">28,270,365&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Concho Resources, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">151,500&#160;</td><td align="right" valign="bottom">17,599,755&#160;</td>
</tr>
<tr>
<td align="left" valign="top">ConocoPhillips Co.&#160;</td><td valign="top"/><td align="right" valign="bottom">489,300&#160;</td><td align="right" valign="bottom">23,383,647&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Continental Resources, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">296,000&#160;</td><td align="right" valign="bottom">11,028,960&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Denbury Resources, Inc.  (b)&#160;</td><td valign="top"/><td align="right" valign="bottom">458,400&#160;</td><td align="right" valign="bottom">1,769,424&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Devon Energy Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">343,700&#160;</td><td align="right" valign="bottom">11,919,516&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Diamondback Energy, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">345,700&#160;</td><td align="right" valign="bottom">29,930,706&#160;</td>
</tr>
<tr>
<td align="left" valign="top">EOG Resources, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">717,786&#160;</td><td align="right" valign="bottom">59,303,479&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Evolution Petroleum Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">42,495&#160;</td><td align="right" valign="bottom">235,422&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Gran Tierra Energy, Inc. (Canada)  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">343,300&#160;</td><td align="right" valign="bottom">1,012,362&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Gulfport Energy Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">102,500&#160;</td><td align="right" valign="bottom">3,208,250&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Hess Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">554,100&#160;</td><td align="right" valign="bottom">33,035,442&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Jones Energy, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">31,300&#160;</td><td align="right" valign="bottom">150,240&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Laredo Petroleum, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">40,800&#160;</td><td align="right" valign="bottom">496,944&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Marathon Oil Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">1,101,400&#160;</td><td align="right" valign="bottom">15,518,726&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Matador Resources Co.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">19,600&#160;</td><td align="right" valign="bottom">422,380&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Memorial Resource Development Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">490,200&#160;</td><td align="right" valign="bottom">6,411,816&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Murphy Oil Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">117,600&#160;</td><td align="right" valign="bottom">4,203,024&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Newfield Exploration Co.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">962,100&#160;</td><td align="right" valign="bottom">34,876,125&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Noble Energy, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">1,225,808&#160;</td><td align="right" valign="bottom">44,263,927&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Oasis Petroleum, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">292,900&#160;</td><td align="right" valign="bottom">2,838,201&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Parsley Energy, Inc. Class A (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">466,900&#160;</td><td align="right" valign="bottom">10,934,798&#160;</td>
</tr>
<tr>
<td align="left" valign="top">PDC Energy, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">369,988&#160;</td><td align="right" valign="bottom">23,231,547&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Pioneer Natural Resources Co.&#160;</td><td valign="top"/><td align="right" valign="bottom">97,616&#160;</td><td align="right" valign="bottom">16,214,018&#160;</td>
</tr>
<tr>
<td align="left" valign="top">QEP Resources, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">327,800&#160;</td><td align="right" valign="bottom">5,877,454&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Range Resources Corp.  (b)&#160;</td><td valign="top"/><td align="right" valign="bottom">46,100&#160;</td><td align="right" valign="bottom">2,033,471&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Rice Energy, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">523,700&#160;</td><td align="right" valign="bottom">9,065,247&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Ring Energy, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">265,432&#160;</td><td align="right" valign="bottom">1,911,110&#160;</td>
</tr>
<tr>
<td align="left" valign="top">RSP Permian, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">233,200&#160;</td><td align="right" valign="bottom">7,138,252&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Sanchez Energy Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">112,300&#160;</td><td align="right" valign="bottom">1,009,577&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Seven Generations Energy Ltd.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">450,500&#160;</td><td align="right" valign="bottom">7,935,004&#160;</td>
</tr>
<tr>
<td align="left" valign="top">SM Energy Co.&#160;</td><td valign="top"/><td align="right" valign="bottom">544,900&#160;</td><td align="right" valign="bottom">16,979,084&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Southwestern Energy Co.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">120,300&#160;</td><td align="right" valign="bottom">1,615,629&#160;</td>
</tr>
<tr>
<td align="left" valign="top">TAG Oil Ltd.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">342,200&#160;</td><td align="right" valign="bottom">231,824&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Whiting Petroleum Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,150,600&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">13,807,200&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">539,898,761&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Oil &amp; Gas Refining &amp; Marketing - 3.9%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Keyera Corp.  (b)&#160;</td><td valign="top"/><td align="right" valign="bottom">115,300&#160;</td><td align="right" valign="bottom">3,713,456&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Valero Energy Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">483,426&#160;</td><td align="right" valign="bottom">28,459,289&#160;</td>
</tr>
<tr>
<td align="left" valign="top">World Fuel Services Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">69,433&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">3,244,604&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">35,417,349&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Oil &amp; Gas Storage &amp; Transport - 8.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Cheniere Energy Partners LP Holdings LLC&#160;</td><td valign="top"/><td align="right" valign="bottom">190,100&#160;</td><td align="right" valign="bottom">3,703,148&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Cheniere Energy, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">339,800&#160;</td><td align="right" valign="bottom">13,211,424&#160;</td>
</tr>
<tr>
<td align="left" valign="top">DCP Midstream Partners LP&#160;</td><td valign="top"/><td align="right" valign="bottom">78,600&#160;</td><td align="right" valign="bottom">2,567,862&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Enterprise Products Partners LP&#160;</td><td valign="top"/><td align="right" valign="bottom">286,200&#160;</td><td align="right" valign="bottom">7,638,678&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Gener8 Maritime, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">79,800&#160;</td><td align="right" valign="bottom">576,954&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Golar LNG Ltd. (b)&#160;</td><td valign="top"/><td align="right" valign="bottom">167,300&#160;</td><td align="right" valign="bottom">2,773,834&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Kinder Morgan, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">1,183,900&#160;</td><td align="right" valign="bottom">21,026,064&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Magellan Midstream Partners LP&#160;</td><td valign="top"/><td align="right" valign="bottom">44,134&#160;</td><td align="right" valign="bottom">3,180,737&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Rice Midstream Partners LP&#160;</td><td valign="top"/><td align="right" valign="bottom">117,300&#160;</td><td align="right" valign="bottom">1,955,391&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Shell Midstream Partners LP&#160;</td><td valign="top"/><td align="right" valign="bottom">81,800&#160;</td><td align="right" valign="bottom">3,089,586&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Targa Resources Corp.  (b)&#160;</td><td valign="top"/><td align="right" valign="bottom">201,200&#160;</td><td align="right" valign="bottom">8,140,552&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Teekay LNG Partners LP&#160;</td><td valign="top"/><td align="right" valign="bottom">23,000&#160;</td><td align="right" valign="bottom">316,020&#160;</td>
</tr>
<tr>
<td align="left" valign="top">The Williams Companies, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">139,800&#160;</td><td align="right" valign="bottom">2,710,722&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Williams Partners LP&#160;</td><td valign="top"/><td align="right" valign="bottom">63,200&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">1,910,536&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">72,801,508&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL OIL, GAS &amp; CONSUMABLE FUELS&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">702,658,803&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Semiconductors &amp; Semiconductor Equipment - 0.8%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Semiconductor Equipment - 0.8%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">SolarEdge Technologies, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">265,100&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">7,102,029&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">TOTAL COMMON STOCKS&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">(Cost $813,747,655)&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">885,520,338&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold; color: #ffffff; background-color: #000000;">
<td align="left" valign="top">Money Market Funds - 4.9%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Cash Central Fund, 0.38% (c)&#160;</td><td valign="top"/><td align="right" valign="bottom">11,913,674&#160;</td><td align="right" valign="bottom">11,913,674&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Securities Lending Cash Central Fund, 0.42% (c)(d)&#160;</td><td valign="top"/><td align="right" valign="bottom">31,839,985&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">31,839,985&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">TOTAL MONEY MARKET FUNDS&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">(Cost $43,753,659)&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">43,753,659&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">TOTAL INVESTMENT PORTFOLIO - 103.6%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">(Cost $857,501,314)&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td style="font-weight: bold;" align="right" valign="top">929,273,997&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">NET OTHER ASSETS (LIABILITIES) - (3.6)%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">(32,203,979)&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">NET ASSETS - 100%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="top" style="border-bottom: double 3px black; font-weight: bold;">$897,070,018&#160;</td>
</tr>
</table>
<br/>
<p style="font: bold 12pt Arial, Helvetica, sans-serif;">Legend</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(a)&#160;Non-income producing</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(b)&#160;Security or a portion of the security is on loan at period end.</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(c)&#160;Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request.</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(d)&#160;Investment made with cash collateral received from securities on loan.</p>
<br/>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Affiliated Central Funds</p>
<p style="font: normal 10pt Arial, Helvetica, sans-serif;">Information regarding fiscal year to date income earned by the Fund from investments in Fidelity Central Funds is as follows:</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="7" cellpadding="0" width="745">
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">Fund&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Income earned&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Cash Central Fund&#160;</td><td align="right" valign="bottom">$21,975&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Securities Lending Cash Central Fund&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">67,117&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Total&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$89,092&#160;</td>
</tr>
</table>
<br/>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Investment Valuation</p>
<p style="font: normal 10pt Arial, Helvetica, sans-serif;">All investments are categorized as Level 1 under the Fair Value Hierarchy. The inputs or methodology used for valuing securities may not be an indication of the risk associated with investing in those securities. Additional information on valuation inputs is provided later in this section.</p>
<p>Investments are valued as of 4:00 p.m. Eastern time on the last calendar day of the period. Security transactions are accounted for as of trade date. The Board of Trustees (the Board) has delegated the day to day responsibility for the valuation of the Fund's investments to the Fidelity SelectCo, LLC (SelectCo)Fair Value Committee (the Committee). In accordance with valuation policies and procedures approved by the Board, the Fund attempts to obtain prices from one or more third party pricing vendors or brokers to value its investments. When current market prices, quotations or currency exchange rates are not readily available or reliable, investments will be fair valued in good faith by the Committee, in accordance with procedures adopted by the Board. Factors used in determining fair value vary by investment type and may include market or investment specific events. The frequency with which these procedures are used cannot be predicted and they may be utilized to a significant extent. The Committee oversees the Fund&#146;s valuation policies and procedures and reports to the Board on the Committee's activities and fair value determinations. The Board monitors the appropriateness of the procedures used in valuing the Fund's investments and ratifies the fair value determinations of the Committee. The Fund categorizes the inputs to valuation techniques used to value its investments into a disclosure hierarchy consisting of three levels: Level 1 - quoted prices in active markets for identical investments: Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds etc.): Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available). Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. Valuation techniques used to value the Fund's investments by major category are as follows:</p>
<p>Equity securities, including restricted securities, for which market quotations are readily available, are valued at the last reported sale price or official closing price as reported by a third party pricing vendor on the primary market or exchange on which they are traded and are categorized as Level 1 in the hierarchy. In the event there were no sales during the day or closing prices are not available, securities are valued at the last quoted bid price or may be valued using the last available price and are generally categorized as Level 2 in the hierarchy. For foreign equity securities, when market or security specific events arise, comparisons to the valuation of American Depositary Receipts (ADRs), futures contracts, Exchange-Traded Funds (ETFs) and certain indexes as well as quoted prices for similar securities may be used and would be categorized as Level 2 in the hierarchy. Utilizing these techniques may result in transfers between Level 1 and Level 2. For equity securities, including restricted securities, where observable inputs are limited, assumptions about market activity and risk are used and these securities may be categorized as Level 3 in the hierarchy.</p>
<p>Investments in open-end mutual funds, including the Fidelity Central Funds, are valued at their closing net asset value each business day and are categorized as Level 1 in the hierarchy.</p>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Other Information</p>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Income Tax Information</p>
<p>At April 30, 2016, the cost of investment securities for income tax purposes was $886,841,353. Net unrealized appreciation aggregated $42,432,644, of which $116,795,949 related to appreciated investment securities and $74,363,305 related to depreciated investment securities.</p>
<p>For additional information on the Fund's policy regarding valuation of investments and other significant accounting policies, please refer to the Fund's most recent semiannual or annual shareholder report.</p>
<br/>
<br/>
<br/>
<br/>
<p style="font-style: italic;">
</p><p style="font-style: italic;">The fund's schedule of investments as of the date on the cover of this report has not been audited. This report is provided for the general information of the fund's shareholders. For more information regarding the fund and its holdings, please see the fund's most recent prospectus and annual report.</p>

<p style="font-style: italic;">
</p><p style="font-style: italic;">Third party trademarks and service marks are the property of their respective owners. All other trademarks and service marks are the property of FMR LLC or an affiliate.</p>

<hr size="2" noshade="noshade"/>
</div>
<div style="font: normal 11pt Arial, Helvetica, sans-serif; width: 780px">
<!-- Automatically produced using the ProofPlus Content Management System -->
<p style="font: bold 18pt Arial, Helvetica, sans-serif; margin-bottom: 0px;" align="center">Quarterly Holdings Report<br clear="all"/>for</p>
<p style="font: bold 20pt Arial, Helvetica, sans-serif; margin-top: 0px;" align="center">Fidelity Advisor&#174; Health Care Fund</p>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-top: 0px;" align="center">April 30, 2016</p>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>AFHC-QTLY-0616<br/>1.800327.112<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<a name="">
<p style="font: bold 16pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Investments April 30, 2016 (Unaudited)</p>
</a>
<p style="font: normal 11pt Arial, Helvetica, sans-serif; margin-top: 0px;">Showing Percentage of Net Assets</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="0" cellpadding="5" width="745">
<tr style="font-weight:bold; color: #ffffff; background-color: #000000;">
<td align="left" valign="top">Common Stocks - 99.9%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">&#160;</td><td/><td style="font-weight: bold;" align="center" valign="bottom">Shares&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Value&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Biotechnology - 27.7%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Biotechnology - 27.7%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">AbbVie, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">665,100&#160;</td><td align="right" valign="bottom">$40,571,100&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Ablynx NV  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">659,208&#160;</td><td align="right" valign="bottom">9,959,931&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Acceleron Pharma, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">142,448&#160;</td><td align="right" valign="bottom">4,266,318&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Acorda Therapeutics, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">425,500&#160;</td><td align="right" valign="bottom">10,999,175&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Actelion Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">90,000&#160;</td><td align="right" valign="bottom">14,541,853&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Advanced Accelerator Applications SA sponsored ADR&#160;</td><td valign="top"/><td align="right" valign="bottom">59,900&#160;</td><td align="right" valign="bottom">2,067,149&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Advaxis, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">557,000&#160;</td><td align="right" valign="bottom">4,311,180&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Alexion Pharmaceuticals, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">441,100&#160;</td><td align="right" valign="bottom">61,436,408&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Alnylam Pharmaceuticals, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">159,655&#160;</td><td align="right" valign="bottom">10,703,271&#160;</td>
</tr>
<tr>
<td align="left" valign="top">AMAG Pharmaceuticals, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">175,915&#160;</td><td align="right" valign="bottom">4,665,266&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Amgen, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">1,051,800&#160;</td><td align="right" valign="bottom">166,499,940&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Amicus Therapeutics, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">870,000&#160;</td><td align="right" valign="bottom">6,498,900&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Anacor Pharmaceuticals, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">344,537&#160;</td><td align="right" valign="bottom">21,616,251&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Arena Pharmaceuticals, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">2,625,396&#160;</td><td align="right" valign="bottom">4,515,681&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Array BioPharma, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,333,700&#160;</td><td align="right" valign="bottom">4,254,503&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Ascendis Pharma A/S sponsored ADR  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">400,000&#160;</td><td align="right" valign="bottom">6,748,000&#160;</td>
</tr>
<tr>
<td align="left" valign="top">BeiGene Ltd. ADR&#160;</td><td valign="top"/><td align="right" valign="bottom">63,059&#160;</td><td align="right" valign="bottom">1,750,518&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Biogen, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">143,784&#160;</td><td align="right" valign="bottom">39,539,162&#160;</td>
</tr>
<tr>
<td align="left" valign="top">BioMarin Pharmaceutical, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">175,500&#160;</td><td align="right" valign="bottom">14,861,340&#160;</td>
</tr>
<tr>
<td align="left" valign="top">bluebird bio, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">45,120&#160;</td><td align="right" valign="bottom">2,001,072&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Blueprint Medicines Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">205,000&#160;</td><td align="right" valign="bottom">3,111,900&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Celgene Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">201,908&#160;</td><td align="right" valign="bottom">20,879,306&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Cellectis SA sponsored ADR  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">220,700&#160;</td><td align="right" valign="bottom">6,005,247&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Curis, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,519,300&#160;</td><td align="right" valign="bottom">3,038,600&#160;</td>
</tr>
<tr>
<td align="left" valign="top">CytomX Therapeutics, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">145,600&#160;</td><td align="right" valign="bottom">1,881,152&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Galapagos Genomics NV sponsored ADR&#160;</td><td valign="top"/><td align="right" valign="bottom">142,500&#160;</td><td align="right" valign="bottom">6,456,675&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Gilead Sciences, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">455,662&#160;</td><td align="right" valign="bottom">40,193,945&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Heron Therapeutics, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">163,315&#160;</td><td align="right" valign="bottom">3,501,474&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Incyte Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">76,300&#160;</td><td align="right" valign="bottom">5,514,201&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Insmed, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">902,998&#160;</td><td align="right" valign="bottom">10,971,426&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Intercept Pharmaceuticals, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">53,621&#160;</td><td align="right" valign="bottom">8,082,830&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Mirati Therapeutics, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">274,000&#160;</td><td align="right" valign="bottom">5,677,280&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Neurocrine Biosciences, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">280,000&#160;</td><td align="right" valign="bottom">12,762,400&#160;</td>
</tr>
<tr>
<td align="left" valign="top">ProNai Therapeutics, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">97,200&#160;</td><td align="right" valign="bottom">544,320&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Puma Biotechnology, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">400,000&#160;</td><td align="right" valign="bottom">12,276,000&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Regeneron Pharmaceuticals, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">98,400&#160;</td><td align="right" valign="bottom">37,068,264&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Spark Therapeutics, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">133,942&#160;</td><td align="right" valign="bottom">4,807,178&#160;</td>
</tr>
<tr>
<td align="left" valign="top">TESARO, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">314,200&#160;</td><td align="right" valign="bottom">13,020,448&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Trevena, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,000,000&#160;</td><td align="right" valign="bottom">7,790,000&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Ultragenyx Pharmaceutical, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">209,440&#160;</td><td align="right" valign="bottom">14,162,333&#160;</td>
</tr>
<tr>
<td align="left" valign="top">United Therapeutics Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">43,700&#160;</td><td align="right" valign="bottom">4,597,240&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Vertex Pharmaceuticals, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">875,700&#160;</td><td align="right" valign="bottom">73,856,538&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Xencor, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">330,000&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">4,042,500&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">732,048,275&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Capital Markets - 0.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Asset Management &amp; Custody Banks - 0.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">RPI International Holdings LP  (c)&#160;</td><td valign="top"/><td align="right" valign="bottom">61,683&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">8,276,625&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Diversified Consumer Services - 0.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Specialized Consumer Services - 0.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Carriage Services, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">215,735&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">5,270,406&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Health Care Equipment &amp; Supplies - 25.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Health Care Equipment - 22.8%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Atricure, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">600,000&#160;</td><td align="right" valign="bottom">9,540,000&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Boston Scientific Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">6,439,800&#160;</td><td align="right" valign="bottom">141,160,416&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Edwards Lifesciences Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">350,400&#160;</td><td align="right" valign="bottom">37,215,984&#160;</td>
</tr>
<tr>
<td align="left" valign="top">HeartWare International, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">264,500&#160;</td><td align="right" valign="bottom">8,823,720&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Integra LifeSciences Holdings Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">244,600&#160;</td><td align="right" valign="bottom">17,322,572&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Intuitive Surgical, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">70,000&#160;</td><td align="right" valign="bottom">43,845,200&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Invuity, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">517,800&#160;</td><td align="right" valign="bottom">3,521,040&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Medtronic PLC&#160;</td><td valign="top"/><td align="right" valign="bottom">3,188,700&#160;</td><td align="right" valign="bottom">252,385,603&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Neovasc, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,100,000&#160;</td><td align="right" valign="bottom">3,531,000&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Nevro Corp.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">300,000&#160;</td><td align="right" valign="bottom">20,175,000&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Novocure Ltd.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">185,300&#160;</td><td align="right" valign="bottom">2,390,370&#160;</td>
</tr>
<tr>
<td align="left" valign="top">ResMed, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">243,500&#160;</td><td align="right" valign="bottom">13,587,300&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Wright Medical Group NV  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,300,000&#160;</td><td align="right" valign="bottom">24,414,000&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Zeltiq Aesthetics, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">370,000&#160;</td><td align="right" valign="bottom">11,063,000&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Zimmer Biomet Holdings, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">126,800&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">14,679,636&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">603,654,841&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Health Care Supplies - 2.7%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">ICU Medical, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">99,900&#160;</td><td align="right" valign="bottom">9,924,066&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Penumbra, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">200,000&#160;</td><td align="right" valign="bottom">10,900,000&#160;</td>
</tr>
<tr>
<td align="left" valign="top">The Cooper Companies, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">237,100&#160;</td><td align="right" valign="bottom">36,295,268&#160;</td>
</tr>
<tr>
<td align="left" valign="top">The Spectranetics Corp.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">760,000&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">12,920,000&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">70,039,334&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL HEALTH CARE EQUIPMENT &amp; SUPPLIES&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">673,694,175&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Health Care Providers &amp; Services - 17.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Health Care Distributors &amp; Services - 4.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Amplifon SpA&#160;</td><td valign="top"/><td align="right" valign="bottom">761,295&#160;</td><td align="right" valign="bottom">7,004,277&#160;</td>
</tr>
<tr>
<td align="left" valign="top">EBOS Group Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">1,312,664&#160;</td><td align="right" valign="bottom">14,628,419&#160;</td>
</tr>
<tr>
<td align="left" valign="top">McKesson Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">507,308&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">85,136,429&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">106,769,125&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Health Care Facilities - 3.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">AmSurg Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">128,000&#160;</td><td align="right" valign="bottom">10,365,440&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Brookdale Senior Living, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">406,070&#160;</td><td align="right" valign="bottom">7,496,052&#160;</td>
</tr>
<tr>
<td align="left" valign="top">HCA Holdings, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">351,600&#160;</td><td align="right" valign="bottom">28,345,992&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Surgical Care Affiliates, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">387,805&#160;</td><td align="right" valign="bottom">18,750,372&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Universal Health Services, Inc. Class B&#160;</td><td valign="top"/><td align="right" valign="bottom">212,600&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">28,420,368&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">93,378,224&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Health Care Services - 1.4%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Adeptus Health, Inc. Class A (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">150,000&#160;</td><td align="right" valign="bottom">10,218,000&#160;</td>
</tr>
<tr>
<td align="left" valign="top">American Renal Associates Holdings, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">218,757&#160;</td><td align="right" valign="bottom">6,151,447&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Envision Healthcare Holdings, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">571,304&#160;</td><td align="right" valign="bottom">12,928,610&#160;</td>
</tr>
<tr>
<td align="left" valign="top">United Drug PLC (United Kingdom)&#160;</td><td valign="top"/><td align="right" valign="bottom">800,000&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">7,153,790&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">36,451,847&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Managed Health Care - 8.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Aetna, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">210,100&#160;</td><td align="right" valign="bottom">23,587,927&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Anthem, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">279,800&#160;</td><td align="right" valign="bottom">39,387,446&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Cigna Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">447,000&#160;</td><td align="right" valign="bottom">61,927,380&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Humana, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">65,200&#160;</td><td align="right" valign="bottom">11,544,964&#160;</td>
</tr>
<tr>
<td align="left" valign="top">UnitedHealth Group, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">600,000&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">79,008,000&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">215,455,717&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL HEALTH CARE PROVIDERS &amp; SERVICES&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">452,054,913&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Health Care Technology - 2.9%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Health Care Technology - 2.9%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">athenahealth, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">245,900&#160;</td><td align="right" valign="bottom">32,778,470&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Castlight Health, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">336,800&#160;</td><td align="right" valign="bottom">1,212,480&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Connecture, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">489,461&#160;</td><td align="right" valign="bottom">1,130,655&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Evolent Health, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">243,600&#160;</td><td align="right" valign="bottom">2,925,636&#160;</td>
</tr>
<tr>
<td align="left" valign="top">HealthStream, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">691,590&#160;</td><td align="right" valign="bottom">15,643,766&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Medidata Solutions, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">528,000&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">23,036,640&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">76,727,647&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Life Sciences Tools &amp; Services - 2.4%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Life Sciences Tools &amp; Services - 2.4%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Agilent Technologies, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">1,146,800&#160;</td><td align="right" valign="bottom">46,927,056&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Bruker Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">386,400&#160;</td><td align="right" valign="bottom">10,935,120&#160;</td>
</tr>
<tr>
<td align="left" valign="top">PRA Health Sciences, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">152,500&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">7,236,125&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">65,098,301&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Pharmaceuticals - 22.9%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Pharmaceuticals - 22.9%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Allergan PLC  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">502,300&#160;</td><td align="right" valign="bottom">108,778,088&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Amphastar Pharmaceuticals, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">600,000&#160;</td><td align="right" valign="bottom">7,380,000&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Astellas Pharma, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">1,012,300&#160;</td><td align="right" valign="bottom">13,648,430&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Bristol-Myers Squibb Co.&#160;</td><td valign="top"/><td align="right" valign="bottom">1,223,600&#160;</td><td align="right" valign="bottom">88,319,448&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Catalent, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">599,700&#160;</td><td align="right" valign="bottom">17,709,141&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Dechra Pharmaceuticals PLC&#160;</td><td valign="top"/><td align="right" valign="bottom">600,000&#160;</td><td align="right" valign="bottom">9,696,191&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Eisai Co. Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">280,100&#160;</td><td align="right" valign="bottom">17,338,111&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Endo International PLC  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">768,400&#160;</td><td align="right" valign="bottom">20,746,800&#160;</td>
</tr>
<tr>
<td align="left" valign="top">GlaxoSmithKline PLC&#160;</td><td valign="top"/><td align="right" valign="bottom">893,700&#160;</td><td align="right" valign="bottom">19,100,565&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Horizon Pharma PLC  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">948,600&#160;</td><td align="right" valign="bottom">14,579,982&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Jazz Pharmaceuticals PLC  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">163,100&#160;</td><td align="right" valign="bottom">24,579,170&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Jiangsu Hengrui Medicine Co. Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">1,430,000&#160;</td><td align="right" valign="bottom">10,310,764&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Lee's Pharmaceutical Holdings Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">4,366,536&#160;</td><td align="right" valign="bottom">3,533,140&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Merck &amp; Co., Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">173,300&#160;</td><td align="right" valign="bottom">9,503,772&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Mylan N.V.&#160;</td><td valign="top"/><td align="right" valign="bottom">216,400&#160;</td><td align="right" valign="bottom">9,026,044&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Pfizer, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">913,800&#160;</td><td align="right" valign="bottom">29,890,398&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Prestige Brands Holdings, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">230,800&#160;</td><td align="right" valign="bottom">13,104,824&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Sanofi SA sponsored ADR&#160;</td><td valign="top"/><td align="right" valign="bottom">500,000&#160;</td><td align="right" valign="bottom">20,550,000&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Sun Pharmaceutical Industries Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">1,000,010&#160;</td><td align="right" valign="bottom">12,213,805&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Teva Pharmaceutical Industries Ltd. sponsored ADR&#160;</td><td valign="top"/><td align="right" valign="bottom">2,276,000&#160;</td><td align="right" valign="bottom">123,928,200&#160;</td>
</tr>
<tr>
<td align="left" valign="top">The Medicines Company  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">300,600&#160;</td><td align="right" valign="bottom">10,698,354&#160;</td>
</tr>
<tr>
<td align="left" valign="top">TherapeuticsMD, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">2,050,000&#160;</td><td align="right" valign="bottom">16,912,500&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Valeant Pharmaceuticals International, Inc. (Canada)  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">106,500&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">3,552,840&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">605,100,567&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Professional Services - 0.9%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Human Resource &amp; Employment Services - 0.9%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">WageWorks, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">440,000&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">23,698,400&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">TOTAL COMMON STOCKS&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">(Cost $2,503,745,911)&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">2,641,969,309&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold; color: #ffffff; background-color: #000000;">
<td align="left" valign="top">Convertible Preferred Stocks - 0.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Health Care Providers &amp; Services - 0.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Health Care Services - 0.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">1Life Healthcare, Inc. Series G  (a)(c)&#160;</td><td valign="top"/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">(Cost $2,121,583)&#160;</td><td/><td align="right" valign="top">322,145&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">2,812,326&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold; color: #ffffff; background-color: #000000;">
<td align="left" valign="top">Money Market Funds - 1.7%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Cash Central Fund, 0.38% (d)&#160;</td><td valign="top"/><td align="right" valign="bottom">8,599,247&#160;</td><td align="right" valign="bottom">8,599,247&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Securities Lending Cash Central Fund, 0.42% (d)(e)&#160;</td><td valign="top"/><td align="right" valign="bottom">35,723,775&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">35,723,775&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">TOTAL MONEY MARKET FUNDS&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">(Cost $44,323,022)&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">44,323,022&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">TOTAL INVESTMENT PORTFOLIO - 101.7%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">(Cost $2,550,190,516)&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td style="font-weight: bold;" align="right" valign="top">2,689,104,657&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">NET OTHER ASSETS (LIABILITIES) - (1.7)%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">(45,444,734)&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">NET ASSETS - 100%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="top" style="border-bottom: double 3px black; font-weight: bold;">$2,643,659,923&#160;</td>
</tr>
</table>
<br/>
<p style="font: bold 12pt Arial, Helvetica, sans-serif;">Legend</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(a)&#160;Non-income producing</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(b)&#160;Security or a portion of the security is on loan at period end.</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(c)&#160;Restricted securities - Investment in securities not registered under the Securities Act of 1933 (excluding 144A issues). At the end of the period, the value of restricted securities (excluding 144A issues) amounted to $11,088,951 or 0.4% of net assets.</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(d)&#160;Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request.</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(e)&#160;Investment made with cash collateral received from securities on loan.</p>
<br/>
<p style="font: normal 10pt Arial, Helvetica, sans-serif;">Additional information on each restricted holding is as follows:</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="7" cellpadding="0" width="745">
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">Security&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Acquisition Date&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Acquisition Cost&#160;</td>
</tr>
<tr>
<td align="left" valign="top">1Life Healthcare, Inc. Series G&#160;</td><td align="right" valign="bottom">4/10/14&#160;</td><td align="right" valign="bottom">$2,121,583&#160;</td>
</tr>
<tr>
<td align="left" valign="top">RPI International Holdings LP&#160;</td><td align="right" valign="bottom">5/21/15 - 3/23/16&#160;</td><td align="right" valign="bottom">$8,207,868&#160;</td>
</tr>
</table>
<br/>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Affiliated Central Funds</p>
<p style="font: normal 10pt Arial, Helvetica, sans-serif;">Information regarding fiscal year to date income earned by the Fund from investments in Fidelity Central Funds is as follows:</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="7" cellpadding="0" width="745">
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">Fund&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Income earned&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Cash Central Fund&#160;</td><td align="right" valign="bottom">$108,890&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Securities Lending Cash Central Fund&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">288,711&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Total&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$397,601&#160;</td>
</tr>
</table>
<br/>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Investment Valuation</p>
<p style="font: normal 10pt Arial, Helvetica, sans-serif;">The following is a summary of the inputs used, as of April 30, 2016, involving the Fund's assets and liabilities carried at fair value. The inputs or methodology used for valuing securities may not be an indication of the risk associated with investing in those securities. Additional information on valuation inputs, and their aggregation into the levels used below, is provided later in this section.</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="7" cellpadding="0" width="745">
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">&#160;</td><td style="font-weight: bold;" align="center" valign="bottom" colspan="4">Valuation Inputs at Reporting Date:&#160;</td>
</tr>
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">Description&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Total&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Level 1&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Level 2&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Level 3&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top"><u>Investments in Securities:</u>&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Common Stocks&#160;</td><td align="right" valign="bottom">$2,641,969,309&#160;</td><td align="right" valign="bottom">$2,580,072,438&#160;</td><td align="right" valign="bottom">$53,620,246&#160;</td><td align="right" valign="bottom">$8,276,625&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Convertible Preferred Stocks&#160;</td><td align="right" valign="bottom">2,812,326&#160;</td><td align="right" valign="bottom">--&#160;</td><td align="right" valign="bottom">--&#160;</td><td align="right" valign="bottom">2,812,326&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Money Market Funds&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">44,323,022&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">44,323,022&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">--&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">--&#160;</td>
</tr>
<tr>
<td style="font-weight: bold" valign="top">Total Investments in Securities:&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$2,689,104,657&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$2,624,395,460&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$53,620,246&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$11,088,951&#160;</td>
</tr>
</table>
<br/>
<p style="font: normal 10pt Arial, Helvetica, sans-serif;">The following is a summary of transfers between Level 1 and Level 2 for the period ended April 30, 2016. Transfers are assumed to have occurred at the beginning of the period, and are primarily attributable to the valuation techniques used for foreign equity securities, as discussed at the end of this section:</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="7" cellpadding="0" width="745">
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">Transfers&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Total&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Level 1 to Level 2&#160;</td><td align="right" valign="bottom">$45,480,783&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Level 2 to Level 1&#160;</td><td align="right" valign="bottom">$0&#160;</td>
</tr>
</table>
<br/>
<p>Investments are valued as of 4:00 p.m. Eastern time on the last calendar day of the period. Security transactions are accounted for as of trade date. The Board of Trustees (the Board) has delegated the day to day responsibility for the valuation of the Fund's investments to the Fidelity SelectCo, LLC (SelectCo) Fair Value Committee (the Committee). In accordance with valuation policies and procedures approved by the Board, the Fund attempts to obtain prices from one or more third party pricing vendors or brokers to value its investments. When current market prices, quotations or currency exchange rates are not readily available or reliable, investments will be fair valued in good faith by the Committee, in accordance with procedures adopted by the Board. Factors used in determining fair value vary by investment type and may include market or investment specific events. The frequency with which these procedures are used cannot be predicted and they may be utilized to a significant extent. The Committee oversees the Fund&#146;s valuation policies and procedures and reports to the Board on the Committee's activities and fair value determinations. The Board monitors the appropriateness of the procedures used in valuing the Fund's investments and ratifies the fair value determinations of the Committee. The Fund categorizes the inputs to valuation techniques used to value its investments into a disclosure hierarchy consisting of three levels: Level 1 - quoted prices in active markets for identical investments: Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds etc.): Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available). Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. Valuation techniques used to value the Fund's investments by major category are as follows:</p>
<p>Investments are valued as of 4:00 p.m. Eastern time on the last calendar day of the period. Security transactions are accounted for as of trade date. The Board of Trustees (the Board) has delegated the day to day responsibility for the valuation of the Fund's investments to the Fidelity Management &amp; Research Company (FMR) Fair Value Committee (the Committee). In accordance with valuation policies and procedures approved by the Board, the Fund attempts to obtain prices from one or more third party pricing vendors or brokers to value its investments. When current market prices, quotations or currency exchange rates are not readily available or reliable, investments will be fair valued in good faith by the Committee, in accordance with procedures adopted by the Board. Factors used in determining fair value vary by investment type and may include market or investment specific events. The frequency with which these procedures are used cannot be predicted and they may be utilized to a significant extent. The Committee oversees the Fund&#146;s valuation policies and procedures and reports to the Board on the Committee's activities and fair value determinations. The Board monitors the appropriateness of the procedures used in valuing the Fund's investments and ratifies the fair value determinations of the Committee. The Fund categorizes the inputs to valuation techniques used to value its investments into a disclosure hierarchy consisting of three levels: Level 1 - quoted prices in active markets for identical investments: Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds etc.): Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available). Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. Valuation techniques used to value the Fund's investments by major category are as follows:</p>
<p>Equity securities, including restricted securities, for which market quotations are readily available, are valued at the last reported sale price or official closing price as reported by a third party pricing vendor on the primary market or exchange on which they are traded and are categorized as Level 1 in the hierarchy. In the event there were no sales during the day or closing prices are not available, securities are valued at the last quoted bid price or may be valued using the last available price and are generally categorized as Level 2 in the hierarchy. For foreign equity securities, when market or security specific events arise, comparisons to the valuation of American Depositary Receipts (ADRs), futures contracts, Exchange-Traded Funds (ETFs) and certain indexes as well as quoted prices for similar securities may be used and would be categorized as Level 2 in the hierarchy. Utilizing these techniques may result in transfers between Level 1 and Level 2. For equity securities, including restricted securities, where observable inputs are limited, assumptions about market activity and risk are used and these securities may be categorized as Level 3 in the hierarchy.</p>
<p>Investments in open-end mutual funds, including the Fidelity Central Funds, are valued at their closing net asset value each business day and are categorized as Level 1 in the hierarchy.</p>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Other Information</p>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Income Tax Information</p>
<p>At April 30, 2016, the cost of investment securities for income tax purposes was $2,564,590,058. Net unrealized appreciation aggregated $124,514,599, of which $399,497,398 related to appreciated investment securities and $274,982,799 related to depreciated investment securities.</p>
<p>For additional information on the Fund's policy regarding valuation of investments and other significant accounting policies, please refer to the Fund's most recent semiannual or annual shareholder report.</p>
<br/>
<br/>
<br/>
<br/>
<p style="font-style: italic;">
</p><p style="font-style: italic;">The fund's schedule of investments as of the date on the cover of this report has not been audited. This report is provided for the general information of the fund's shareholders. For more information regarding the fund and its holdings, please see the fund's most recent prospectus and annual report.</p>

<p style="font-style: italic;">
</p><p style="font-style: italic;">Third party trademarks and service marks are the property of their respective owners. All other trademarks and service marks are the property of FMR LLC or an affiliate.</p>

<hr size="2" noshade="noshade"/>
</div>
<div style="width:576px"><p style="margin:0px"><br/></p>
<p style="margin-top:0px; margin-bottom:-2px; width:96px; font-size:12pt; float:left">Item 2.</p>
<p style="margin:0px; text-indent:-2px; font-size:12pt"><u>Controls and Procedures</u></p>
<p style="margin:0px; clear:left"><br/></p>
<p style="margin:0px; font-size:12pt">(a)(i) &#160;The President and Treasurer and the Chief Financial Officer have concluded that the Fidelity Advisor Series VII<font style="font-family:Arial Unicode MS,Times New Roman">&#8217;</font>s (the <font style="font-family:Arial Unicode MS,Times New Roman">&#8220;</font>Trust<font style="font-family:Arial Unicode MS,Times New Roman">&#8221;</font>) disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act) provide reasonable assurances that material information relating to the Trust is made known to them by the appropriate persons, based on their evaluation of these controls and procedures as of a date within 90 days of the filing date of this report.</p>
<p style="margin:0px"><br/></p>
<p style="margin:0px; font-size:12pt">(a)(ii) &#160;There was no change in the Trust<font style="font-family:Arial Unicode MS,Times New Roman">&#8217;</font>s internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act) that occurred during the Trust<font style="font-family:Arial Unicode MS,Times New Roman">&#8217;</font>s last fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Trust<font style="font-family:Arial Unicode MS,Times New Roman">&#8217;</font>s internal control over financial reporting.</p>
<p style="margin:0px"><br/></p>
<p style="margin:0px"><br/>
<br/></p>
<p style="page-break-before:always;margin-top:0;margin-bottom:-4pt;font-size:4pt"/><p style="margin-top:0px; margin-bottom:-2px; width:96px; font-size:12pt; float:left">Item 3.</p>
<p style="margin:0px; text-indent:-2px; font-size:12pt"><u>Exhibits</u></p>
<p style="margin:0px; clear:left"><br/></p>
<table style="margin-top:0px; font-size:10pt" cellpadding="0" cellspacing="0"><tr height="0" style="font-size:0"><td width="499.2"/></tr>
<tr><td style="margin-top:0px" valign="top" width="499.2" height="29"><p style="margin:0px; font-size:12pt">Certification pursuant to Rule 30a-2(a) under the Investment Company Act of 1940 (17 CFR 270.30a-2(a)) is filed and attached hereto as Exhibit 99.CERT.</p>
</td></tr>
</table>
<p style="margin:0px" align="center"><br/></p>
<p style="margin:0px" align="center"><br/>
<br/></p>
<p style="margin:0px; font-size:12pt; page-break-before:always" align="center">SIGNATURES</p>
<p style="margin:0px"><br/></p>
<p style="margin:0px; font-size:12pt">Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</p>
<p style="margin:0px"><br/></p>
<p style="margin:0px; font-size:12pt">Fidelity Advisor Series VII</p>
<p style="margin:0px"><br/></p>
<p style="margin:0px"><br/></p>
<table style="margin-top:0px; font-size:10pt" cellpadding="0" cellspacing="0"><tr height="0" style="font-size:0"><td width="147.6"/><td width="219.6"/></tr>
<tr><td style="margin-top:0px" valign="top" width="147.6"><p style="margin:0px; font-size:12pt">By:</p>
</td><td style="margin-top:0px" valign="top" width="219.6"><p style="margin:0px; font-size:12pt"><u>/s/Adrien E. Deberghes</u></p>
</td></tr>
<tr><td style="margin-top:0px" valign="top" width="147.6"><p style="margin:0px"><br/></p>
</td><td style="margin-top:0px" valign="top" width="219.6"><p style="margin:0px; font-size:12pt">Adrien E. Deberghes</p>
</td></tr>
<tr><td style="margin-top:0px" valign="top" width="147.6"><p style="margin:0px"><br/></p>
</td><td style="margin-top:0px" valign="top" width="219.6"><p style="margin:0px; font-size:12pt">President and Treasurer</p>
</td></tr>
<tr><td style="margin-top:0px" valign="top" width="147.6"><p style="margin:0px"><br/></p>
</td><td style="margin-top:0px" valign="top" width="219.6"><p style="margin:0px"><br/></p>
</td></tr>
<tr><td style="margin-top:0px" valign="top" width="147.6"><p style="margin:0px; font-size:12pt">Date:</p>
</td><td style="margin-top:0px" valign="top" width="219.6"><p style="margin:0px; font-size:12pt">June 28, 2016</p>
</td></tr>
</table>
<p style="margin:0px"><br/></p>
<p style="margin:0px; font-size:12pt">Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.</p>
<p style="margin:0px"><br/></p>
<p style="margin:0px"><br/></p>
<table style="margin-top:0px; font-size:10pt" cellpadding="0" cellspacing="0"><tr height="0" style="font-size:0"><td width="151.2"/><td width="216"/></tr>
<tr><td style="margin-top:0px" valign="top" width="151.2"><p style="margin:0px; font-size:12pt">By:</p>
</td><td style="margin-top:0px" valign="top" width="216"><p style="margin:0px; font-size:12pt"><u>/s/Adrien E. Deberghes</u></p>
</td></tr>
<tr><td style="margin-top:0px" valign="top" width="151.2"><p style="margin:0px"><br/></p>
</td><td style="margin-top:0px" valign="top" width="216"><p style="margin:0px; font-size:12pt">Adrien E. Deberghes</p>
</td></tr>
<tr><td style="margin-top:0px" valign="top" width="151.2"><p style="margin:0px"><br/></p>
</td><td style="margin-top:0px" valign="top" width="216"><p style="margin:0px; font-size:12pt">President and Treasurer</p>
</td></tr>
<tr><td style="margin-top:0px" valign="top" width="151.2"><p style="margin:0px"><br/></p>
</td><td style="margin-top:0px" valign="top" width="216"><p style="margin:0px"><br/></p>
</td></tr>
<tr><td style="margin-top:0px" valign="top" width="151.2"><p style="margin:0px; font-size:12pt">Date:</p>
</td><td style="margin-top:0px" valign="top" width="216"><p style="margin:0px; font-size:12pt">June 28, 2016</p>
</td></tr>
</table>
<p style="margin:0px"><br/></p>
<p style="margin:0px"><br/></p>
<table style="margin-top:0px; font-size:10pt" cellpadding="0" cellspacing="0"><tr height="0" style="font-size:0"><td width="151.2"/><td width="216"/></tr>
<tr><td style="margin-top:0px" valign="top" width="151.2"><p style="margin:0px; font-size:12pt">By:</p>
</td><td style="margin-top:0px" valign="top" width="216"><p style="margin:0px; font-size:12pt"><u>/s/Howard J. Galligan III</u></p>
</td></tr>
<tr><td style="margin-top:0px" valign="top" width="151.2"><p style="margin:0px"><br/></p>
</td><td style="margin-top:0px" valign="top" width="216"><p style="margin:0px; font-size:12pt">Howard J. Galligan III</p>
</td></tr>
<tr><td style="margin-top:0px" valign="top" width="151.2"><p style="margin:0px"><br/></p>
</td><td style="margin-top:0px" valign="top" width="216"><p style="margin:0px; font-size:12pt">Chief Financial Officer</p>
</td></tr>
<tr><td style="margin-top:0px" valign="top" width="151.2"><p style="margin:0px"><br/></p>
</td><td style="margin-top:0px" valign="top" width="216"><p style="margin:0px"><br/></p>
</td></tr>
<tr><td style="margin-top:0px" valign="top" width="151.2"><p style="margin:0px; font-size:12pt">Date:</p>
</td><td style="margin-top:0px" valign="top" width="216"><p style="margin:0px; font-size:12pt">June 28, 2016</p>
</td></tr>
</table>
<p style="margin:0px; font-size:12pt">&#160;</p>
<p style="margin:0px"><br/></p>
<p style="margin:0px"><br/></p>
<p style="margin:0px"><br/>
<br/></p>
</div>


</text>
</description></filename></sequence></type></document>
</body>                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   ="219.6"><p style="margin:0px; font-size:12pt">President and Treasurer</p>
</td></tr>
<tr><td style="margin-top:0px" valign="top" width="147.6"><p style="margin:0px"><br/></p>
</td><td style="margin-top:0px" valign="top" width="219.6"><p style="margin:0px"><br/></p>
</td></tr>
<tr><td style="margin-top:0px" valign="top" width="147.6"><p style="margin:0px; font-size:12pt">Date:</p>
</td><td style="margin-top:0px" valign="top" width="219.6"><p style="margin:0px; font-size:12pt">December 29, 2016</p>
</td></tr>
</table>
<p style="margin:0px"><br/></p>
<p style="margin:0px; font-size:12pt">Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.</p>
<p style="margin:0px"><br/></p>
<p style="margin:0px"><br/></p>
<table style="margin-top:0px; font-size:10pt" cellpadding="0" cellspacing="0"><tr height="0" style="font-size:0"><td width="151.2"/><td width="216"/></tr>
<tr><td style="margin-top:0px" valign="top" width="151.2"><p style="margin:0px; font-size:12pt">By:</p>
</td><td style="margin-top:0px" valign="top" width="216"><p style="margin:0px; font-size:12pt"><u>/s/Adrien E. Deberghes</u></p>
</td></tr>
<tr><td style="margin-top:0px" valign="top" width="151.2"><p style="margin:0px"><br/></p>
</td><td style="margin-top:0px" valign="top" width="216"><p style="margin:0px; font-size:12pt">Adrien E. Deberghes</p>
</td></tr>
<tr><td style="margin-top:0px" valign="top" width="151.2"><p style="margin:0px"><br/></p>
</td><td style="margin-top:0px" valign="top" width="216"><p style="margin:0px; font-size:12pt">President and Treasurer</p>
</td></tr>
<tr><td style="margin-top:0px" valign="top" width="151.2"><p style="margin:0px"><br/></p>
</td><td style="margin-top:0px" valign="top" width="216"><p style="margin:0px"><br/></p>
</td></tr>
<tr><td style="margin-top:0px" valign="top" width="151.2"><p style="margin:0px; font-size:12pt">Date:</p>
</td><td style="margin-top:0px" valign="top" width="216"><p style="margin:0px; font-size:12pt">December 29, 2016</p>
</td></tr>
</table>
<p style="margin:0px"><br/></p>
<p style="margin:0px"><br/></p>
<table style="margin-top:0px; font-size:10pt" cellpadding="0" cellspacing="0"><tr height="0" style="font-size:0"><td width="151.2"/><td width="216"/></tr>
<tr><td style="margin-top:0px" valign="top" width="151.2"><p style="margin:0px; font-size:12pt">By:</p>
</td><td style="margin-top:0px" valign="top" width="216"><p style="margin:0px; font-size:12pt"><u>/s/Howard J. Galligan III</u></p>
</td></tr>
<tr><td style="margin-top:0px" valign="top" width="151.2"><p style="margin:0px"><br/></p>
</td><td style="margin-top:0px" valign="top" width="216"><p style="margin:0px; font-size:12pt">Howard J. Galligan III</p>
</td></tr>
<tr><td style="margin-top:0px" valign="top" width="151.2"><p style="margin:0px"><br/></p>
</td><td style="margin-top:0px" valign="top" width="216"><p style="margin:0px; font-size:12pt">Chief Financial Officer</p>
</td></tr>
<tr><td style="margin-top:0px" valign="top" width="151.2"><p style="margin:0px"><br/></p>
</td><td style="margin-top:0px" valign="top" width="216"><p style="margin:0px"><br/></p>
</td></tr>
<tr><td style="margin-top:0px" valign="top" width="151.2"><p style="margin:0px; font-size:12pt">Date:</p>
</td><td style="margin-top:0px" valign="top" width="216"><p style="margin:0px; font-size:12pt">December 29, 2016</p>
</td></tr>
</table>
<p style="margin:0px; font-size:12pt">&#160;</p>
<p style="margin:0px"><br/></p>
<p style="margin:0px"><br/></p>
<p style="margin:0px"><br/>
<br/></p>
</div>


</text>
</description></filename></sequence></type></document>
</body>